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QUILL ON SCALPEL
Pelvic Ring Fractures
J.P. Waddell, MD, FRCSC
Member, Editorial Board, Canadian Journal o f Surgery. Professor o f  Surgery, University o f 
Toronto, Division o f  Orthopedics, St. Michael's Hospital, Toronto, Ont.
Severe injury to the pelvic ring has long been recognized as a 
cause of early morbidity and mortal­
ity in traumatized patients. Pelvic 
fractures are often complicated by 
associated visceral and neurologic 
injury and serious retroperitoneal 
hemorrhage. Patients who survive 
the initial injury often have long­
term problems associated with the 
pelvic injury, such as persistent 
visceral dysfunction, pelvic deformi­
ty and pain.
With experience, orthopedic and 
trauma surgeons have learned that 
the immediate fixation of long-bone 
fractures substantially improves the 
prognosis for the multiply injured 
patient. This is also becoming evi­
dent in the case of pelvic fractures. 
The benefit derived from immediate 
fixation of pelvic fractures has 
greatly enhanced the effectiveness 
of the initial resuscitation of trau­
matized patients.
In this issue (pages 447 to 450)
O’Brien presents the rationale for 
immediate fixation of pelvic frac­
tures in the multiply injured patient 
to help control blood loss and dis­
comfort and to permit better nurs­
ing care. McLaren, Rorabeck and 
Halpenny (pages 492 to 494) dem­
onstrate unequivocally that anatom­
ic reduction and sound healing of 
displaced posterior pelvic ring inju­
ries will result in a better long-term 
outcome for patients with pelvic 
ring disruption. Therefore, there
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are compelling reasons to consider 
improved methods of obtaining re­
duction and securing fixation of 
these fractures.
Long neglected as a fracture for 
which no form of active treatment 
was possible, pelvic fractures have 
been given low priority in the man­
agement of the polytraumatized pa­
tient. As understanding of the pos­
sibility of controlling the acute 
symptoms and preventing late com­
plications has improved, aggressive 
management of pelvic trauma has 
become the norm in many trauma 
centres. In patients whose pelvic 
trauma appears to be associated 
with hemorrhage, I recommend a 
trial application of the pneumatic 
antishock garment (PASG). We use 
this in our hospital as an emergen­
cy method of managing pelvic trau­
ma because it stabilizes the pelvis 
and permits patients to be trans­
ferred from the emergency room to 
the radiology department and to the 
operating room rapidly and with a 
minimum of difficulty.
At St. Michael’s Hospital we tend 
to follow the recommendation of 
McLaren’s group: an anterior exter­
nal fixator is applied as definitive 
management of the pelvic fracture 
on the day of injury; open reduction 
with internal fixation of the pos­
terior injury is carried out later if 
necessary. Although we recognize 
that some patients with multiple 
injuries will not be able to return to 
the operating room for days or 
weeks because of their other inju­
ries, we believe that the immediate 
problem with pelvic fractures lies in 
a lack of stabilization and not lack 
of anatomic reduction. Therefore, in 
our opinion, the risk of increased 
hemorrhage and the prolonged 
anesthetic time that results from 
immediate open reduction and inter­
nal fixation of such injuries out­
weighs the potential benefits of 
early anatomic stabilization, despite 
O’Brien’s claims to the contrary.
The following sequential steps in 
management might be deduced 
from these two papers.
•  Identification of the pelvic 
fracture as the most important 
cause of ongoing hemorrhage in 
traumatized patients.
•  Immediate stabilization of the 
pelvic fracture with a PASG to 
assist in hemodynamic stabilization 
and patient transfer. The garment 
should not be left inflated for lon­
ger than 1 hour. Improved hemody­
namic status secondary to pelvic 
stabilization with the PASG demon­
strates that the pelvic fracture is 
the cause of ongoing hemorrhage.
•  Stabilization of the fracture by 
the application of an anterior frame
without delay. Definitive open re­
duction and internal fixation can be 
carried out on the day of injury if it 
does not necessitate prolonged an­
esthesia or increase the risk of 
hemorrhage and is technically pos­
sible. If not, the use of an anterior 
fixation frame should be instituted 
and continued until anatomic reduc­
tion and internal fixation of the 
posterior injury are feasible.
Active, aggressive management 
of pelvic fractures will decrease 
both the morbidity and mortality in 
polytrauma patients. To be success­
ful, treatment depends on a thor­
ough understanding of pelvic anato­
my, fracture classification and sur­
gical technique.*
SESAP VI Question
Item 125
A 40-year-old man is admitted after being pinned under a steel beam. A 
severe unstable pelvic fracture is the only injury. He is given 10 units of 
blood during the first 4 hours of hospitalization, but his hematocrit 
remains 20%. His blood pressure is 90/60 and pulse is 120. The next 
step in management should be
(A) continued transfusion only
(B) arterial embolization of internal iliac arteries
(C) celiotomy to oversew bleeding vessel
(D) embolization of pelvic veins
(E) placement of an external pelvic fixation device
For the incomplete statement above select the best of the five 
completions.
For the critique of Item 125 see page 498.
(Reproduced by permission from SESAP VI Syllabus; Surgical Educa­
tion and Self-Assessment Program No. 6. For enrolment in Surgical 
Education and Self-Assessment No. 6, please apply to the American 
College of Surgeons, 55 East Erie St., Chicago, IL 60611.)
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Laparoscopic Cholecystectomy 
Fantastic?
N. Schmidt, MD, FRCSC
Member, Editorial Board, Canadian Journal o f  Surgery. Clinical professor, Department o f  
Surgery, University o f British Columbia, Vancouver, BC
Six months ago I offered the following words of wisdom: 
“ there are not enough facilities, 
resources or ‘superlaparoscopists’ 
available for all centres to offer all 
possible treatments to all biliary 
tract sufferers” .1 I was trying to 
suggest that change in biliary tract 
management is moving so fast that 
general surgeons will lose out un­
less they step firmly into the centre 
o f the biliary tract mosaic. General 
surgeons must take an increased 
interest in all aspects of biliary tract 
management, otherwise even the 
ordinary cholecystectomy will disap­
pear from their slate of operative 
procedures.
Laparoscopy as a diagnostic pro­
cedure dates back at least to 1937.2 
A surgical technique well developed 
by gynecologists for use in the 
abdomen and female pelvis, it has 
been used extensively by only a few 
general surgeons who have found it 
valuable in abdominal diagnosis and 
treatment.3 Apart from peritoneal 
visualization, lysis of adhesions, the 
occasional removal of an appendix 
and biopsy for primary and second­
ary tumours, little imagination was 
given to other possible uses. Scant 
attention was paid to the idea of 
removing the gallbladder in this 
manner until Reddick and col­
leagues published their initial clini­
cal experience, a series of five pa­
tients.4 Only a few months before 
Perissat had described the French
experience in a short clinical pre­
sentation at the International Surgi­
cal Society meeting in Toronto 
(September 1988). Following these 
descriptions ideas in laparoscopic 
surgery swept the world through 
publications, videotapes, news re­
ports and training programs. Gener­
al surgeons are queuing up for 
training courses in laparoscopic 
cholecystectomy all over North 
America. Some centres are reaping 
large financial rewards and even 
surgical politics and turf issues are 
not far behind. General surgeons 
dare not remain skeptical if they 
wish to continue to manage pa­
tients with gallbladder problems.
New advances and procedures in 
the field of general surgery come 
infrequently. This technique is a 
refreshing innovation and is largely 
the result of advances in technolo­
gy, allowing the procedure to be 
done with safe disposable laparo­
scopic trochars and disposable, mul­
tiple-use endoclipping devices. Best 
of all, clear, high-resolution video­
cameras and videoscopes offer a 
view of the gallbladder and its duc­
tal and arterial anatomy never seen 
before. With practice, the initial 
uncomfortable eye-hand coordina­
tion required to operate by indirect 
videoviewing eases. With care, a 
satisfying cholecystectomy using 
cautery or laser dissection and clip­
ping of structures allows the deliv­
ery of the gallbladder through a
small stab wound in the abdominal 
wall. This is all done with or with­
out operative cholangiography. 
When patients awaken from anes­
thesia they often require only mild 
oral analgesia and can usually be 
discharged from hospital the follow­
ing morning, having made a very 
easy recovery from a procedure 
whose duration averages 90 min­
utes. Compared with the standard 5 
to 7 days in hospital, a large inci­
sion and 4 to 6 weeks’ recupera­
tion, it is no wonder that most 
patients requiring cholecystectomy 
are now inquiring about and re­
questing the laparoscopic proce­
dure.
Is laparoscopic cholecystectomy 
really so simple and are there risks 
and contraindications to the proce­
dure? The indications for the proce­
dure are the same as for standard 
cholecystectomy. Relative contrain­
dications relate to the operating 
team’s experience and will include 
acute cholecystitis, jaundice, cirrho­
sis, pancreatitis, obesity, pregnancy, 
past surgical procedures to the ab­
domen, chronicity, fibrous contrac­
ture of the gallbladder and cardiac 
and respiratory insufficiency. Oper­
ative cholangiography is possible, 
but bile-duct exploration is not. 
Bile-duct stones, if present, can be 
treated by biliary lithotripsy, endo­
scopic retrograde cholangiopan- 
creatographic papillotomy or percu­
taneous transhepatic approaches to
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the biliary tree. The patient must be 
informed of the same possible risks 
and complications as open cholecys­
tectomy and of the possible need to 
“convert” the procedure to an open 
operation. Problems of bleeding 
have occurred, necessitating open 
laparotomy for control. Common 
bile ducts have been injured as a 
result of anatomical obscurity and 
tenting of the duct with gallbladder 
retraction (Canadian Laparoscopic 
Surgery Interest Group: Unpub­
lished data, 1990). The risk of these 
problems diminishes with experi­
ence, but great care must always be 
taken, especially in the early part of 
the surgeon’s learning curve. Confi­
dence with the technique rises with 
the number of procedures per­
formed, but 20 to 30 procedures 
are considered necessary before the 
surgeon extends the indications to 
include more complicated gallblad­
der disease.
Who should be offering this op­
eration and how does one obtain 
the training? The Canadian Associa­
tion of General Surgeons (CAGS) 
has suggested qualifications for 
granting privileges to general sur­
geons wanting to practise laparo­
scopic cholecystectomy. These 
guidelines are spelled out in the 
editorial “Laparoscopic cholecystec­
tomy: let us control the virus” in 
this issue of the journal (pages 435 
and 436).
If the CAGS guidelines are fol­
lowed experience with diagnostic 
pelvic laparoscopy alone is not suf­
ficient qualification. Nonsurgeons 
experienced with endoscopic proce­
dures are not qualified. Laparoscop­
ic surgical skills are not the same as 
endoscopic skills, although there is 
certainly a transfer of coordination 
from doing colonic polypectomies
to the eye-hand coordination of 
laparoscopic cholecystectomy.
To obtain training for this new 
procedure, general surgical resi­
dents are learning the technique as 
the operation becomes increasingly 
available and popular. Practising 
general surgeons are learning the 
technique in the United States and 
Europe, until Canadian training 
programs become established at 
university centres across the coun­
try.
The impact of this new approach 
on cholecystectomy is obvious. 
Hundreds of laparoscopic cholecys­
tectomies are being done in the US 
as day-care and overnight-stay am­
bulatory procedures. It is becoming 
the standard procedure for the 
treatment of chronic cholecystitis. 
About 75% of patients who are 
referred have indications for the 
procedure and, of these, 95% under­
go the procedure, with a conversion 
rate of 5% to open cholecystectomy 
(Zucker KA: Personal communica­
tion, 1990). Surgeons in the US 
perform four to five laparoscopic 
cholecystectomies per day and have 
the instruments, operating-room 
time and assistants to do so. The 
procedure has reduced the cost of 
hospital stay and the turnover rate 
to the surgeons’ economic advan­
tage. In Canada the evolution of the 
procedure will be different. With 
the limitations presently evident in 
the Canadian health care system of 
operating room time, ambulatory 
care space, instrument availability 
and high cost to the hospital bud­
get for the first 48 hours of surgi­
cal care, there is no enthusiasm for 
doing four to five laparoscopic 
cholecystectomies daily. Perfor­
mance of this many procedures in 1 
week has already caused the admin­
istration in one hospital to limit the 
rate and number of procedures. In 
smaller community hospitals sur­
geons may have to team up to do 
their procedures since two or three 
operators are required. In single­
surgeon communities, this proce­
dure may not be feasible at all, 
resulting in gallbladder surgery 
going to larger centres. Already the 
waiting list is growing as people put 
off the standard procedure until the 
“new operation” is available. With 
the decreased morbidity of this pro­
cedure additional patients with only 
minor gallbladder symptoms, who 
had decided against the standard 
procedure, may now also be added 
to the list.
So it appears that the excitement 
and enthusiasm for this new ap­
proach to gallbladder treatment 
with all its advantages and possibili­
ties may open new complexities in 
delivering that surgical care. The 
problem of not enough “super- 
laparoscopists” may not be the lim­
iting factor after all. The con­
straints of a rationed health care 
system may confound us in new 
ways to thwart what appears to be a 
fast, expedient and safe advance in 
treating gallbladder disease. This 
new approach is fantastic, let’s get 
on with it.
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QUILL ON SCALPEL
Laparoscopic Cholecystectomy: 
Let Us Control the Virus
Roger G. Keith, MD, FRCSC
Secretary, Canadian Association o f  General Surgeons. Member, Editorial Board, Canadian 
Journal o f  Surgery. Professor and chairman, Department o f Surgery, University o f  
Saskatchewan, Saskatoon, Sask.
The virus of laparoscopic chole­cystectomy has become epi­
demic in its uncontrolled spread 
throughout North America. The 
promotion of this new technique as 
a panacea for cholecystitis is direct­
ly attributable to intense commer­
cial profiteering, surgical entrepre­
neurship and, not least, patient de­
mand as a result of descriptions in 
nonscientific publications.
Commercial interest in the non­
scientific introduction of this tech­
nique to the surgeons of North 
America was demonstrated at the 
recent annual meeting of the Ameri­
can College of Surgeons, attended 
by more than 10 000 specialists and 
trainees. In an unprecedented man­
ner, the overwhelming singular 
theme advertised throughout the 
30 000 m2 of commercial exhibit 
space was the unofficial statement 
that the future of general surgery is 
laparoscopic cholecystectomy — 
purchase equipment, be trained or 
fall behind scientifically and finan­
cially.
At the same meeting scientific 
presentations were delivered by ex­
perienced innovators of the tech­
nique, and a postgraduate course 
was devoted to the subject. Over­
subscription and attendance exceed­
ing space availability exemplified 
the response of surgeons over the 
past 15 months.
Training programs for surgical 
specialties in Canada are controlled 
by university departments of sur­
gery, with approval for accredita­
tion designated by the Royal Col­
lege of Physicians and Surgeons of
Canada, which then conducts certi­
fying examinations based on nation­
ally approved guidelines. National 
specialty societies have contributed 
to guidelines or modified training 
programs through structured rela­
tions with the Royal College. In 
general surgery, this has been the 
case with gastrointestinal endos­
copy, general surgical oncology, co­
lonic and rectal surgery and critical 
care; this valuable working arrange­
ment between the Canadian Associ­
ation of General Surgeons (CAGS) 
and the Royal College will likely 
continue.
With this background of repre­
sentation of the interests of general 
surgeons in Canada, the Board and 
Advisory Council of the CAGS ap­
proved the following guidelines for 
laparoscopic cholecystectomy at its 
annual meeting in Toronto, Septem­
ber 1990.
•  Only general surgeons experi­
enced with open cholecystectomy 
and management of its potential 
complications should perform lapa­
roscopic cholecystectomy.
•  Laparoscopy should be 
learned through appropriate in­
struction.
•  The individual should have 
completed and experienced super­
vised performance in a structured 
course of a laparoscopic program 
that includes laparoscopic cholecys­
tectomy. The individual must ob­
serve and take part in the perfor­
mance of the procedure in humans 
with individuals already fully experi­
enced.
•  The training programs in lapa­
roscopic cholecystectomy must be 
developed and located in university 
centres throughout Canada and 
should be coordinated through the 
surgical chairmen or the general 
surgical division chairmen. The 
CAGS endoscopy committee would 
be available for resource purposes.
•  Training for laparoscopic cho­
lecystectomy should be available to 
all interested general surgeons.
The CAGS has a unique advan­
tage over surgical societies and as­
sociations in the United States: 
statements of policy may be accept­
ed for integration into guidelines of 
bodies responsible for training, ac­
creditation and licensure in Canada. 
This is not the case in the US and 
recently has become a problem fac­
ing respected specialty societies, 
which have developed policy and 
guidelines but cannot control the 
problem of self-certification by indi­
vidual experts or interest groups 
not having official sanction from 
university departments of surgery 
or from national examining boards 
whose vested interest is in the train­
ing and accreditation of surgical 
specialists.
History will confirm that the 
basis for sound development of 
principles and techniques in the 
practice of medicine and surgery 
has been the application of the 
scientific method. Surgical educa­
tion is based on the graduated 
acquisition of knowledge and skills 
in a structured program at an aca­
demic centre. The duration of train­
ing has been extended in Canada 
and the US because of the complex-
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ities of new therapies constantly 
being introduced to various special­
ties. Criteria for determining com­
petence are examined and reviewed 
regularly by bodies responsible for 
certification and licensure.
Never before has commercialism 
and entrepreneurship undermined 
the process of surgical specializa­
tion or the acquisition of surgical 
skills. Surely, 72 hours of surgical 
instruction with a pig model by a 
paid surgical tutor without privilege 
of accredited certification cannot 
constitute training to a level of 
competence. Ideally, hospital cre­
dentials committees will recognize 
that equipment acquisition alone 
does not imply competence in lapa­
roscopic cholecystectomy.
Is there justification for this ex­
pression of concern over the proc­
ess of training and credentialing? 
The recorded opinion at the Ameri­
can College of Surgeons meeting of 
the internationally acknowledged 
authority Dr. William P. Longmire, 
Jr., urged reservation and conserva­
tism in the current approach to 
laparoscopic cholecystectomy. A re­
cent editorial by Cuschieri, Berci 
and McSherry1 supported the con­
cept of restraint and adequate train­
ing with reference to organizations 
establishing guidelines and accredi­
tation for the procedure.
Current documentation in the US 
indicates an increasing incidence of 
surgical injuries as the number of 
laparoscopic interventionists esca­
lates. Deaths resulting from laparo­
scopic cholecystectomy in several 
states have resulted in legislators 
curtailing this procedure in one 
southwestern state. It would be 
unacceptable if a promising tech­
nique became limited in application 
through the action of regulatory 
bodies and the profession was prov­
en indefensible because of a lack of 
acceptable training guidelines and a 
credentialing process. The CAGS 
has provided guidelines upon which
university departments of surgery 
can develop programs for accredited 
training of residents and postcer­
tification trainees. The process will 
be restricted initially by the develop­
ment of academic programs and the 
availability of equipment. Neverthe­
less, the delays should not consti­
tute justification for inadequate 
training and the acquisition of per­
formance-limiting materials.
The specialty of general surgery 
encompasses biliary and gastroin­
testinal surgery. Capable manage­
ment includes open surgery, endos­
copy, interventional techniques in­
cluding percutaneous image-guided 
diagnostics and therapeutics, and 
diagnostic and therapeutic laparos­
copy. Newer methods will certainly
develop in this era of advancing 
scientific technology. The special­
ist’s responsibility is to maintain 
competence, enhance performance, 
demonstrate sound judgement and 
deliver safe, effective therapy. Spe­
cialty societies and the Royal Col­
lege in Canada are dedicated to 
enabling the individual specialist to 
achieve the goals required, through 
defined and coordinated regulations 
available as resources to members 
and fellows.
Reference
1. Cuschieri A, Berci G, McS herry CK: 
Laparoscopic cholecystectomy (E). Am J 
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Canadian Association of General Surgeons 
Resident Research Award
The Canadian Surgical Research Fund will award a prize to the resident in 
general surgery submitting the best research paper.
Prize
1) Return Airfare, hotel expenses, and a per-diem allowance to present the work 
at the Annual Meeting of the Canadian Association of General Surgeons to be held 
in conjunction with the Annual Meeting of the Royal College of Physicians and 
Surgeons of Canada, Quebec, Quebec, Sept. 20-23, 1991.
2) $500.
Eligibility
Any resident or fellow in general surgery. The research must have been performed 
during surgical training at a Canadian medical school.
Abstract and Brief Description
An abstract must be submitted to the Royal College, but CAGS must be 
designated as the first choice for presentation. The abstract must be accompanied 
by a brief expanded description of the work performed. This should be a 
maximum of two double-spaced pages and include the following headings: Title, 
Introduction, Materials and Methods, Results and Discussion. Applicants must also 
submit a letter confirming their status as a resident or fellow and indicating 
that the work is submitted for the resident research award competition.
Deadline
Feb. 27, 1991.
Inquiries should be addressed to:
Dr. Gerald M. Fried
Chairman, CAGS Research Committee 
Montreal General Hospital 
1650 Cedar Avenue, #  9863 
Montreal, Quebec H3G 1A4
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CORRESPONDENCE
Perforated Sigmoid 
Diverticulum Occurring 
After Surgery
To the editors. In a recent issue of 
this journal (Can J Surg 1989; 32: 
370-372) Voitk and Mustard re­
ported on three patients who suf­
fered perforation in sigmoid diver­
ticula after unrelated surgical pro­
cedures. The authors invited other 
colleagues to report similar cases in 
an attempt to identify any common 
factors, to estimate the prevalence 
of this complication and to alert 
clinicians to its occurrence.
We recently treated a similar 
case.
Case Report
An obese 66-year-old woman pre­
sented with acute pain in the left 
iliac fossa. Physical examination re­
vealed a pelviabdominal mass. Two 
years earlier she had undergone 
total abdominal hysterectomy for 
uterine bleeding secondary to fi­
broids.
Ultrasonography suggested the 
presence of a left ovarian cyst. At 
laparotomy an 8-cm thin-walled 
lymphocele was found; the fluid 
was drained and part of the wall 
excised. The ovaries appeared nor­
mal and were preserved.
For 5 days her recovery was 
smooth, but on day 6 she had 
abdominal distension and tender­
ness and was vomiting. A plain film 
of the abdomen showed increased 
gas in both the small and large 
bowel, suggesting abdominal ileus. 
She was treated conservatively. By 
day 9, the abdominal distension was
more pronounced, and her leuko­
cyte count was 47 X 109/L. Perito­
nitis was diagnosed.
At laparotomy, fecal peritonitis 
was found. There was a perforated 
diverticulum in an area of acutely 
inflamed sigmoid colon. Peritoneal 
toilet and a Hartmann resection 
were done.
The patient’s recovery was de­
layed by a wound infection.
B.N. Nathan, FRCS, FRCS(Edin)
Surgical registrar
0. Awar, FRCS(Edin)
Surgical registrar
R.D.C. Southcott. FRCS
Consultant surgeon
Department o f Surgery.
Mayday University Hospital,
Croydon,
Surrey CR4 7YE 
UK
Laparoscopic
Cholecystectomy
To the editors. Laparoscopic chole­
cystectomy has become an impor­
tant tool in the treatment of choleli­
thiasis. Over the last 3 months we 
have treated 36 patients using this 
technique, with no complications. 
Two patients had subacute chole­
cystitis, 1 had a hydrops of the 
gallbladder and 33 had chronic 
cholecystitis. We treated overweight 
and thin patients. Many did not 
require analgesia postoperatively. 
All patients recovered promptly and 
were discharged within 3 days of 
surgery, most of them on the sec­
ond postoperative day.
We prefer this technique to stan­
dard open cholecystectomy in most 
patients, with the exception of 
those who are morbidly obese, have 
scars in the upper abdomen from 
previous surgery or have severe 
acute cholecystitis on echography 
and clinical examination. We have 
performed the procedure in patients 
who had had surgery for appendici­
tis or had infraumbilical midline 
incisions from a hysterectomy.
We do not perform operative cho­
langiography at present because we 
cannot remove common-duct stones 
by laparoscopy. When preoperative 
liver function tests or echography 
of the biliary tree suggest a possible 
common-duct stone, retrograde 
cholangiography is performed be­
fore the laparoscopic cholecystecto­
my and stones extracted if neces­
sary. If symptoms of choledocholi- 
thiasis develop after laparoscopic 
cholecystectomy, retrograde cho­
langiography is performed with 
stone extraction. All patients are 
informed about the procedure by 
the physician and by a special con­
sent form that describes the tech­
nique, the potential benefits and the 
possible complications of laparo­
scopic cholecystectomy.
There is a definite learning curve 
associated with this new technique. 
Our operative time has decreased 
from more than 2 hours to little 
over 1 hour. Laparoscopy is now a 
necessary tool in the surgeon’s ar- 
mentarium.
Yves-Marie Dion, MD, MSc, FRCSC 
Jacques Morin, MD, FRCSC
Hopital St-Frangois d ’Assise,
Universite Laval,
10, rue de I ’Espinay,
Quebec. Que 
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Update on Trauma Care in Canada 
1. Recent Advances in Thermal Injuries
Edward E. Tredget, MD, MSc, FRCSC
Thermal injury frequently occurs in traumatized patients in North America and 
causes serious morbidity and mortality, predominantly to children and young adults. 
Over the past decade, considerable technologic advances have improved survival 
after burn injury. Ongoing research coupled with current surgical advances in 
equipment, technique, early wound closure and alternative forms of wound coverage 
offer the potential for greater survival with enhanced quality of life for traumatized 
patients with burn injuries. However, sepsis and inhalation injury remain important 
ongoing causes of death, for which the understanding and solutions appear to be 
unfolding as research into the multisystem effects of the inflammatory process 
continues.
Les brulures sont frequentes chez les victimes d’accidents en Amerique du Nord. 
Elies sont la cause d’une morbidity et d’une mortalite serieuses, principalement chez 
les enfants et chez jeunes adultes. Au cours de la derniere decennie, des progres 
technologiques importants ont permis d’ameliorer la survie des brules, et la 
recherche actuelle associee aux progres de l’equipement et des techniques chirurgi- 
cales, a la fermeture precoce des plaies et aux formes alternatives de pansement des 
plaies offre la possibility d’une plus grande survie et d’une meilleure qualite de vie 
pour le patient accidente victime de brulures. Toutefois, la sepsie et les lesions par 
inhalation demeurent d’importantes causes de mortalite dont la connaissance et les 
solutions semblent se devoiler au fur et a mesure de la poursuite des recherches sur 
les effets plurisystemiques du processus inflammatoire.
Thermal injury remains a major health problem in North Ameri­
ca. Approximately 2 million burn 
injuries occur annually in the Unit­
ed States where a person has a 1 in 
70 lifetime chance of hospitaliza­
tion as a result of burn injury.1 
From our experience in treating 
1705 hospitalized burn victims over 
the past 11 years,2 we know that 
thermal injury is common among
Accepted for publication Jan. 17, 1990
young adults aged 20 to 39 years 
(92% males), and children (Fig. 1). 
These patients require intensive, 
prolonged hospital care (mean hos­
pital stay ± standard error 26.2 ± 
0.8 days). Of the 25% of burn 
patients who suffer major injuries 
(more than 20% of the total body 
surface area [TBSA]) the death rate 
is directly related to age and TBSA 
burned (Fig. 2). However, improve­
ments in resuscitative care and pa­
tient management combined with 
research advances in our under­
standing of the physiology of major 
trauma have led to declining death 
rates, to the extent that the size of 
burn injury associated with a 50% 
death rate (LA50) in the pediatric 
population is greater than 90% in 
experienced burn-care centres.3 
Thus, the challenge for Canadians 
in burn care in the next decade will 
be to achieve similar levels of clini­
cal excellence and subsequently to 
limit the morbidity associated with 
major traumatic injuries, thus im­
proving the quality of survival. 
These goals cannot be met by clini­
cal care alone. Research also is 
needed in the basic surgical sci­
ences as they affect trauma, in 
which burn injury represents its 
prototypic extreme.4
Clinical Advances in Burn Care
Technologic improvements in in­
struments have allowed surgeons to 
harvest split-thickness skin from 
almost any region of unburned 
skin.5 Currently, most burn-care 
centres employ electrically driven 
dermatomes for uniform and precise 
control of depth and dimensions of 
harvested skin grafts. This maxi­
mizes the available donor sites and 
limits morbidity within the unin­
jured donor skin, which has been a 
common problem with the use of 
hand-held skin graft knives.
Early, staged surgical interven­
tion is now common in modern 
burn care, although excessive or 
total excision of a large burn in a 
single procedure is associated with
From the Firefighters' Burn Treatment Unit, Division o f Plastic Surgery, Department o f  
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massive blood loss and no improve­
ment in survival.3 5' 7 In our experi­
ence with 272 burned hands, tan­
gential excision and split-thickness 
skin grafting is associated with 
high rates of success, early return 
of function and low requirements 
for secondary surgery.8 Poor-quality 
wound coverage, reduced range of 
motion and increased requirements 
for secondary surgery are the con­
sequences of delayed wound closure 
in hand burns, as illustrated in one 
or our patients who had suffered an 
85% TBSA injury. Spontaneous 
healing of the more superficially 
injured hand was allowed, and this 
resulted in hypertrophic scarring 
and reduced function. Similar, early 
tangential excision of facial burns 
with scalp-skin coverage of esthetic 
facial units has been proposed as an 
improved method of treatment of 
severe facial burns. However, most 
surgeons remain reluctant to per­
form early excision of facial burns, 
preferring elective reconstructive 
surgery in the rehabilitative stages.9
Wound Coverage for Major 
Burns
The past decade has been one of
FIG. 1. Age distribution of patients 
hospitalized for burn injury over 
11-year period.
rapid development in the area of 
wound-coverage techniques for 
major burns. Early coverage of the 
wound has been attempted to limit 
the metabolic, infectious and 
wound-healing complications of 
major burns.1 Allograft skin cover­
age remains the most readily avail­
able source of high-quality skin 
coverage. However, it is now recog­
nized that current cryoprotective 
techniques are only partially suc­
cessful in preserving viability. Most 
burn centres therefore prefer to use 
fresh material. Although one case 
of transmission of the human im­
munodeficiency virus (HIV) has 
been documented with allograft 
skin,10 this occurred at a time when 
tissue was used without serologic 
testing of the donor. Current esti­
mates of the risk of HIV transmis­
sion through allograft skin are less 
than 1 in 1 million when proper 
screening techniques are used, less 
than the risk associated with blood 
transfusion.11 Nevertheless, in most 
of the burn centres allograft skin is 
reserved for life-threatening inju­
ries.
Artificial skin, a Silastic-covered 
dermal matrix of chrondroitin sul­
fate and bovine type I collagen,12 is 
currently in the final stages of Unit­
ed States Food and Drug Adminis­
tration evaluation, and reported tri­
als of this material suggest that it 
may become an important form of 
wound coverage in the period im­
mediately after burn injury.13 Also, 
reports of the high esthetic quality 
of wound coverage suggest that 
this material may be a very useful 
reconstructive tool.
Cultured epithelial autografting 
techniques are being used in two 
Canadian centres with good suc­
cess. This method of wound cover­
age requires 3 to 4 weeks for tissue 
culture of biopsy sized autografts to 
grow into multiple gauze-backed 
sheets of epithelial cells for trans­
planting to wounds.14 Methods 
combining cultured epithelial auto­
grafts with allograft dermis have 
also been successful in a limited 
number of patients to date15 and are 
based on the recognition that the 
allodermis is relatively nonimmuno- 
genic compared with the epithelial
FIG. 2. Probability of death related to age of patient and body surface area burned.
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elements of skin. Consequently, the 
Chinese have developed methods to 
use pieces of autograft of postage- 
stamp size (1 to 2 mm2) with large 
sheets of allograft to cover major 
thermal burns.1617 Improved meth­
ods of immunosuppression have 
also allowed other burn centres to 
prolong the use of allograft skin 
indefinitely for selected patients 
with major burns who lack suffi­
cient donor sites for coverage of 
their wounds,18 a technique origi­
nally proposed by Burke and col­
leagues,19 using antilymphocyte 
globulin.
Surgical Metabolism after 
Major Injury
Since the early work of Cuthbert- 
son, it has been known that severe 
trauma is associated with increases 
in the resting energy expenditure 
rate and loss of lean body mass in 
the form of urinary urea nitrogen.20 
The development of indirect calo­
rimeters for measuring energy con­
sumption has allowed accurate de­
livery of appropriate nutrients to 
patients with major burns. The use 
of stable isotopes and gas chroma­
tography with mass spectroscopy 
(GCMS) in burn and other trauma 
patients has shown the detrimental 
effects of providing carbohydrate to 
burn patients in excess of 5 
mg/kg-min^1 and the importance 
of providing protein and amino 
acids in balanced proportions to 
maximize protein synthesis when 
massive catabolism can be only par­
tially limited.20 Through similar 
techniques, the use of highly en­
riched, branched chain amino acids 
in burned patients has been found 
to be unwarranted.21 Also, the intra­
venous use of fat emulsions has 
been limited by the growing under­
standing of their potential deleteri­
ous effects in burn patients who 
already have high circulating reticu­
loendothelial loads and altered pros­
taglandin metabolism.22 Finally, the 
importance of supporting metabo­
lism of the gastrointestinal tissues 
by providing enteral nutrition when­
ever possible has limited the use of 
total parenteral nutrition (TPN) in 
burn patients to those who cannot 
tolerate enteral feeding at all.
The Role of Inflammation in 
Wound Metabolism and 
Healing
With the development of recom­
binant molecular biologic tech­
niques, it has become apparent that 
the burn wound itself is the source 
of polypeptide molecules having au­
tocrine, paracrine and endocrine 
functions. As such, these cytokines 
appear to regulate wound healing 
and collagen metabolism,23 stimu­
late anaerobic metabolism24 and 
seem to be of extreme importance 
in the development of septic 
shock,25 which is the principal 
cause of death in burn patients. For 
example, interleukin I (IL-I) and 
tumour necrosis factor (TNF) both 
appear capable of stimulating local 
fibrosis, hepatic acute-phase protein 
synthesis, muscle protein catabol­
ism, increased lactic acid production 
and Cori cycle activity,24 and a 
septic-shock-like state with changes 
of acute respiratory distress syn­
drome26 in the pulmonary circula­
tion of various animal models.27 The 
ability of TNF monoclonal antibod­
ies to prevent sepsis and death in 
primates infused with live gram­
negative bacteria25 is important in 
the pathophysiology of burn- and 
trauma-related sepsis and offers the 
potential for future treatment of 
such sepsis.
Research developments in the 
pathogenesis of infections due to 
Pseudomonas aeruginosa have iden­
tified the important role that this 
organism plays in the nosocomial 
infections unique to burn patients.28 
There has been little decrease in
death rates due to P. aeruginosa 
infections over the past decade de­
spite improvements in antimicrobial 
therapy. Sporadic epidemics of this 
organism have been reported in 
many burn centres including our 
own.28 29 Although it is the second 
most frequent organism found in 
wounds or blood cultures of burn 
patients, when present it is lethal.
The Pseudomonas organism is 
closely associated with aquatic envi­
ronments and hospital equipment. 
As such, identification of these or­
ganisms in hydrotherapy equip­
ment, which has traditionally been 
used for wound care in our institu­
tion, has allowed us to eliminate 
septic deaths in our burn centre 
over the past 18 months; in the 
previous 6 months six patients had 
died of sepsis.29
Finally, inhalation injury is be­
coming recognized as a second and 
increasingly important cause of 
morbidity and mortality in burn 
care.30 Although research has iden­
tified the importance of prostanoids 
and cytokines as potentially damag­
ing products of pulmonary macro­
phages in the pathogenesis of this 
injury, the treatment of severe inha­
lation injury still remains supportive 
only. Further, our own experience 
and that of others31 has shown that 
early diagnosis of inhalation injury 
can be established through diagnos­
tic bronchoscopy or xenon lung 
scanning in the first 24 hours after 
a burn injury. However, this group 
of patients has an increased death 
rate (1.7% versus 34.7% p < 0.01, 
X2 analysis), prolonged hospitaliza­
tion (23.7 ± 0.7 versus 74.4 ± 6.2 
days [mean ± SEM], p < 0.01) and 
the severity of the injury is neither 
quantifiable nor predictable as com­
pared with that of burn patients 
without respiratory tract involve­
ment.2 Thus, inhalation injury rep­
resents an important and as yet 
poorly understood cause of morbidi­
ty and mortality in burn injury.
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Management of Patients With 
Major Burn Injuries
Most burn injuries are trivial or 
minor in nature, and patients can be 
adequately managed as outpatients. 
However, improvements in morbidi­
ty and mortality of seriously burned 
patients can be achieved through 
the establishment of regional cen­
tres experienced with the care of 
such injuries.32 Initial management 
of patients with major burn injuries 
in centres not familiar with their 
care is the same as that given to 
any multiply injured trauma victim. 
Thereafter, the early placement 
of large-bore intravenous lines 
through preferably unburned tissue 
for delivery of Ringer’s lactate solu­
tion is important. Delivery of this 
crystalloid solution is begun at ap­
proximately 4 m g/kg for the per­
cent TBSA but is assessed by the 
maintenance of a urinary output of 
0.5 to 1.0 ml/kg-h-1 in children or 
30 to 60 ml/h in adults through 
placement of an indwelling Foley 
catheter.
Total body surface area burned is 
assessed from standard charts em­
ploying the “rule of nines”.5 32 Sub­
sequent management and need for 
transfer to a burn centre is thereaf­
ter decided on by the nature and 
extent of the wounds and accom­
panying morbid factors. Guidelines 
for this have been suggested by the 
American Burn Association (Table 
I ) .
Table I. American Burn Association: 
Guidelines for Transfer of Burn Patients
Second and third degree burns when: 
Burned surface area > 10% and age < 
10 yr or > 50 yr 
Burned surface area > 20%
Face, hands, feet, genitalia, perineum 
and major joints are involved 
Third-degree burns > 5% total body 
surface area
Electrical, chemical and inhalation injuries 
Circumferential extremity and chest burns 
Major burns associated with multiple 
trauma
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2. Update on Pediatric Trauma
Geoffrey K. Blair, MD, FRCSC, FACS
Selective conservatism is the key to the rational management of pediatric trauma, 
realizing that children may harbour severe occult injuries. The modern treatment of 
childhood abdominal trauma best exemplifies this approach: nonoperative 
management of splenic trauma is now standard for children, and a selective 
conservative approach is advised in the handling of childhood liver and pancreatic 
injuries. Prevention of childhood injuries should be the goal. The development of a 
national database of childhood trauma should provide the basis for action to educate 
and legislate for prevention. When prevention fails, however, up-to-date quality 
pediatric trauma care is the key.
Un conservatisme selectif constitue la cle du traitement rationnel des traumatismes 
pediatriques, quand on realise que les enfants peuvent etre porteurs de lesions 
occultes graves. Le traitement moderne des traumatismes abdominaux chez l’enfant 
illustre au mieux cet abord: le traitement non operatoire du traumatisme splenique 
est maintenant la norme chez Tenfant et une approche conservatrice selective est 
recommandee face aux blessures hepatiques et pancreatiques. On doit viser a 
prevenir les blessures chez l’enfant. La mise sur pied d’une banque de donnees 
nationale sur les traumatismes pediatriques devrait sous-tendre une action en vue 
d’eduquer et de legiferer en matiere de prevention. Si la prevention echoue, on doit 
s’en remettre a des soins modernes et de qualite des traumatismes pediatriques.
T he evolution of theory in pedi­atric trauma over the past 15 
years has drastically changed the 
way we approach the injured child. 
Children are not just small adults 
— they suffer different types of 
injuries that demand a different 
treatment approach.
The basic principles of initial 
evaluation and resuscitation are the 
same for children as for adults; that 
is, those set out in the Advanced 
Trauma Life Support Course from 
the American College of Surgeons.1 
However, airway, breathing and cir­
culation problems can be more diffi­
cult to identify in the injured child.
Occult injury is often overlooked.
The cardinal rules of pediatric 
trauma management must be:
•  Don’t waste time.
•  Suspect occult injury.
•  Be aware of key differences 
between an injured child and an 
injured adult — anatomic, physio­
logic and emotional differences and 
drug metabolism.
I shall focus on some current 
issues in dealing with the child 
suffering from abdominal injuries.
Splenic Injury
Surprisingly the proper manage­
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ment of the fractured spleen is still 
being debated. Splenic injury may 
be the result of a low-energy im­
pact. The child, because of the 
relative lack of truncal musculature 
and a very flexible thoracic cage, 
may sustain a splenic fracture with 
little outward evidence of injury.
The majority of children present­
ing with splenic injury are hemody- 
namically stable, do not require 
transfusion and are managed safely 
nonoperatively.23 In children the 
nonoperative management of sple­
nic injuries is now standard. But it 
is a selective approach, and sur­
geons should realize that a minority 
of children will require laparotomy, 
splenorrhaphy or splenectomy. The 
Hospital for Sick Children in Toron­
to led the way years ago when 
surgeons first proposed this “radi­
cal” conservatism, and four exten­
sive reviews of their experience with 
this protocol have since been publi­
shed.2' 5
With most children who suffer 
splenic injury not requiring blood 
transfusion, the argument that op­
erative repair or removal of the 
spleen lowers the risk of transfu­
sion-related infections — acquired 
immune deficiency syndrome or 
hepatitis — seems specious.6 Late 
bleeding from a rupture spleen and 
splenosis are also extremely rare.6 
But life-threatening post-splenecto­
my sepsis is not. Splenorrhaphy 
certainly is possible but may not be 
easily executed. Perhaps too many 
times a ruptured, but not bleeding, 
spleen has been mobilized at lapa­
rotomy for intended repair. In the 
process, it has bled more, and, 
despite a valiant effort at saving the 
organ, a splenectomy is performed. 
Those spleens can heal themselves.
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Over the past 5 years at British 
Columbia Children’s Hospital, 45 
children who suffered traumatic 
splenic rupture have been cared for 
— all nonoperatively. We have not 
had to perform either splenectomy 
or splenorrhaphy in that period. 
Our method of nonoperative man­
agement is outlined in Table I.
Other Solid Organ Injuries
It perhaps was only a matter of 
time until the nonoperative ap­
proach was applied to other child­
hood solid organ injuries. In a 
cross-Canada study carried out by 
the Canadian Association of Pa­
ediatric Surgeons in 1988 only 18 
of 64 childhood liver injuries re­
quired operation. The remainder 
were handled nonoperatively in a 
manner similar to that for splenic 
trauma.7 However, we must remem­
ber that serious hemorrhage from 
liver injuries is more common than 
from splenic injury. Patients with 
hepatic or splenic injury must be 
very carefully selected for conserva­
tive management (Fig. 1).
Methods o f Diagnosis
How can we best detect these 
solid organ injuries? It is well 
known that clinical methods often 
fail. Diagnostic peritoneal lavage is 
not the answer because it is invasive 
and nonspecific and, since the pres­
ence of blood in the peritoneal 
cavity no longer necessitates sur­
gery, peritoneal lavage positive for 
blood will not necessarily change 
the management of the patient.
Computed tomography and, to a 
lesser extent, abdominal ul­
trasonography can allow quantifica­
tion of the abdominal bleeding, re­
veal its site and specifically evaluate 
the rest of the abdomen and its 
organs. Ultrasonography is a rea­
sonable screening test, but is less
reliable in detecting splenic frac­
tures than computed tomography 
or liver-spleen scanning.
However, peritoneal lavage does 
have a limited role in assessing the 
traumatized child. It may be useful 
for rapid assessment of the hypo­
tensive child or as a preliminary 
screening method before transfer 
from an institution that lacks ul­
trasonography or computed tomog­
raphy facilities. On the other hand 
it may be an unreliable means of 
discovering gut rupture after blunt 
injury.
Gastrointestinal Injury
Fortunately, occult gastrointesti­
nal perforation after blunt injury in 
childhood is relatively rare. Over a 
15-year period at the Hospital for 
Sick Children in Toronto, only 16 
gastrointestinal perforations sec­
ondary to blunt trauma were seen, a
number constituting approximately 
1% of the childhood abdominal 
traumatic injuries managed during 
that period.8
Initially, the clinical picture of 
gastrointestinal injury in childhood 
can mimic splenic trauma, but the 
peritoneal signs tend to persist and 
worsen, whereas the tenderness as­
sociated with a hemoperitoneum 
most often settles during the first 
day of injury. A delay in the diagno­
sis of traumatic gut rupture in­
creases the risk of sepsis. Free air is 
most often not seen on the plain 
film initially, and if there is a suspi­
cion of perforation, a contrast 
study, at least, is warranted.
Intestinal injuries are often seen 
in children old enough to be out of 
infant car seats, relegated to the 
back seat of the vehicle with only a 
lap-belt restraint. In an accident, 
the forceful flexion over the lap belt 
without a shoulder strap to restrain 
the upper body, may result in the
Table I. Nonoperative Protocol for Splenic Trauma
Admit to monitored bed —  critical care nursing for 1 -  2 d. Supportive care, transfuse if 
hemoglobin < 80 g/L.
Complete bed rest in hospital for 1 wk.
Discharge on restricted non-violent activity for 6 wk.
Follow-up at 6 wk —  physical examination
—  complete blood count, urinalysis
—  abdominal ultrasonography, primarily to look for splenic cyst.
Release to full normal activity if follow-up gives normal results.
Llver/splenic trauma 1
1
Sta ble
1-------
< 40 ml/kg daily
1
~ 1
Unstable1
Transfusion1
------ }
>  40 ml/kg daily 1
1 f \ 1 iObservation
FIG. 1. Algorithm for management of childhood liver or spleen trauma.
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“lap-belt syndrome” — abdominal 
wall disruption, major intra-abdomi­
nal injury, including bowel perfora­
tion and spinal fracture with possi­
ble spinal cord damage. Such inju­
ries could easily be prevented by 
introducing rear-seat shoulder re­
straints.
Other Traumatic Injuries in 
Children
The back seat ‘Tap-belt syn­
drome” is only one example of 
many injuries suffered more fre­
quently by children than adults. 
Another is the handle-bar injury.9 A 
child in falling off a bicycle may 
have the butt of the handlebar 
cause duodenal injury, a tear or, 
more commonly, a hematoma, or 
traumatic pancreatitis. The young­
ster may appear well initially. Oc­
cult injury may become manifest 12 
to 24 hours after the accident by 
continued or increasing pain, vomit­
ing or collapse.
Pancreaticoduodenal Injury
Controversy is currently raging 
over the appropriate early manage­
ment of childhood pancreatico­
duodenal injuries. In our effort to 
treat children nonoperatively, are 
we perhaps missing the occasional 
duodenal disruption most appropri­
ately found and treated at early 
laparotomy?
Traumatic pancreatitis in children 
may best be treated by early explo­
ration, appropriate debridement and 
attention to ductal injury. Yet, 
Burnweit and Filler10 from the Hos­
pital for Sick Children in Toronto 
reported that the majority of their 
children with traumatic pancreatitis 
did well with conservative therapy, 
and operation was avoided in all but 
20%. Their report also cited the 
successful use of percutaneous 
drainage for persistent pancreatic
pseudocysts in children. Of 14 
pseudocysts treated in their series, 
8 resolved without operation, 5 re­
quired percutaneous drainage and 
only 1 was drained internally.
Comments
Thus, the pattern of traumatic 
injuries seen in children is no doubt 
different from those seen in adults. 
We must develop and sustain a 
working database of childhood inju­
ries in Canada. Only in this way will 
we be able to effect proper pro­
grams and legislation to prevent 
childhood injuries.
Our assumptions or presump­
tions about the types of injuries 
that are causing childhood death 
and disability in Canada may not be 
correct.11 For instance, in a recent 
study, Brison, Wicklund and Muel­
ler12 found that, from 1979 to 
1983, 58% of childhood pedestrian 
accidents occurred in driveways and 
parking lots not on public thor­
oughfares. Also 76% of these “non­
traffic” fatalities involved light 
trucks or vans. Data such as this 
are useful, perhaps suggesting new 
approaches to at least one aspect of 
childhood injury prevention.
The United States figures and 
statistics, however, may not accu­
rately reflect the situation in Cana­
da. For instance, we surely see far 
fewer gunshot injuries to young 
Canadians. (But with a worsening 
drug problem in Canada are gun­
shot injuries in youth not going to 
increase as well?)
Now, through the efforts of Dr. 
Barry Pless of the Montreal Chil­
dren’s Hospital, and the Health Pro­
tection Branch of Health and Wel­
fare Canada, a Children’s Hospital 
Injury Reporting and Prevention 
Program has been started. Members 
of this group will survey and com­
pile the childhood injuries and 
treatment from children’s hospitals
across Canada. It is hoped that this 
database will have a major impact 
on injury prevention for children in 
Canada’s future.
Prevention of the primary injury 
should be our major goal. In Cana­
da, education and legislation to­
gether could achieve a significant 
reduction in the suffering related to 
childhood trauma. Children in this 
country would materially benefit 
from legislation to mandate rear- 
seat shoulder restraints in cars, the 
wearing of bicycle helmets, all-ter­
rain vehicle (ATV) regulations, 
boating regulations necessitating a 
minimum age for operation and 
stricter gun control than we have at 
present. Last, but not least, stricter 
laws and penalties for alcohol abuse 
would also help. Injury prevention 
education programs aimed at par­
ents and children would comple­
ment such legislation.
Where prevention has failed we 
must ensure that injured children 
have ready access to quality medical 
care. This does not necessarily 
mean a level 1 pediatric trauma 
facility in every town in Canada. 
Rather we need physicians and 
nurses who are truly interested in 
pediatric trauma and can ensure an 
up-to-date approach to the unique 
problems of the injured child.
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This two-volume textbook represents 
the natural evolution of subspecializa­
tion within orthopedic surgery. This 
evolution is evident in the establishment 
of societies for the study of diseases of 
certain anatomic regions and is support­
ed by increasing publication of journals 
and textbooks to collate and distribute 
the information.
The two volumes, with 46 contribu­
tors, provide a comprehensive review of 
current knowledge on the pathogenesis 
and treatment of disorders of the shoul­
der. The text is appropriately divided 
into two sections: general topics and 
specific diseases and injuries of the 
shoulder.
The first section consists of chapters 
devoted to developmental anatomy, 
gross anatomy, embryology, biome­
chanics, and radiologic clinical and ar­
throscopic examinations. These chap­
ters are comprehensive and follow each 
other in a logical sequence, starting 
with embryology.
8. Blair GK, Wesson DE, Filler RM et al: 
Traumatic gastrointestinal perforations 
in children. Paper presented at the meet­
ing of the Canadian Association of Pa­
ediatric Surgeons, Montreal, PQ, Sep­
tember 1984
9. Fraser GC: Handlebar injury of the 
pancreas. Report of a case complicated 
by pseudocyst formation with spontane­
ous internal rupture. J  Pediatr Surg 
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of blunt pancreatic trauma in children.
In the second section, specific chap­
ters are devoted to both injuries and 
diseases and cover such troublesome 
areas as fractures of the proximal hu­
merus, fractures of the adult clavicle, 
acromioclavicular joint injuries and dis­
eases, and glenohumeral instability. The 
shoulder region is divided anatomically 
and injuries and diseases peculiar to it 
are explored, which makes reference to 
this text for a specific clinical problem 
extremely simple.
One particularly helpful aspect of 
this book is that each contributor is a 
recognized expert in the field in which 
he or she is writing; where appropriate 
the author gives a full explanation of 
his or her preferred method of treat­
ment at the end of the chapter. Thus, in 
addition to a comprehensive review of 
recommendations from other works, 
there is a definitive suggestion based on 
the author’s own experience.
The illustrations are excellent. The 
radiographs are clearly reproduced and 
the line drawings are uniform in clarity 
and orientation. In particular, those 
drawings that have been used to illus­
trate surgical procedures are most help­
ful for the reader not familiar with every 
nuance of the described operation.
This volume presents a wealth of 
well-referenced clinical material and 
would be a valuable addition to any 
comprehensive orthopedic library. Its 
primary purpose is as a reference book 
and therefore it should be included in
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the library of any hospital in which 
orthopedic surgery is performed. Its 
value to individual practitioners is less 
certain unless those individuals have a 
specific interest in the treatment of 
shoulder problems.
J.P. Waddell, MD, FRCSC
Division of Orthopedics,
St. Michael’s Hospital,
30 Bond St.,
Toronto, Ont.
REVISIONAL SURGERY IN RHEU­
MATOID ARTHRITIS. Edited by M. 
Hamalainen, F.-W. Hagena, W. 
Schwagerl and J. Teigland. Vol. 13 of 
Rheumatology. The Interdisciplinary 
Concept. Edited by M. Schatten- 
kirchner and F.-W. Hagena. 265 pp. 
Illust. Karger, Basel. 1990. $173.50 
(US). ISBN 3-8055-4930-X
Based on a European rheumatologic 
congress, this book contains four sec­
tions: revision total joint surgery in 
patients with rheumatoid arthritis, the 
cervical spine in rheumatoid arthritis, 
assessment in rheumatoid arthritis and 
a miscellaneous group of papers. These 
are huge topics to attempt to cover in 
one small book, and the editors are to 
be congratulated on what they have 
achieved.
continued on page 469
446 CJS, VOL. 33, NO. 6. DECEMBER 1990
ROYAL COLLEGE SYMPOSIUM
3. Pelvic Ring Fractures
Peter J. O’Brien, MD, FRCSC
Correct assessment and treatment of pelvic ring fractures in the multiply injured 
patient is important because it can result in fewer deaths and less long-term 
disability. There is ample evidence to show that surgical stabilization of unstable 
pelvic ring fractures is a life-saving intervention that should be done on the day of 
injury. Anterior frame external fixation is the standard form of treatment and is 
life-saving. However, it is not ideal biomechanically, and over the next decade open 
reduction and internal fixation of pelvic ring fractures will likely become the 
treatment of choice.
Chez le polytraumatise, revaluation appropriee et le traitement adequat des 
fractures de l’anneau pelvien sont importants car il peut en resulter une diminution 
des deces et de Tincapacite a long terme. II existe une vaste preuve demontrant que 
la stabilisation chirurgicale d’une fracture instable de Tanneau pelvien est une 
intervention salvatrice qui devrait etre effectuee le jour meme de la blessure. Le 
traitement standard consiste a poser un appareil de fixation externe en position 
anterieure; celui-ci peut sauver la vie. Cependant, ceci n’est pas ideal au plan 
biomecanique et, au cours de la prochaine decennie, il est probable que la reduction 
ouverte avec fixation interne deviendra le traitement de premier choix des fractures 
de l’anneau pelvien.
Pelvic ring fractures in associa­tion with multiple trauma pres­
ent a diagnostic and therapeutic 
challenge for physicians. Accurate 
assessment and correct treatment of 
pelvic fractures in the multiply in­
jured patient can reduce mortality 
and morbidity. Treatment algo­
rithms have been published for the 
management of the traumatized pa­
tient with a pelvic fracture.12 Occa­
sionally a pelvic fracture must be 
treated early after injury to control 
ongoing blood loss from retroperi­
toneal hemorrhage in the multiply 
injured patient. In the majority of 
cases, however, assessment of the 
pelvic fracture is left until all other
system injuries have been diagnosed 
and life-threatening problems have 
been dealt with. Definitive treat­
ment of pelvic fractures, however, 
should not be delayed and should 
be undertaken on the day of injury. 
For some patients with unstable 
pelvic fractures this will require 
open reduction and internal fixation 
(Fig. 1).
Importance of Pelvic Ring 
Fractures in Multiple Trauma
Survival
Accurate assessment and correct 
treatment of unstable pelvic frac­
From the Department o f  Orthopedics, Faculty o f  Medicine, University o f  British Columbia, 
Vancouver. BC
Presented as part o f the symposium “ Update on trauma care in Canada "  by the Canadian 
Association o f General Surgeons and the Trauma Association o f Canada at the 58th annual 
meeting o f the Royal College o f Physicians and Surgeons o f  Canada, Edmonton. Alta., Sept. 24, 
1989
Accepted for publication Nov. 30, 1989
Reprint requests to: Dr. P.J. O'Brien, Department o f Orthopedics, University o f  British 
Columbia, 910 W 10th Ave., 3rd Floor, Vancouver, BC V5Z 4E3
tures in multiply injured patients 
can play a direct role in patient 
survival. Death rates for multiply 
injured patients with major pelvic 
fractures have been reported by a 
number of authors.1'3-8 In 1986 
Goldstein and colleagues4 reported 
a 6% death rate in their small series 
of patients, all treated by early open 
reduction and internal fixation of 
the pelvic fracture. Dalai and col­
leagues,3 in 1989, reported a death 
rate of 15.5% in a large series of 
pelvic fractures. Haasbeek and 
Burns5 recently recorded a rate of 
24% in multiply injured patients 
with pelvic fractures treated non- 
surgically. The orthopedic treat­
ment of fractures directly affects 
patient survival. Immediate surgical 
stabilization of long-bone fractures 
and pelvic fractures is life-saving 
and should not be delayed. It 
should be done on the day of injury.
Multiply injured patients are best 
prepared for fracture surgery on the 
day of their injury, because their 
nutritional status is better then 
than it will be for many days, their 
respiratory status often deteriorates 
in the days following injury and 
precludes further surgical interven­
tion and, finally, colonization with 
resistant hospital organisms has not 
yet occurred. The advantages of 
early stabilization of fractures in­
clude the following: early mobiliza­
tion; easier nursing care; less pain, 
because the fracture fragments are 
rigidly immobilized, so that less 
analgesia is required; decreased in­
cidence of adult respiratory distress 
syndrome, thromboembolic disease, 
fat embolism and decubitus ulcers.
There are, however, some disad­
vantages. Many patients have al­
ready undergone thoracotomy, lapa­
rotomy, neurosurgical or urologic 
procedures. Orthopedic intervention 
adds surgical stress and blood loss.
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These factors, however, can be ade­
quately dealt with by a well-trained 
anesthesia staff. The advantages of 
early stabilization far outweigh the 
disadvantages.
Improved survival with early sur­
gical stabilization of fractures has 
been documented.6'79-12 Goris and 
associates9 presented a prospective 
study that documented a death rate 
5.5 times higher in patients who 
“had their fractures treated in trac­
tion’’ than in those who had early 
surgical stabilization. Similarly, 
Meek, Vivoda and Pirani7 recorded 
a 28.5% death rate in multiply 
injured patients in whom the ortho­
pedic management was nonsurgical 
compared with a 4.5% death rate in 
multiply injured patients who un­
derwent surgical stabilization of the 
fractures on the day of injury. De­
creased death rates have also been 
documented specifically in terms of 
pelvic fracture treatment.610 In our 
hospital, the death rate for multiply 
injured patients treated nonsurgi- 
cally was 29% compared with 6% 
for those who had surgical stabili­
zation of their pelvic fractures ini­
tially. It is apparent, therefore, that 
the advantages afforded by surgical 
fixation are life-saving.
Musculoskeletal Outcome
Traumatized patients who survive
their injuries with major pelvic dis­
ruption may be left with a perma­
nent disability as a result of the 
pelvic fracture. Tile8 and Browner 
and colleagues13 have documented 
chronic posterior pain in up to 30% 
of these patients in long-term fol­
low-up. Tile found that the inci­
dence was as high as 60% if the 
sacroiliac joint was involved in the 
fracture. He also documented a 
nonunion rate of 4%, a malunion 
rate of 4% and a permanent nerve- 
injury rate of 5.5%. Although the 
orthopedic outcome of the pelvic 
injury depends to some degree on 
the amount of energy involved in 
producing the fracture, the stability 
of the pelvis and the associated 
injuries, treatment also plays a 
major role in determining how 
these patients will do in the long 
term. Accurate reduction and stable 
fixation should lead to a decreased 
incidence of long-term complica­
tions.
Clinical Assessment of Pelvic 
Fractures
It is important to emphasize the 
priority protocol for the assessment 
and resuscitation of the multiply 
injured patient. Pelvic fractures are 
usually assessed after life-threaten­
ing injuries to other systems have 
been dealt with. Physical examina­
tion may reveal swelling and ecchy- 
mosis. Direct palpation may elicit 
tenderness over the anterior and 
posterior pelvic injury site. Patients 
multiply injured from blunt trauma, 
however, are often obtunded so that 
tenderness cannot be elicited. A 
defect from symphysis diastasis may 
be palpable. The rotatory and verti­
cal stability of the pelvis must be 
assessed. The examiner can test for 
rotatory instability by placing a 
hand on each iliac crest and apply­
ing force to close and open the 
pelvic ring; abnormal motion and 
crepitus denote rotational instabili­
ty. The examiner can test for verti­
cal instability by applying traction 
through the lower extremity with 
one hand on the pelvis; any vertical 
movement of the hemipelvis in ref­
erence to the opposite side denotes 
instability.
Pelvic fractures may, however, be 
difficult to document clinically in 
the multiply injured patient. Altered 
level of consciousness, obesity, 
swelling and multiple injuries can 
obscure the physical signs. MacKer- 
sie and associates,14 in their review 
of 789 cases of blunt trauma, found 
that 75% of the pelvic fractures 
were clinically occult. Radiologic 
evaluation, therefore, is essential in 
all multiply injured patients with an 
altered level of consciousness. Plain 
radiographs should include an­
teroposterior, inlet and outlet views. 
The anteroposterior film will dem­
onstrate most pelvic fracture pat­
terns. The inlet view demonstrates 
the posterior injury more clearly; it 
also shows the shape of the pelvis 
and demonstrates whether the in­
juring force was of lateral compres­
sion, decreasing pelvic volume or 
anteroposterior compression, in­
creasing the pelvic size. The inlet 
view will also demonstrate any pos­
terior displacement of the hemipelv­
is. The outlet view shows the sa­
crum in profile and helps document 
sacral fracture patterns. It is also
Primary Survey and Resuscitation Control Ongoing Blood Loss
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FIG. 1. Assessment and treatment of multiply injured patient with pelvic fracture.
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useful for demonstrating any verti­
cal displacement of the hemipelvis.
Computed tomography is also 
valuable in the assessment of pelvic 
ring fractures, particularly in docu­
menting the posterior injury. Most 
pelvic fractures can be seen fairly 
clearly on plain films. However, for 
those physicians who do not have 
much experience in assessment and 
treatment of pelvic fractures, com­
puted tomography can more clearly 
demonstrate the posterior injury. 
This technique can also show undis­
placed fractures of the sacrum that 
are often invisible on the plain 
films. Such fractures, however, do 
not usually affect the treatment 
plan. Computed tomography, there­
fore, is a useful method for defining 
posterior injuries but is not essen­
tial in all cases of pelvic ring frac­
ture. However, it is essential in the 
preoperative planning of pelvic frac­
tures that involve the acetabulum.
Classification of Pelvic 
Fractures
A number of classifications238 
have been described for pelvic ring 
fractures. We use Tile’s classifica­
tion,8 which divides pelvic fractures 
into three types. Type A are stable 
fractures, type B are rotationally 
unstable but vertically stable and 
include both open-book and lateral
compression types, and type C frac­
tures are rotationally and vertically 
unstable (Table I).
When considering the classifica­
tion, we must distinguish between 
the lateral compression types and 
the anteroposterior compression 
and vertical shear types. Lateral 
compression fractures result in an 
infolding of the pelvis and, there­
fore, a decrease in pelvic volume. 
Retroperitoneal blood loss can usu­
ally be controlled by tamponade. As 
the pelvic hematoma increases in 
size the pelvic volume cannot in­
crease beyond normal because the 
injuring forces result in an initial 
decrease in pelvic volume. Lateral 
compression fractures are frequent­
ly impacted and are relatively stable. 
On the other hand, anteroposterior 
compression and vertical shear pel­
vic fractures result in an increase in 
pelvic volume. As retroperitoneal 
bleeding occurs and a hematoma 
forms, there is nothing to confine 
the blood loss so there is no tam­
ponade. The shear forces that pro­
duce these types of fractures also 
tend to tear vascular structures. 
Patients with anteroposterior com­
pression and vertical shear fractures 
are at a higher risk of being he- 
modynamically unstable because of 
the pelvic fracture injury alone, and 
these injuries are more difficult for 
the orthopedist to manage.
Treatment of Pelvic Ring 
Fractures
It is important to emphasize that 
patients who have sustained a 
major pelvic ring fracture have been 
exposed to considerable force and 
should be considered multiply in­
jured. Initial treatment should be 
based on the priority protocol sys­
tem for the management of multiply 
injured patients. The definitive 
treatment of the pelvic fracture fol­
lows treatment of other system in­
juries.
Stable pelvic fractures usually do 
well and are not associated with 
long-term disability. Treatment of 
the symptoms of stable pelvic frac­
tures will usually result in a satis­
factory outcome for the patient. In 
contrast, unstable fracture patterns 
are difficult to treat.
It is occasionally necessary to 
stabilize the pelvic fracture during a 
resuscitative phase of the manage­
ment of a multiply injured patient. 
If the patient is hemodynamically 
unstable and ongoing blood loss in 
the retroperitoneal space, secondary 
to a pelvic ring fracture, is thought 
to be contributing to the patient’s 
ongoing hypovolemia, an anterior 
frame external fixator can be ap­
plied. This can be done either in the 
emergency room or in the operating 
room after laparotomy. A simple 
anterior frame can be applied percu- 
taneously in about 20 minutes. We 
use a Slatis-type trapezoidal frame. 
This frame can be turned down in a 
caudad direction if necessary to 
allow access to the abdomen for 
laparotomy.
The external fixator will (a) de­
crease pelvic volume and allow for 
tamponade, (b) decrease blood loss 
from cancellous bone surfaces, (c) 
minimize shear forces and therefore 
reduce the risk of further vessel and 
soft-tissue injury in the pelvis and 
(d) allow for early patient mobiliza­
tion.
Biomechanical studies81516 have
T a b le  1. Classification of Pelvic Disruption*
Type D efin ition
A Stable
A1 Fractures of the pelvis not involving the ring
A2 Stable, m inimally displaced fractures of the ring
B Rotationally unstable, vertically stable
B1 Open book
B2 Lateral compression: ipsilateral
B3 Lateral compression: contralateral (bucket handle)
C Rotationally and vertically unstable
C1 Unilateral
C2 Bilateral
C3 Associated with an acetabular fracture
'Reproduced by permission from Tile M: Pelvic ring fractures: should they be fixed? J  B one J o in t
S u r g [B r ]m % \  70: 1 -12 .
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shown that no anterior external 
fixator is biomechanically strong 
enough for the patient to walk 
without loss of reduction in unsta­
ble pelvic fractures. Therefore, a 
simple anterior external fixator is 
not definitive treatment for an un­
stable pelvic ring fracture.
Some have recommended anteri­
or frame external fixation as provi­
sional fixation in unstable pelvic 
fractures.813 This would allow a few 
days for the patient’s condition to 
stabilize; definitive open reduction 
with internal fixation of the pelvic 
fracture could be done later. This 
form of management presents two 
problems. First a number of compli­
cations may develop from the multi­
ple trauma over the first few days 
and weeks after injury. These may 
preclude further surgical interven­
tion so that the chance to obtain 
ideal surgical stabilization of the 
pelvic ring fracture is lost. The 
second problem was described by 
Browner and colleagues,13 who re­
ported a series of patients in which 
they used an external fixator for 
provisional fixation followed by de­
layed internal fixation. In none of 
the patients could they obtain an 
anatomic reduction, and 25% had 
persistent posterior pain. I believe, 
therefore, that use of the anterior 
frame external fixator should be 
limited to the following situations: 
(a) in hemodynamically unstable pa­
tients who have ongoing retroperi­
toneal blood loss, (b) in multiply 
injured patients who have unstable 
lateral compression fractures, (c) in 
multiply injured patients whose sur­
geon is not familiar with open re­
duction and internal fixation tech­
niques, (d) in conjunction with open 
reduction and internal fixation and 
(e) in patients with open pelvic 
fractures.
Angiography and embolization of 
pelvic arterial bleeding is indicated 
in those who are hemodynamically 
unstable, despite having an external
fixator applied to the pelvis, and in 
whom all other sources of bleeding 
have been ruled out. It may play a 
larger role in the future. Goldstein 
and colleagues4 have suggested 
using this technique before open 
reduction and internal fixation.
Open reduction and internal fixa­
tion of the anterior and posterior 
fracture site in a pelvic ring fracture 
is biomechanically strong. If it is 
done on the day of injury anatomic 
reduction can be obtained and rigid 
internal fixation can be accom­
plished. This, theoretically, should 
lead to a better musculoskeletal 
outcome as the pelvis will heal in 
the reduced position. However, little 
experience has been reported con­
cerning early open reduction and 
internal fixation of pelvic ring frac­
tures. External fixation or open 
reduction and internal fixation are 
life-saving because they provide sta­
ble fixation of the pelvic fracture. 
Open reduction with internal fixa­
tion is biomechanically stronger and 
should reduce long-term morbidity. 
The procedure appears to be the 
treatment of choice for pelvic ring 
fractures, but this has yet to be 
proved. The potential disadvantages 
of open reduction are uncontrolled 
blood loss from decompression of 
the retroperitoneal hematoma and a 
higher infection rate.
More experience with open re­
duction and internal fixation of pel­
vic ring fractures in multiply in­
jured patients is needed before de­
finitive recommendations for its use 
can be made. At present the proce­
dure is indicated only in unstable 
pelvic ring fracture, principally in 
Tile’s type B1 and C fractures. This 
type of surgery should only be 
undertaken in a trauma centre that 
has sophisticated back-up facilities.
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4. Resuscitation Through the Three 
Phases of Hemorrhagic Shock After 
T rauma
Charles E. Lucas, MD
There are three phases of acute hemorrhagic shock after trauma. In phase I (from 
injury to operation for control of bleeding) the patient suffers from low cardiac 
output, tachycardia, reduced organ perfusion, oliguria and decreased capillary 
hydrostatic pressure, which in turn reduces extravascular fluid loss. Contraction of 
the interstitial space matrix replenishes plasma volume. Optimal therapy includes 
blood and crystalloid replacement to restore plasma volume, red cell mass and 
interstitial fluid. Three litres of crystalloid are usually required for each litre of 
blood lost. After operation, a period of obligatory extravascular fluid sequestration 
occurs as the intracellular and interstitial spaces expand (phase II). Optimal 
replacement therapy during this phase maintains plasma volume. Replacement is 
provided according to the patient’s vital signs, because extravascular fluid 
expansion cannot be influenced by therapeutic manipulation. Phase III is a 
mobilization and diuretic phase. During this phase systolic hypertension may occur, 
and the patient must be treated with restriction of fluid, diuresis and careful 
monitoring of the heart and lungs. Attempts to alter these physiologic responses 
with supplemental albumin have proved detrimental. The albumin causes salt and 
water retention in the nephron, leading to weight gain, higher central filling 
pressures and worsening pulmonary function, and a greater need for diuretic and 
inotropic therapy. Albumin therapy also induces relocation of non-albumin proteins 
into the interstitial space, leading to impaired immunocompetence and coagulation. 
Successful resuscitation is facilitated by adaptation to these physiologic responses of 
hemorrhagic shock rather than manipulation of them.
Apres un traumatisme, on observe trois phases dans le choc hemorragique. Au cours 
de la phase I (de la blessure jusqu’a l’operation pour juguler l’hemorragie), le 
patient souffre d’un faible debit cardiaque, de tachycardie, d’une perfusion reduite 
des organes, d’oligurie et d'une pression capillaire hydrostatique diminuee qui, en 
contrepartie, reduit l’epanchement extravasculaire. La contraction de l’espace 
interstitiel retablit le volume plasmatique. La meilleure therapie fait appel aux 
transfusions de sang et de cristalloides pour retablir le volume plasmatique, la 
masse erythrocytaire et les liquides insterstitiels. Trois litres de solute cristalloide 
sont habituellement necessaires pour remplacer chaque litre de sang perdu. Apres 
l’operation, une periode de sequestration obligatoire des liquides extravasculaires 
survient alors que les espaces intracellulaire et interstitiel s’elargissent (phase II).
Le meilleur traitement de suppleance pendant cette phase consiste a maintenir le 
volume plasmatique. Comme l’expansion des liquides extravasculaires ne peut etre 
influencee par des manipulations therapeutiques, l’expansion volumique est dictee 
par les signes vitaux. La phase III en est une de mobilisation et de diurese. Pendant 
cette phase, une hypertension systolique peut survenir. Le patient doit alors etre 
traite par restriction liquidienne, diurese et surveillance des fonctions cardiaque et 
pulmonaire. Les tentatives pour modifier ces reponses physiologiques a l’aide 
d’albumine se sont averees prejudiciables. L’albumine cause une retention de sel et 
d’eau dans le nephron, ce qui entraine un gain ponderal, une augmentation des 
pressions centrales de remplissage et une deterioration de la fonction pulmonaire, et 
un besoin accru de medication diuretique et inotrope. L’administration d’albumine 
provoque egalement une relocalisation des autres proteines dans l’espace intersti­
tiel, entrainant ainsi des alterations de l’immunocompetence et des mecanismes de 
coagulation. Le succes de la reanimation est davantage facilite par une adaptation 
aux reponses physiologiques au choc hemorragique, que par des tentatives pour les 
modifier.
T o resuscitate a patient from hemorrhagic shock (HS) after 
trauma the physician must have 
knowledge of the normal physiolo­
gy and responses to HS. The body 
of a patient weighing 70 kg con­
tains 60% water — 28 L of intracel­
lular fluid (ICF) (red blood cell mass 
2 L, muscle-organ mass 26 L) and 
14 L of extracellular fluid (ECF) 
(plasma 3 L, interstitial fluid 11 L). 
The plasma and red blood cell mass 
give a blood volume of 5 L which, 
with a normal cardiac output, circu­
lates through the body each min­
ute.
Fluid movement through the cap­
illary vessels is controlled by hydro­
static, osmotic and oncotic forces. 
Salt and water exit from the pre­
capillary arterioles into the intersti­
tial fluid space due to increased 
intravascular hydrostatic pressure.1 
Simultaneously, protein, including 
albumin and the globulins, exits, by 
convective forces, with the water 
into the interstitial fluid space (Fig. 
1). Salt and water probably re-enter 
the plasma at the venular end of the 
capillary owing to both oncotic and
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osmotic forces. In contrast, protein 
flux is unidirectional from the capil­
laries through the interstitial fluid 
space into the lymphatics whence 
plasma re-enters at a remote site.23 
The normal lymph-to-plasma pro­
tein ratio varies with size, shape, 
charge and other traits of each 
molecule.
The interstitial fluid space com­
prises a sol portion and a gel por­
tion called the matrix. Contrary to 
popular conceptions, the interstitial 
fluid space with its matrix is dynam­
ic and controls much of the re­
sponse to HS after trauma.2 Most 
interstitial water, salt and protein is 
held within this matrix and affects 
protein flux through the interstitial 
fluid space. The ultrafine proteo­
glycans can attract protein by 
chemical, ionic and electrical forces. 
When the matrix unravels and ex­
poses the proteoglycans to the sol 
fluid, albumin attaches; in contrast, 
when the matrix contracts, proteog­
lycans are excluded from the sol 
and albumin passes freely into lym­
phatics and thence into the plasma.
Hemorrhagic shock may be divid­
ed into three distinct sequential 
phases:4 phase I, the period of ac­
tive hemorrhage extending from the 
time of injury until the end of 
operation for hemostasis; phase II, 
the period of obligatory extravascu- 
lar fluid sequestration lasting until 
the time of maximal weight gain; 
phase III, the period of fluid mobili­
zation and diuresis. Patients with 
HS whose systolic blood pressure 
drops below 80 mm Hg for 30 to 40 
minutes and who require 10 to 20 
blood transfusions in phase I will 
have a phase II lasting 30 hours 
and a phase III lasting 4 days.
Phase I
A patient who suffers severe HS 
with a systolic pressure of 70 mm 
Hg will have an acute 40% to 50% 
fall in blood volume (Fig. 2). The 
homeostatic responses include the 
release of catecholamines, antidiu­
retic hormone, renin and aldoster­
one. Other hormones compliment­
ing this acute response include glu­
cagon, growth hormone, parahor- 
mone and insulin.5 This causes a 
fall in cardiac output and a rise in 
peripheral vascular resistance. The 
kidneys excrete little urine when 
treatment is first initiated.6 Capil­
lary water efflux falls because hy­
drostatic pressure in the precapil­
lary arteriole is reduced. Further­
more, plasma volume expansion 
from the interstitial fluid space at 
the venular end of the capillary 
rises due to the relative increases in 
the oncotic and osmotic pressures 
within the plasma.1-3 Contraction of 
the interstitial fluid space drives 
albumin into the lymphatic system 
and plasma.7
Therapy must restore not only 
the red blood cell mass but also the 
huge deficit in balanced electrolyte 
solution from both the plasma and 
the interstitial fluid space. The rec­
ommended ratio of balanced electro­
lyte infusion to estimated whole 
blood loss is 3:1. Thus, a patient 
with an acute blood loss of 2 L will 
need 6 L of balanced electrolyte
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FIG. 1. Person weighing 70 kg has 42 
L of water in both the intracellular 
fluid (ICF) (28 L) and extracellular 
fluid (ECF) (14 L). Salt and water exits 
plasma by hydrostatic forces. Albumin 
and globulin flow by connective forces 
into interstitial fluid space. P.V. =  
plasma volume, IFS =  interstitial fluid 
space, LF =  lymphatic flow, RA =  
lymph to plasma albumin ratio, RG =  
lymph to plasma globulin ratio.
EARLY PHASE I (Emergency Room)
HIIII
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FIG. 2. Upon presentation to emergency room with severe hemorrhagic shock (HS), 
patient with acute 40% reduction in plasma volume will have vasoconstriction with 
contraction of interstitial fluid space matrix causing replenishment of plasma 
volume (PV). RBF = renal blood flow, GFR =  glomerular filtration rate.
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solution to restore plasma volume 
and interstitial fluid deficits. Bal­
anced electrolyte solution used for 
resuscitation should not contain 
glucose, since the release of cate­
cholamines, glucagon and growth 
hormone causes acute hyperglyce­
mia.45 When endogenous hypergly­
cemia from HS is augmented by 
exogenous glucose in the balanced 
electrolyte solution, the hyperglyce­
mia may exceed 55.5 mmol/L and 
cause inappropriate osmotic diure­
sis when homeostasis calls for fluid 
conservation. The volume of bal­
anced electrolyte solution infused is 
guided by the response of blood 
pressure, pulse pressure and urine 
output.
After blood volume has been re­
stored and vital signs have been 
stabilized, operation can be per­
formed for definitive hemostasis. 
Once bleeding is controlled, the 
blood pressure quickly returns to­
ward normal. When this occurs, 
urine output often is low because of 
the continued refilling of the deplet­
ed interstitial fluid space from the 
plasma. Instead of diuretics, which 
further deplete the plasma volume, 
the patient needs additional bal­
anced electrolyte solution to aug­
ment refilling of the interstitial fluid 
space. In these circumstances a 
bolus infusion of 1 to 2 L of 
electrolyte solution over 30 minutes 
usually induces spontaneous urine 
flow. This approach helps postoper­
ative management since the volume 
of urine flow will reflect circulatory 
needs when no diuretics were ad­
ministered during operation.
Phase II
After operation, the patient will 
enter into an obligatory extravascu- 
lar fluid sequestration phase (phase 
II). This obligatory expansion oc­
curs into both the ICF and the 
ECF.2’8 Intracellular fluid expansion
is associated with changes in cell 
membrane potential because of de­
creased efflux of sodium and water 
from the cell. This decreased efflux 
may be owing to a decrease in 
adenosine triphosphate (ATP) 
which fuels the sodium-potassium 
ATPase pump. Interstitial fluid 
space expansion is likely caused by 
unravelling of the interstitial space 
matrix with exposure of the pro­
teoglycans to albumin and other 
proteins.2-3 Formerly, ECF expan­
sion during phase II was thought to 
result from increased capillary per­
meability. This concept, however, 
discounts normal albumin kinetics. 
Contrary to popular opinion, only 
45% of ECF albumin is located in 
the plasma; the remainder is within 
the interstitial fluid space. Further­
more, 7% of the 45% in the plasma 
exits the plasma hourly as an equal 
amount exits the interstitial fluid 
space through the lymphatics to 
re-enter the plasma at a remote site. 
In contrast to the “colloid leak” 
theory, our studies have shown that 
the hourly loss of albumin from the 
plasma during phase II is decreased 
to 6%.2 Since, in phase II, plasma 
volume and serum albumin concen­
trations are quite low, this 6% es­
cape rate represents a very small 
amount of albumin flux from the 
plasma. Thus, the mechanism by 
which serum albumin levels become 
low in phase II must be the result of 
an even lower amount of albumin 
which re-enters the plasma from the 
interstitial fluid space (Fig. 3). This 
decrease reflects albumin entrap­
ment within the expanded matrix of 
the interstitial fluid space; the con­
ceptual and therapeutic implications 
of this are enormous. Fluid shifts 
and protein changes with HS result 
more from changes in the dynamics 
of the interstitial fluid space matrix 
and cell membrane responses than 
from leaky capillaries. Thus, thera­
py should restore red blood cell 
mass and plasma volume as judged
by vital signs and not sequential 
weights. During phase II, the 
weight gain often exceeds 10 kg. 
Loop diuresis to prevent or correct 
this ECF expansion may be injuri­
ous because of reductions in plasma 
volume in an already depleted state. 
This may lead to renal shutdown 
which is almost always fatal after 
HS from trauma. Renal function 
during phase II is best maintained 
by a continuous aggressive regimen 
of fluid replacement according to 
our guidelines.
Phase III
Once the ICF and interstitial fluid 
space reach full expansion, the pa­
tient will enter into the fluid mobili­
zation and diuretic phase (phase 
III). During this phase, the cell 
membrane potential returns toward 
normal as the sodium-potassium 
ATPase pump restores normal ionic 
fluxes and the interstitial fluid 
space matrix contracts, thereby in­
creasing protein flux through the 
lymphatics back to the plasma (Fig. 
4). During phase III, the plasma 
volume and the plasma albumin 
level rise, although the serum albu­
min level remains well below normal 
(Fig. 4). Contrary to popular opin­
ion, the amount of albumin “leak­
age” through the capillary system 
into the interstitial fluid space is 
increased (8%). Thus, serum albu­
min concentration in this phase is 
controlled more by changes in the 
interstitial fluid space matrix than 
by capillary permeability. Regard­
less of physiologic mechanisms, the 
hemodynamic responses during 
phase III necessitate an abrupt re­
duction in fluid infusion. The tran­
sition from phase II to phase III 
causes a gradual increase in blood 
pressure and pulse pressure so that 
the need for bolus infusions to 
maintain hourly urine output 
ceases. When these subtle changes
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first appear, immediate restriction 
of fluid intake will reduce the likeli­
hood of postresuscitative hyperten­
sion syndrome.9 This syndrome is 
associated with a sustained rise in 
systolic and diastolic blood pressure 
and is also associated with an in­
crease in the ratio of plasma volume 
to interstitial fluid space when com­
pared with similarly injured patients 
who do not have HS. Therapy in­
cludes fluid restriction and gentle 
diuresis to prevent congestive heart 
decompensation.49
During late phase II and early 
phase III, central pressure may rise 
precipitously. Rather than assuming 
that an elevated wedge pressure 
reflects inotropic failure, the physi­
cian can give a fluid bolus of 500 
ml of balanced electrolyte solution 
over 30 minutes and monitor the 
ratio of left ventricular stroke work 
to pulmonary capillary wedge pres­
sure. When the slope created by 
that monitoring is steep, it can be 
assumed that the elevated central 
pressure is due to lung failure and
not heart failure (Fig. 5). Oliguria 
and hypotension in this setting are 
treated by further fluid replacement 
despite the elevated central pres­
sure. Once the patient enters the 
fluid mobilization phase, fluids are 
slowed and continued recovery can 
be expected as organ function grad­
ually returns to normal.
The Colloid Controversy
Starling, in 1896, stated that the 
vascular efflux of water correlates 
directly with capillary conductivity 
(often misappropriately referred to 
as permeability) multiplied by the 
capillary surface area, with the cap­
illary being influenced by the plas­
ma hydrostatic pressure, interstitial 
hydrostatic pressure, plasma oncot­
ic pressure and interstitial oncotic 
pressure. The equation states that 
the flux of water out of the plasma 
will be inversely related to capillary 
oncotic pressure if all of the above 
factors remain constant.1 Starling
highlighted the inadequacies of this 
equation by emphasizing that it 
does not apply to man because 
there is a third fluid system, the 
lymphatic system, which exits from 
the interstitial space. There are dy­
namic fluid fluxes between the in­
terstitial fluid space and the ICF, 
and dynamic changes probably 
occur in osmotic and hydrostatic 
forces whenever one factor in the 
equation is altered. Despite these 
disclaimers, modern physicians em­
ploy Starling’s equation to justify 
albumin supplementation to the re­
suscitation regimen for HS. When 
our retrospective, nonrandomized 
studies suggested that albumin 
therapy increased pulmonary dys­
function, we stopped using supple­
mental albumin.6 This led to severe 
criticism by other trauma experts, 
thereby, stimulating a prospective 
randomized analysis of albumin 
supplementation.
During a 2-year interval, 94 pa­
tients with HS after trauma were 
randomized to receive albumin or
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FIG. 3. During phase II, plasma volume and serum albumin 
concentration decrease despite reduced efflux of albumin (6%) 
from plasma volume. Thus, increases in interstitial and 
intracellular fluid result from changes in interstitial fluid 
space matrix and cell membrane changes rather than from 
“capillary leak syndrome”.
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FIG. 4. During phase III, plasma volume expands as fluid 
moves from cells and interstitial space.
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no albumin. The average shock 
time exceeded 30 minutes and an
average of 15 blood transfusions 
were given during phase I. The
patients who did not receive albu­
min received blood, balanced elec­
trolyte solution and some fresh- 
frozen plasma to assist coagulation. 
The patients who received albumin 
received human serum albumin also 
in an amount calculated to restore 
serum albumin levels and colloid 
oncotic pressure toward normal and 
based upon multiple sequential 
measurements in similar patients. 
The patients who received albumin 
had a capillary oncotic pressure 
(normal 22 to 24 mm Hg) of 19.7 
mm Hg compared with 14.8 mm Hg 
in the group not given albumin.2 4
Consequent to therapy with 
human serum albumin, the patients 
had a marked rise in serum albumin 
concentration, plasma volume and 
effective renal plasma flow as mea­
sured by para-aminohippurate clear­
ance (Fig. 6). Despite the increase 
in renal plasma flow, these patients 
had a fall in glomerular filtration 
rate, sodium clearance, osmolar 
clearance and urine output.10 
Human serum albumin therapy 
causes an increase in both the on­
cotic and osmotic pressure within 
the glomerulus. This leads to salt 
and water retention and to an in­
crease in the oncotic pressure with­
in the peritubular vessels perfusing 
the inner medulla of the kidney. 
Controversy exists among renal 
physiologists regarding the mecha­
nism by which human serum albu­
min causes sodium retention.11 Our 
findings suggested that the sodium 
retention after human serum albu­
min therapy was due to a sodium- 
potassium exchange at the tubular 
level. These renal effects disrupt the 
original purpose of the human 
serum albumin infusion which is to 
exert an oncotic effect within the 
vascular system in order to extract 
extravascular fluid from the pulmo­
nary interstices and deliver this 
fluid to the kidneys for excretion. 
Unfortunately, the renal effects of 
human serum albumin therapy lead
FIG. 5. When bolus of fluid leads to rise in left ventricular stroke work (LVSW) 
with little change in central pressure (PA„), associated hypotension and oliguria 
are best treated by additional fluid replacement, since elevated pressure results 
from lung failure and not inotropic failure.
FIG. 6. Effects of albumin supplementation in severely injured patients with HS. 
These are statistically significant when compared with similarly injured patients 
not receiving albumin supplementation. F i02/ p 0 2 = fractional intake of ox- 
ygen/oxygen pressure, CVP-Ppw = central venous pressure-pulmonary capillary 
wedge pressure, ERPF = effective renal plasma flow, GFR = glomerular filtration 
rate, CNa =  sodium clearance, Cosm = osmolar clearance.
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to salt and water retention with an 
increased need for diuretic therapy, 
a higher incidence of renal failure, 
worsening pulmonary function, as 
reflected by higher central pres­
sures, increased physiologic shunt­
ing in the lungs and prolonged need 
for ventilatory support.11 The death 
rate after human serum albumin 
therapy was significantly (p < 0.05, 
unpaired Student’s f-test) increased.
Protein Kinetics
The albumin-treated patients had 
a substantial reduction in serum 
globulin levels; this included most 
of the globulin fractions and all 
immunoglobulins.7’12 The reduction 
in immunoglobulin content was as­
sociated with decreased immuno­
globulin activity to tetanus toxoid.
The albumin-treated patients re­
quired more blood transfusions dur­
ing the first 5 postoperative days. 
This was associated with decreased 
fibrinogen activity and prothrombin 
times in albumin patients. Frozen 
plasma samples from the two 
groups of patients then showed 
reduced fibrinogen and prothrombin 
content in the albumin patients.13 
These findings have been repro­
duced in a canine model after albu­
min therapy for HS.14
Further canine studies assessed 
the mechanism of these changes on 
circulating proteins. Animals receiv­
ing 5% albumin therapy for HS had 
a significant, progressive rise in 
serum albumin concentration and a 
fall in the serum globulin concen­
tration. They also had a fall in 
coagulation protein factors and in
coagulation protein activity. When 
1.25% albumin was given, the 
serum changes were no longer sta­
tistically different for the two 
groups, but the albumin-treated ani­
mals had a significant increase in 
lymphatic proteins including albu­
min and globulins.15
We concluded that albumin ther­
apy causes a relocation of intravas­
cular proteins to the interstitial 
fluid space in order to maintain an 
ideal oncotic balance of plasma vol­
ume to interstitial fluid. These con­
clusions have been supported by 
subsequent canine studies in which 
Hespan and fluorocarbon therapy 
were compared with balanced elec­
trolyte solution.1617 The driving 
force of the intravascular colloid 
appears to be dose dependent; as 
the intravascular oncotic pressure 
increases, the amount of albumin 
and globulin leaving the plasma by 
way of prenodal skin lymphatics 
also increases.
Future generations of traumato­
logists will no longer accept the 
sequential studies on plasma- 
volume changes in the scientific 
study of various therapeutic modali­
ties for HS. Our students and resi­
dents in surgery should be stimulat­
ed to look within the interstitial 
fluid space and the ICF when future 
scientific studies on the homeostat­
ic effects of HS are planned.
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5. Trauma and Hypothermia
Andrew L. McCallum, MD, FRCPC
Trauma may be accompanied by hypothermia in all climates. Because of the 
associated increased death rate due to hypothermia (core body temperature less than 
35°C), traumatized patients must be protected from it. The body maintains heat 
balance by hypothalamic regulation of endogenous heat generation and heat loss. 
Decreased core temperature causes generalized physiologic deceleration and 
homeostatic disturbances in all organ systems.
To prevent hypothermia in polytraumatized patients a number of methods may be 
used: warming crystalloid, increasing ambient temperature, the use of warming 
devices, irrigation of body cavities with warmed fluids, heating of inspired gases 
and, in severe cases when there is circulatory instability, the use of extracorporeal 
membrane oxygenation.
Sous tous les dimats, les traumatismes peuvent etre accompagnes d’hypothermie. 
Comme l’hypothermie (une temperature corporelle profonde inferieure a 35°C) 
s’accompagne d’une augmentation du taux de mortalite, les victimes de traumatis­
mes doivent en etre protegees. Le corps maintient son homeothermie par regulation 
hypothalamique de la generation endogene de chaleur et de la perte thermique. 
L’hypothermie cause un ralentissement physiologique generalise et des derange­
ments homeostatiques sont observes dans tous les systemes organiques en rapport 
avec un abaissement de la temperature profonde.
Plusieurs methodes peuvent etre utilisees pour prevenir Thypothermie chez les 
polytraumatises: solutes cristalloides rechauffes, augmentation de la temperature 
ambiante, utilisation d’appareils de rechauffement, irrigation des cavites corporelles 
a l’aide de solutes chauds, rechauffement des gaz inspires et, dans les cas graves, 
quand il y a instability circulatoire, emploi de membranes d’oxygenation extracorpo- 
relle.
Trauma may be accompanied by hypothermia (core body tem­
perature less than 35 °C) in all 
climates. There are two possible 
causes for this phenomenon: first, 
the victim is injured in an environ­
ment which is cold or wet enough 
to produce hypothermia; second,
the victim must undergo complicat­
ed and prolonged resuscitation for 
major trauma. The former cause 
has been reported only once in the 
last 5 years.1 The latter cause is 
much more common. Recent publi­
cations indicate that hypothermia 
accompanies 42% to 66% of major
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trauma (Injury Severity Score [ISS] 
greater than 25).23 Most disturbing 
is the association between hypo­
thermia and increased mortality in 
trauma patients noted by Jurkovich 
and colleagues.3 They found that 
the death rate in seriously injured 
patients varied between 69% and 
100% if the body core temperature 
(Tc) was less than 33°C. Clearly, 
polytrauma victims must be protect­
ed from hypothermia. In this paper 
I shall outline mechanisms by 
which core temperature is lowered 
in trauma victims and discuss meth­
ods by which hypothermia can be 
prevented in trauma patients and 
treated when it does occur.
Temperature Regulation
Heat is transferred in four ways: 
by radiation, conduction, convec­
tion and evaporation. Since water 
has a specific heat 32 times greater 
than that of air, humans who are 
immersed in cool-cold water or 
who receive cool fluids or blood 
intravenously may become hypo­
thermic owing to conductive heat 
loss.4 Mammals are homeotherms 
and have evolved a complex physio­
logical system to maintain normo- 
thermia. In man, the temperature 
control centre is in the anterior 
preoptic hypothalamus. This centre 
receives afferent nerves from the 
spinothalamic tracts, and they relay 
information from visceral, great ves­
sel and skin temperature receptors. 
The hypothalamus maintains Tc at 
37.5° to 38.5°C and responds to 
deviations from this range in a
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predictable fashion. It responds to a 
decrease in Tc by causing vasocon­
striction of the outer shell arterioles 
and venous plexi, causing shivering 
(isometric muscular heat produc­
tion), and by alerting the conscious 
brain to the fact that the body is 
cold, leading to protective actions 
such as donning extra clothes. 
Other mechanisms of heat produc­
tion such as non-shivering ther­
mogenesis are relatively unimpor­
tant in adults.4
Pathophysiology of 
Hypothermia
Hypothermia causes generalized 
physiological deceleration in all 
body systems. Cerebral oxygen con­
sumption decreases 3% to 7% for 
each degree decrease in Tc, thus 
providing a relative protective effect 
on the brain. In the 1950s, cerebral 
circulation was deliberately stopped 
for up to 1 hour, without ill effect, 
in the operating room in patients 
who underwent cardiac surgery 
with induced hypothermia (Tc of 
18°C).5 The same phenomenon ren­
ders the clinical and electroencepha- 
lographic detection of brain death 
impossible. Usually hypothermia 
does not induce unconsciousness if 
the Tc is greater than 30 °C.4-6
The major effects of hypothermia 
on the heart are twofold. First there 
is a generalized slowing of sinoatri­
al node activity accompanied by a 
decrease in myocardial contractility. 
Second there is an increased poten­
tial for dysrhythmias, manifesting 
as atrial fibrillation in the early 
stage of hypothermia, but seen as 
spontaneous ventricular fibrillation 
in patients with a Tc less than 
29°C. Rough handling, endotrache­
al intubation and cannulation of the 
central veins and heart have been 
found to induce ventricular fibrilla­
tion in hypothermic patients, but 
fear of these complications should
not inhibit treatment.7 Examination 
of the electrocardiogram may show 
the pathognomonic J or Osborn 
wave.4-6'8-9 Cold initially induces 
bronchorrhea and later causes pul­
monary edema, leading to a de­
crease in arterial oxygen pressure. 
Hypoxia is exacerbated by the cold- 
induced leftward shift of the oxyhe­
moglobin dissociation curve. Respi­
ratory frequency decreases propor­
tionately to Tc. Finally, nasal hu­
midification and exhalation of 
warmed gas may lead to the loss of 
40 to 45 J /h .6
Vasoconstriction of the outer 
shell blood vessels results in a rela­
tive increase in central blood vol­
ume and a higher renal blood flow. 
Thus, a relative diuresis occurs in 
hypothermic patients. The diuresis 
is increased by the decrease in oxi­
dative metabolism in the nephron, 
leading to a diminished reabsorp­
tion of water.4-6
Electolyte disturbances may ac­
company decreased Tc. Depression 
of Na-K ATPase action in the sodi­
um-potassium pump may lead to 
extracellular fluid hyperkalemia and 
hyponatremia that is usually not of 
clinical importance.
The alterations in blood pH with 
hypothermia are complex and con­
fusing. The net effect of decreased 
Tc is to decrease pH. Current rec­
ommendations are to measure blood 
pH and gases without correction as 
though they had been drawn at 
normal Tc, thereby giving normal 
values for the warmed patient.10-11 
Hypothermia is associated with de­
creased insulin activity when Tc is 
less than 30°C. However, blood 
glucose levels are variable; about 
50% of hypothermic patients are 
hypoglycemic. Some authorities 
have recommended the routine ad­
ministration of intravenous 50% 
glucose to all patients who have 
hypothermia, in order to correct 
hypoglycemia.6
Blood viscosity increases by 2%
for every degree Celsius, concomi­
tant with an increase in hematocrit. 
Decreased Tc causes platelets to be 
sequestered in the liver and alters 
coagulation cascade function so 
that disseminated intravascular co­
agulation may occur. Coagulopathy 
may be aggravated by acidemia and 
by dilution of coagulation factors 
and platelets when partial blood 
products are administered.12
General Treatment
The trauma victim is figuratively 
walking a fine line between effective 
compensatory mechanisms and in­
cipient organ-system failure. It is 
much more important to prevent a 
decrease in the Tc in these patients 
than in a normal population. Also, 
very young, very old and debilitated 
patients may have blunted homeo­
static responses to cold stress. 
Thus, trauma victims require care­
ful monitoring of Tc.
Prevention of Hypothermia in 
Trauma
The potential for hypothermia 
must be considered in every trauma 
patient. Table I summarizes the 
factors that predispose the trauma 
patient to hypothermia.
Measures to prevent hypothermia 
must be routine in the trauma re­
suscitation room. The patient 
should be on a warming blanket 
and covered with blankets when not 
being examined. Wet sheets should 
be removed immediately. All pa­
tients need Tc monitoring with a 
continuous-reading thermocouple. 
Ideally, the esophageal temperature 
should be monitored at the distal 
end, because it correlates best with 
myocardial temperature, but moni­
toring of the rectal or tympanic 
membrane temperature is accept­
able as a substitute.13
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Ideally, all intravenous or enteral 
solutions should be warmed before 
they are administered.13-15 All intra­
venous infusion sets should have 
warming devices inserted in-line, as 
these are a safe and convenient way 
to pre-warm intravenous fluid and 
blood for transfusion (commonly at 
4°C). The device that allows the 
greatest rate of infusion with capac­
ity to warm fluid to 42°C is a 
single-channel counter-current heat 
exchanger as measured by thermal 
clearance.16 Intravenous solutions 
can be warmed effectively in a mi­
crowave oven,17-19 but experimenta­
tion with different oven models is 
necessary before using this method 
because of the huge variation in 
heating capacity. One author has 
raised concern about caramelization 
of glucose in intravenous solutions 
due to “hotspots” during heating,17 
but other studies have failed to 
confirm that caramelization is a 
legitimate concern.18'19
The temperature of the operating 
room should be maintained at 21° 
to 24°C,20 because the incidence of 
intraoperative hypothermia rises 
sharply when the ambient tempera­
ture is less than 21°C.
Finally, simple measures such as 
increasing patient insulation with 
blankets or installing a humidifying 
sponge in the ventilating circuit 
(the so-called “artificial nose” ) can 
decrease the rate of heat loss in the 
trauma patient, as can heating in­
spired gases.
Management of Hypothermia in 
Trauma
Relatively little has been written 
about resuscitation of hypothermic 
trauma victims. However, many of 
the techniques now used to treat 
pure hypothermia patients may be 
adapted to the trauma victim.7-21-27 
Table II summarizes the methods 
used to treat hypothermia. Note 
that passive methods of rewarming 
rely on endogenous metabolic heat 
and are thus ineffective in pro­
foundly hypothermic patients (Tc 
less than 30 °C). Active methods are 
subdivided into external and core 
rewarming. Many of the methods 
listed in Table II, such as immersion 
in a water bath, are difficult to use 
in the polytrauma victim. Other 
methods, such as anticoagulation
required for hemodialysis or ex­
tracorporeal membrane oxygenation 
(ECMO), may exacerbate the pa­
tient’s problems. Great care must 
therefore be taken during the resus­
citation of the traumatized and hy­
pothermic patient.
The passive methods of rewarm­
ing should be used routinely. The 
patient can be placed on a warming 
blanket or covered with warmed 
blankets. If available, radiant heat 
can be a useful adjunct. Rewarming 
the extremities should be avoided, 
because there is a risk of afterdrop, 
which is defined as a drop in Tc 
resulting from cold, acidotic blood 
returning from the extremities.
Intravenous fluids should be 
warmed to 41° to 42°C, as should 
inspired gases. Gases also need hu­
midification. Gastric, peritoneal and 
rectal lavage may be useful; they 
can raise the Tc by 5° to 1 0 °C /h .7
It has been argued that no pa­
tient should be actively re-warmed 
because of the risk of inducing 
intractable ventricular fibrillation. 
This phenomenon can occur when 
cold, acidotic blood returns from 
the peripheral shell to the core as a 
result of secondary vasodilation. 
Ventricular fibrillation is usually 
not reversible at a Tc below 29 °C 
but may respond to the administra­
tion of bretylium tosylate.23 The 
risk of spontaneous ventricular fi­
brillation is probably equal to the 
risk of rewarming-induced ventricu­
lar fibrillation, so a recommendation 
for active rewarming can be made. 
The risk of induced ventricular fi­
brillation can be diminished by 
preoxygenation of the patient be­
fore all invasive procedures.26
The physician must avoid re­
warming shock. This occurs be­
cause of rewarming-induced vasodi­
lation in a relatively hypovolemic 
patient. Pre-loading the patient with 
sufficient fluid intravenously can 
prevent this problem.
If the patient is pulseless, cardiac
T a b le  1. Factors Predisposing the Trauma Patient to Hypothermia
P atien t factors Exogenous fac to rs
Nakedness Cool room
Paralysis (no shivering) Cool intravenous solutions
Iatrogenic origin and cold blood transfusions
Cord lesion (4°C)
Head injury Wound irrigation 
Vasodilating anesthetics 
Cool, dry gas fo r ventilation
T a b le  II. Methods of Treatment for Hypothermia
A ctive
P ass ive External C ore
Remove from cold Hot tub Hot food/drink
and wind Forced warm air Warm intravenously
Remove wet clothing Hot-water bottle Gastric lavage
Increase insulation Warming blanket 
Radiant heater
Heated oxygen 
Dialysis 
Cavity lavage 
Extracorporeal mem­
brane oxygenation
CAS, VOL. 33, NO. 6, DECEMBER 1990 459
McCALLUM
massage can be started at half-nor­
mal rates. However, chest compres­
sion can induce ventricular fibrilla­
tion in the hypothermic patient, and 
vital signs may be difficult to de­
tect. Therefore, all vital-sign assess­
ment times should be increased and, 
ideally, invasive hemodynamic mon­
itoring should be instituted. If the 
patient is pulseless ECMO may be 
helpful but is fraught with difficulty 
in the polytrauma patient. This mo­
dality should be considered a last 
resort2122 and used only in the 
pulseless but potentially viable pa­
tient.
Conclusions
Excessive metabolic energy may 
be wasted in maintaining thermic 
homeostasis in the trauma patient. 
The patient may be hypothermic 
before arrival in hospital or become 
so in hospital. Hypothermia in­
creases the death rate in trauma 
patients, so prevention of hypo­
thermia is of paramount impor­
tance. Rewarming the hypothermic 
patient is complex but can be 
achieved by monitoring and rela­
tively simple warming techniques. 
Afterdrop and rewarming shock 
must be anticipated and avoided. 
Because hypothermia has a depres­
sive effect on cerebral function, it is 
essential that complete rewarming 
is carried out and every effort at 
resuscitation is made before a pa­
tient is pronounced dead.
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6. Update on Trauma Registries and 
Trauma Scoring
Developments in microcomputer technology and user friendly software have resulted 
in rapidly expanding interest in trauma registries and injury scoring. The 
trauma registry, particularly when it is population based, is an empowering tool for 
epidemiologic research, planning of trauma systems, development of prevention 
programs, outcome evaluation and research. Injury coding performed in conjunction 
with trauma registry can also provide the basis for institutional quality assurance. 
The Major Trauma Outcome Study has played a major role in this, through the 
development of normative standards, permitting inter-institutional comparisons. 
These issues as well as some of the present Canadian and American initiatives in the 
trauma registry field are reviewed in this paper. Advances in injury scaling are 
addressed as are some of the limitations in existing coding methodologies.
Les progres de la technologie des microordinateurs et le developpement de logiciels 
d’acces facile ont entraine un accroissement rapide de l’interet pour l’enregistrement 
des traumatismes et T evaluation des blessures sur echelles de mesure. L’enregistre­
ment des traumatismes, surtout lorsqu’il est rapporte a une population donnee, est 
un outil puissant de recherche epidemiologique, de planification des systemes, de 
developpement des programmes de prevention et devaluation et de recherche. La 
codification des blessures associee a Tenregistrement des traumatismes peut aussi 
servir au controle de la qualite des etablissements de sante. L’Etude sur Tissue des 
traumatismes graves a joue un role preponderant a cette fin, grace a Tetablissement 
de normes permettant des comparisons entre les etablissements. La presente 
communication traite de ces questions de meme que des initiatives canadiennnes et 
americaines en matiere d’enregistrement des traumatismes. On y traite aussi des 
progres dans le domaine de echelles devaluation des blessures ainsi que des limites 
des methodes actuelles de codification.
Judith A. Vestrup, MD, FRCSC
The ready availability of micro­computers and of user-friendly 
software has resulted in increased 
interest in medical databases. No­
where has this been more evident 
than in the rapidly expanding area 
of trauma registries. The trauma 
registry is rightly recognized as a 
powerful tool for epidemiology 
studies, planning and evaluation of 
prevention programs, quality assur­
ance, trauma systems design, and
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research. I will highlight some of 
the recent developments in trauma 
registry and injury scoring and in 
the implementation of coding and 
registry programs.
Deficiencies in Trauma 
Registries
The first comprehensive effort at 
a population-based trauma registry
began in 1970 when a computer­
ized state-wide trauma registry was 
established in Illinois. The aim was 
to collect over 700 data fields per 
trauma patient, for a 5-year period; 
a loss of federal funding brought an 
end to this registry. Subsequently 
an evaluation review identified a 
number of problems with the ap­
proach taken.1 Underreporting was 
one of many difficulties encoun­
tered, with only 37% of cases admit­
ted to hospital appearing in one 
study sample. The critics concluded 
that registry goals need to be very 
clearly defined and that funding, 
staffing and a mechanism for evalu­
ating the completeness and accura­
cy of case reporting must be in 
place. They also concluded that 
minimizing the number of data ele­
ments to be captured would help in 
achieving compliance with case re­
porting.
Another issue that has been 
raised is the deficiency in hospital- 
based rather than population-based 
registries.23 In particular, Payne 
and Wallers’ study3 of woodwork­
ing and logging injuries showed 
major differences between hospital­
ized and ambulatory patients and 
between primary care and inter- 
institutional transfer patients. To 
achieve a more comprehensive data­
base they recommended that sam­
pling techniques be applied to am­
bulatory care patients and to pre­
hospital deaths.
Development of Trauma 
Registries
The recent impetus for registry 
development has stemmed from in­
creased awareness that “ injury is 
no accident” and that standard epi-
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demiologic tools can be applied to 
the study of injury4 and from the 
need for hospitals to demonstrate to 
funding agencies that their trauma 
programs are both cost effective 
and provide an exemplary standard 
of care (outcome evaluation).
Leadership in the field has been 
shown both by the American Col­
lege of Surgeons and by the United 
States Centers for Disease Control 
(CDC). In the American College of 
Surgeons Major Trauma Outcome 
Study (MTOS) a minimal data set 
was used to accumulate information 
on more than 60 000 injured pa­
tients reported by 118 acute care 
institutions in the US and Canada5 
and normative standards were pro­
duced against which each trauma 
centre can measure its own perfor­
mance. In addition, the MTOS illus­
trated the limitations of using the 
injury severity score (ISS)6 as the 
only measure of trauma severity. 
Thus, the MTOS has made a major 
contribution to the North American 
understanding of the power of the 
trauma registry and its value to 
quality assurance programs.
Another breakthrough occurred 
in 1985 when the CDC received a 
congressional mandate to develop a 
new injury research program. This 
resulted in the establishment of the 
Division of Injury Epidemiology and 
Control,7 which subsequently led to 
the organization of a trauma regis­
try workshop at the CDC in Janu­
ary 1988. This meeting was co­
sponsored by the American College 
of Surgeons, the American College 
of Emergency Physicians and other 
groups having a special interest in 
developing trauma registries.8 They 
demonstrated that an interdisciplin­
ary consensus on a minimal data set 
can be achieved. Subsequently, the 
CDC has produced a trauma regis­
try software package which has 
been acquired by over 40 hospitals 
and is available to institutions in 
Canada and the United States free
of charge (Pollock DA, Biometrics 
Branch, Division of Injury, Epidemi­
ology and Control, Centers for Dis­
ease Control, Atlanta, Ga.: Personal 
communication, 1989).
Although the CDC project had as 
its initial aim the development of a 
standardized hospital-based regis­
try, Australia, with its National In­
jury Surveillance and Prevention 
Project started in 1986, has taken a 
different approach, by attempting to 
develop a broader based system, 
recording all injuries resulting in 
visits to emergency departments not 
just those resulting in hospital ad­
mission. This registry has two com­
ponents, a self-administered ques­
tionnaire on the injury circum­
stances, filled out by the patient or 
a relative, and a clinical component 
completed by a physician. Using 
this format over 100 000 injuries 
have been reported over an 
18-month period. A review of this 
study highlights well the challenges 
in achieving high capture rates and 
evolving a population-based regis­
try.9
In Canada the Trauma Associa­
tion of Canada and the Ontario 
Ministry of Health jointly sponsored 
a national consensus conference in 
June 1989 aimed at developing con­
sensus amongst governmental, clin­
ical, injury prevention and other 
interested agencies on a minimal 
data set that could ultimately be 
used to achieve a national trauma 
registry. This conference was well 
attended, with representation from 
the federal Ministry of Health and 
Welfare, five provincial health min­
istries, the Canadian Medical Asso­
ciation, the Canadian Association of 
Emergency Physicians, the Canadi­
an Association of General Surgeons 
and the Canadian Orthopaedic As­
sociation. At the provincial level, 
both Ontario and British Columbia 
have allocated funding to the devel­
opment of a province-based regis­
try, with similar efforts also under
way in other provinces. It is hoped 
that these projects can be melded 
into a minimal data set that will 
permit interprovincial sharing of 
data and ultimately a national data­
base. A number of trauma hospitals 
in Canada maintain hospital-based 
trauma registries, some having de­
veloped their own software pack­
ages, others making use of com­
mercially available ones. For those 
interested in hospital-based regis­
tries the issues and potential pitfalls 
are well detailed in Payne and Wal­
ler’s study.3
Projects are also under way to 
develop a pediatric trauma registry. 
Tepas and associates10 recently re­
ported on a US national pediatric 
trauma registry, which has collect­
ed data on 10 177 children from 32 
centres and has already resulted in 
a number of presentations and pub­
lications. Like other registries it 
suffers from high initial error rates 
in data reporting, and because it is 
hospital based it lacks an accurate 
population denominator. Despite 
this, the study has helped to estab­
lish patterns of injury disability and 
has tracked changes in clinical 
practice within the reporting insti­
tutions. A Canadian initiative spear­
headed by the Childhood Diseases 
Injury Section of the Labora­
tory Centre for Disease Control in 
Ottawa is about to undertake a 
prospective data collection from the 
10 Canadian pediatric teaching hos­
pitals (Sherman GD, Childhood Dis­
eases and Injury Section, Laborato­
ry Centre for Disease Control, Otta­
wa, Ont.: Personal communication, 
1989). This study will use the same 
database as the National Injury and 
Surveillance and Prevention Project 
of Australia.
There is also growing interest in 
injury-specific trauma registries. 
Currently, the American Burn Asso­
ciation is attempting to develop a 
minimal data set, for use by all its 
associated institutions, with the ob-
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jective of providing a more repre­
sentative view of burn injury issues 
in the US (Heimbach DM, Harbor- 
view Medical Center, Seattle, 
Wash.: Personal communication, 
1989). Dr. Charles Tator collects 
data on sports injuries through the 
Canadian Sports Spine and Head 
Injury Research Centre in Toronto. 
In addition British Columbia has 
established a prospective spinal 
cord injury registry. A Canadian 
spinal cord injury registry has also 
been proposed.
Injury Scoring Systems
An important spin off of all these 
developments has been the growing 
awareness of the importance of in­
jury scoring in permitting inter- 
institutional comparisons of trauma 
populations and outcomes. Indeed, 
it is unlikely today that peer- 
reviewed journals or granting agen­
cies will accept trauma papers or 
research proposals without evidence 
that the patient population is char­
acterized by some form of injury 
coding.
Trauma scoring systems are gen­
erally divided into physiological sys­
tems, which are used for pre-hospi­
tal triage and for assessing the 
efficacy of pre-hospital care inter­
ventions, and anatomical scoring 
systems, which provide information 
on injury severity, thereby permit­
ting the development of normative 
standards for evaluating outcome. 
Although there are many physiolog­
ical scoring systems,11 the most 
commonly used has been the trau­
ma score. Recently, Sacco and col­
leagues5 have proposed a revised 
trauma score that requires field per­
sonnel to record only Glasgow coma 
scale, systolic blood pressure and 
respiratory rate. In addition to sim­
plifying their task, this revision has
resulted in improved predictive val­
ue. The abbreviated injury scale 
(AIS-85), which is the most widely 
accepted anatomic scale for injuries, 
has undergone revision and the new 
version will be available early in 
1990 (Petrucelli E, Executive Direc­
tor, Association for the Advance­
ment Of Automotive Medicine, Des 
Plaines, 111.: Personal communica­
tion, 1989). This revision will pro­
vide increased descriptive material 
for defining injuries and will en­
deavour to incorporate terminology 
currently used in ICD-9 descriptors. 
Although the ISS, which uses the 
AIS of the three most seriously 
injured body regions squared and 
summed to create a severity score, 
has become the standard for report­
ing injury severity, certain me- 
thodologic problems have been 
identified.5-12 Those already familiar 
with the use of the AIS/ISS recog­
nize that the ISS may not always 
accurately reflect the seriousness of 
injury. For example, the ISS makes 
no provision for the additive effect 
of multiple injuries in one body 
region. Bilaterality of musculoskele­
tal injuries, which affects morbidity 
and length of hospital stay is also 
not reflected in the ISS. Some of 
these issues have been addressed by 
Sacco and colleagues5 by the intro­
duction of severity profiles which, if 
validated, hold promise for improv­
ing the predictive value of anatomic 
injury data.
The other important development 
on the horizon is the introduction 
of a variety of coding aids to short­
en the learning curve for injury 
coders and to improve coding con­
sistency. These aids run the gamut 
from software packages designed to 
assist in deriving ICD-9 E codes7 to 
Tri-Code (Tri-Analytics, Inc., Bel 
Air, Md.), which will translate a 
narrative injury description into 
both AIS and ICD-9 codes.
All these developments reflect 
great interest and research activity 
in the areas of injury coding, which 
is leading to refinements both in 
methodology and in applications of 
these scaling systems. The enhance­
ment of scoring systems can only 
add to the power of trauma registry 
in shaping the focus of injury pre­
vention campaigns, setting quality 
assurance standards and planning 
trauma care systems.
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to be the active component of sulfasalazine. 
Although its mode of action has not been 
definitely elucidated, 5-ASA is thought to 
have a topical anti-inflammatory effect which 
is produced by inhibition of prostaglandin 
and/or leukotriene synthesis.
Mesasal™ tablets have an acrylic based resin 
coating which is specifically designed to 
release 5-ASA in the terminal ileum and 
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that 35% of the 5-ASA is absorbed. The 
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excreted mainly by the kidney.
Detectable plasma levels of 5-ASA were 
seen 4 hours after a single oral dose of 
tablets (2 x 250 mg). Peak plasma levels 
of 5-ASA and N-acetyl-5-ASA were 1.2 
and 1.9 pg/mL, respectively, and occurred 
6.5 - 7 hours post-dosing. Mean steady- 
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N-acetyl-5-ASA using a 500 mg t.i.d. 
dosage schedule are 0.7 and 1.2 pg/mL, 
respectively.
Except for a delay of 1.5 - 3 hours in time to 
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contraindicated where there is a history of 
hypersensitivity to salicylates.
Mesasal™ is contraindicated in cases of 
hemorrhagic diathesis.
Mesasal™ is contraindicated in patients with 
existing gastric and duodenal ulcers. 
Mesasal™ is contraindicated in patients with 
urinary tract obstruction.
WARNINGS
In cases of severe liver and kidney disorders, 
caution should be exercised.
Use in Pregnancy:
In the first three months of pregnancy, 
treatment is recommended only if potential 
benefits outweigh the possible risks. 
Pediatric Use:
There is no experience with respect to the 
use of this drug in children; potential 
benefits should be weighed against possible 
risks.
PRECAUTIONS 
Drug Interactions:
The blood-sugar reducing effect of sulfonyl 
ureas may be enhanced. Interactions with 
coumarins, methotrexate, probenecid, 
sulfinpyrazone, spironolactone, furosemide 
and rifampicin cannot be excluded. 
Potentiation of undesirable glucocorticoid 
effects on the stomach is possible.
In long term therapy, periodic urinalysis 
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sulfasalazine.
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Tablets
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CANADIAN SOCIETY OF CARDIOVASCULAR AND 
THORACIC SURGEONS
Aortic Dissection: Current Expectations 
and Treatment. Experience With 258 
Patients Over 20 Years
G. Fradet, MD, MSc, FICS, FRCSC; W.R.E. Jamieson. MD. FACS, FRCSC;
M.T. Janusz, MD, FRCSC; H. Ling, MD, FRCSC; R.T. Miyagishima, MD, FACS, FRCSC;
A.I. Munro, MD, FRCS, FRCSC
Aortic dissection, the most common acute disease of the thoracic aorta, is associated 
with high mortality and morbidity. The authors reviewed their experience over the 
last 20 years with 258 patients who had aortic dissection (259 dissections). The 
diagnosis was made at autopsy in 69 (27%) patients (59 type A, 10 type B). Of the 
remainder, 97 patients had type A dissection (78 acute, 19 chronic) and 93 had type 
B dissection (56 acute, 37 chronic).
The sudden onset of severe, unremitting chest pain associated with hyper- or 
hypotension or a history of hypertension are suggestive of acute aortic dissection. 
The diagnosis should be followed by prompt investigation and treatment. The 
30-day survival rate for patients with type A dissection who underwent surgical 
treatment was 62%; survival rates for patients with type B dissection, acute and 
chronic, were 70% and 86% respectively with pharmacotherapy and 66% and 91% 
with surgery.
The authors stress the importance of early, accurate diagnosis and immediate 
surgical treatment for all patients who have type A dissection and complicated or 
unresponsive (carefully monitored pharmacologic control of blood pressure) type B 
dissection.
La dissection aortique est la pathologie la plus frequente de Taorte thoracique, se 
manifestant par un tableau de presentation clinique soudaine et souvent severe. 
Cette entite est associee a un taux eleve de morbidity et de mortalite. Les auteurs 
ont revu leur experience des 20 dernieres annees representant 258 patients avec 
259 dissections. Chez 69 patients (27 pourcent), le diagnostique ne fut etabli qu’a 
l’autopsie (59 de type A, 10 de type B). Quant au reste de la population, 97 patients 
ont de type A (78 de presentation clinique aigue, 19 chronique) et 93 de type B (56 
de presentation clinique aigue, 37 chronique).
Le diagnostic de dissection aigue de l’aorte devrait etre soupconne lors de 
Tapparition soudaine de douleurs thoraciques severes, souvent persistentes, asso- 
ciees ou non a de l’hypo- ou de Thypertension, ainsi que la presence d’une histoire 
medicale anterieure d’hypertension. Lorsque le diagnostic est soupfonne, une 
investigation prompte ainsi que Tinitiation rapide du traitement approprie est 
necessaire. Le taux de survie obtenu chez les patients de type A qui ont subi un 
traitement chirurgical est de 62 pourcent. Le taux de survie chez les patients de 
type B est de 70 pourcent et 86 pourcent respectivement pour ceux de presentation 
clinique aigue et chronique ayant ete traites par pharmacotherapie alors que ceux 
ayant subi un traitement chirurgical ont un taux de survie de 65 pourcent et 91 
pourcent respectivement.
Les auteurs demontrent Timportance d’un diagnostic precis et rapide suivi d’un 
traitement chirurgical immediat pour toutes les dissections de type A ainsi que 
celles de type B avec presentation clinique severe ou ne repondant pas de fa?on 
satisfaisante au traitement medical ayant pour but le controle pharmacologique de la 
pression sanguine.
T he frequency of aortic dissec­tion annually is 5 to 10 per 1 
million population.1-2 It is a condi­
tion usually associated with cystic 
medial necrosis and atherosclerosis. 
An intimal tear as the initial event is 
followed by antegrade or retrograde 
propagation, or both, o f a dissect­
ing hematoma in the outer half of 
the aortic media. Three scenarios 
can then develop alone or in con­
junction. The dissecting hematoma 
can come to a halt, it can re-enter 
the true arterial channel or it can 
rupture externally. The rapidity 
with which the dissection pro­
gresses and its extent are directly 
related to the mean arterial blood 
pressure and the maximal rate of 
rise o f the blood pressure 
(dP/dTmax).3-5 Without early rec­
ognition and treatment, 50% o f the 
patients who have acute aortic dis-
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section (less than 14 days since the 
onset of symptoms) will die within 
48 hours of the onset of symptoms, 
and 90% of them will die within 3 
months.6-10 Early, accurate diagno­
sis is therefore essential for success­
ful management. However, this is 
difficult because of the multiple 
forms of clinical presentation and 
the often-complicated course of 
acute aortic dissection.
The current therapeutic approach 
has evolved over the last 30 years; 
DeBakey, Cooley and Creech11 re­
ported their early, successful, surgi­
cal experience in 1955. The cur­
rently accepted standard of treat­
ment consists of early aggressive 
surgical therapy for all cases of 
dissection involving the ascending 
aorta (type A). Surgical intervention 
is directed at resection or repair of 
the involved ascending aorta, pre­
serving, if possible, the aortic valve 
(with or without leaflet resuspen­
sion), unless it is found to have a 
primary abnormality.6'7'9’12-17 Con­
troversy still exists about the treat­
ment of type B dissection, which 
involves the descending thoracic 
aorta but not the ascending aorta. 
Many still follow the initial recom­
mendation of Wheat, Palmer and 
Bartley3 to base drug therapy on 
the pharmacologic control of blood 
pressure and pulse pressure for type 
B dissections.1'2'6'7'9'12'14'15'18-20 How­
ever, Miller and colleagues,17 re­
porting the Stanford experience in 
1979, showed improved surgical re­
sults in patients with type B dissec­
tion, likely resulting from improved 
surgical and cardiopulmonary by­
pass techniques and from increased 
expertise. Miller and colleagues rec­
ommended immediate operation for 
all type B dissections as the treat­
ment of choice.
In this paper we review our last 
20 years’ experience with 258 pa­
tients who suffered aortic dissec­
tion, and present and comment on 
the current expectations and treat­
ment of this most common acute 
disease of the aorta.
Patients and Methods
Between January 1966 and De­
cember 1986, 259 aortic dissections 
were documented in 258 patients 
(177 men, 81 women) by angiogra­
phy, computed tomography, opera­
tion or autopsy. The patients 
ranged in age from 19 to 97 years 
(mean 61 years). The type of dissec­
tion was classified according to the 
definition proposed by Daily and 
associates21 from Stanford in 1970: 
type A dissection involves the as­
cending aorta, irrespective of the 
site of the primary intimal tear; all 
other thoracic dissections not in­
volving the ascending aorta are 
classified type B; the process is 
considered acute if there is less 
than 14 days from the onset of 
symptoms to the initiation of treat­
ment. The type of dissection in our 
258 patients is set forth in Table I. 
One patient sustained type A and 
type B dissections 5 years apart. In 
69 instances, the diagnosis was 
established only at autopsy.
Results
The most common symptom at 
the time of presentation, both type 
A and B dissections, was pain (Ta­
ble II), which was usually sudden 
and unremitting. A substantial pro­
portion of our patients presented 
with major complications at the 
time of diagnosis (Table III). These 
included hemopericardium, hemo­
thorax, major vessel involvement, 
cerebrovascular accident, aortic in­
sufficiency or paraplegia (anterior 
spinal artery syndrome).
The 30-day survival rates after 
admission and diagnosis are shown 
in Table IV for the different groups 
of dissection. Of the patients who 
died within 30 days of surgery, 9 
could not be weaned off cardiopul-
Table 1. Classification of 259 Aortic Dissections According to Method of Diagnosis and Treatment
in 258 Patients*
Type A Type B Total no. of
Diagnosis/treatment Acute Chronic Acute Chronic dissections
Autopsy 58 1 9 1 69
Clinical diagnosis
Medical therapy 17 3 27 14 61
Surgical therapy 61 16 29 23 129
Totals 136 20 65 38 259
*0ne patient sustained both type A and type B dissections 5 years apart.
Table II. Symptoms and Signs by Type of Dissection
Type A, no. (%) Type B, no. (%)
Symptom/sign (n =  156) (n =  103)
Anterior chest pain 79 (51) 44 (43)
Back pain 29(18) 43 (42)
Abdominal pain 11 (7) 15(14)
Neck and/or jaw pain 24(15) 2 (2)
Collapse 28(18) 3 (3)
Vascular occlusion 12 (8) 9 (9)
Visual disturbance 3 (2)
Table III. Complications at Time of Initial 
Presentation
Complication No. (%)
Hemopericardium 58 (22)
Hemothorax 22 (8)
Multiple vessel involvement 38 (15)
Cerebrovascular accident 15 (6)
Aortic insufficiency 29(11)
Paraplegia 8 (3)
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monary bypass, 3 suffered massive 
cerebral infarction and 22 died of 
uncontrollable hemorrhage (Table 
V). Among the medically treated 
patients who died (Table VI), two 
(one acute type A and one acute 
type B) had myocardial infarction; 
one was given only supportive med­
ical treatment because of extensive 
mesenteric infarction and eventually 
died of sepsis and shock. Thirteen 
patients (11 acute type A, 2 acute 
type B) died of tamponade, 7 pa­
tients (2 acute type A, 4 acute type 
B and 1 chronic type B) died of 
exsanguination into a pleural cavi­
ty, and 1 patient with chronic type 
B dissection died as a result of 
rupture of the hematoma into the 
abdominal cavity.
The influence of preoperative 
medical therapy was assessed, con­
sidering the outcome of all 51 sur­
gically treated patients with acute 
type B dissection. Nineteen (76%) of 
25 patients patients who underwent 
initial surgical therapy without a 
trial of medical treatment survived 
more than 30 days. Of the remain­
ing 26 patients, who initially under­
went a trial of medical therapy and 
later required surgery because of 
complications or failure of the medi­
cal therapy, 17 (65%) survived. All 
patients who underwent initial sur­
gical treatment presented with un­
remitting or recurrent pain, with or 
without complications.
Discussion
Of the 259 dissections 69 (27%) 
were diagnosed at autopsy, because 
of the variety of clinical presenta­
tions of aortic dissection and the 
difficulty of establishing an early 
diagnosis. This re-emphasizes the 
need for constant awareness of this 
entity, so that the diagnosis can be 
established as early as possible once 
clinical symptoms have appeared, 
particularly in view of the poor 
prognosis of the “undiagnosed” 
aortic dissection and, thus, the un­
treated patient. The acute onset of 
severe chest, back or upper abdomi­
nal pain associated with hyper- or 
hypotension or with a medical his­
tory of hypertension should prompt 
the physician to consider the diag­
nosis of acute aortic dissection. The 
association of hypertension, at the 
time of initial evaluation, with type
B dissection and the frequent asso­
ciation of hypotension with type A 
dissection was shown in our previ­
ously reported analysis of our last 6 
years’ experience.2 A substantial 
proportion of these patients present 
with major complications, empha­
sizing the need for prompt stabiliza­
tion, investigation and treatment to 
minimize morbidity and mortality.
Our approach to the patient sus­
pected of having an acute aortic 
dissection encompasses medical 
therapy for pain and pharmacologic 
control of the pulse pressure 
(dP/dT) to limit the extent of the 
dissection, together with aggressive 
investigation consisting of aortogra­
phy or computed tomography, or
Table V. Cause of In-hospital Deaths After Surgical Treatment by Type of Dissection 
(Number of Dissections)
Type A Type B
Cause Acute Chronic Acute Chronic Totals
Cardiac 4 3 2 _ 9
Cerebral 3 _ _ _ 3
Hemorrhagic 12 3 5 2 22
Other 4 — 3 — 7
Totals 23 6 10 2 41
Table VI. Cause of In-hospital Deaths After Medical Treatment by Type of Dissection 
(Number of Dissections)
Type A Type B
Cause Acute Chronic Acute Chronic Totals
Tamponade 11 — 2 ____ 13
Rupture
Pleural cavity 2 — 4 1 7
Abdominal cavity -- -- — 1 1
Infarction
Myocardial 1 — 1 — 2
Mesenteric 1 — — — 1
Cerebrovascular
accident ____  ____ 1 — 1
Aortic
insufficiency 1 — — — 1
Other _  1 — — 1
Totals 16 1 8 2 27
Table IV. Survival at 30 Days According to Type of Dissection and Treatment
Type A Type B
Acute Chronic Acute Chronic
Treatment No. Survived % No. Survived % No. Survived % No. Survived %
Medical 17 1 6 3 2 66 27 19 70 14 12 86
Surgical 61 38 62 16 10 62 29 19 66 23 21 91
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both, to establish the diagnosis. All 
patients with acute type A dissec­
tion undergo emergency surgery 
with the therapeutic goals already 
described; we achieved a 62% sur­
vival rate in these patients. The 
outcome was much worse when 
surgery was not undertaken for 
reasons stated previously. Patients 
with type B dissection underwent 
an initial trial of medical therapy 
unless they presented with unremit­
ting and recurrent pain with or 
without associated complications. If 
hypertension or pain could not be 
controlled or if complications devel­
oped while pharmacologic control 
(a /J blocker and sodium nitroprus- 
side infusion) of the patient’s blood 
pressure was adequate, immediate 
surgery was undertaken. With this 
protocol, we achieved a 30-day sur­
vival rate after surgery in 65% of 
patients with acute type B and 91% 
of those with chronic type B dissec­
tions; of dissections that responded 
to medical therapy we achieved a 
30-day survival rate of 70% for 
patients acute type B and 86% for 
those with chronic type B dissec­
tions.
In the 1979 report of Miller and 
colleagues17 from Stanford Universi­
ty, all 125 patients underwent sur­
gery, regardless of whether they 
had type A or type B dissection. 
Indeed, nobody in their series was 
denied operative treatment because 
of age or complications at presenta­
tion except patients who were brain 
dead or moribund. They reported 
survival rates of 77% for acute type 
A dissection, 86% for chronic type 
A, 55% for acute type B dissection 
and 78% for chronic type B. Their 
survival rates were better than ours 
for type A dissections, possibly be­
cause of variations in surgical tech­
nique and myocardial protection or, 
more simply, the different popula­
tions studied as reflected by the 
high incidence of complications at 
presentation in our series. This may
be because our referral area includ­
ed the whole province of British 
Columbia where large distances, 
isolation and difficult transportation 
can lead to long transfer times and 
delay in initiating surgical or appro­
priate medical treatment. However, 
our experience with type B dissec­
tion compares favourably with that 
of Stanford University, even with 
our surgical cohort, which repre­
sented a selective group of patients 
having failed a trial of medical ther­
apy or first seen with severe clinical 
presentation. Indeed, our surgical 
results in type B dissections, both 
acute and chronic, are comparable 
to the experience obtained with the 
more favourable medical type B 
cohort who underwent pharmaco­
logic treatment only. It seems that 
selective surgical treatment of these 
patients is appropriate at the time 
of initial presentation.
Conclusions
Acute aortic dissection remains a 
challenge for the physician; it re­
quires an early diagnosis followed 
by aggressive pharmacologic sup­
port and appropriate investigation 
to establish a correct anatomic diag­
nosis. Clearly, suspicion is the key 
in these initial hours. The impor­
tance of pharmacologic control of 
any hypertension and constant 
monitoring as the investigation pro­
ceeds cannot be overemphasized. 
All patients with type A dissection 
should undergo prompt surgical re­
pair. Our experience favours a more 
selective surgical approach to type 
B dissections; however, other fac­
tors than early survival must be 
considered in the establishment of 
final recommendations as to the 
treatment of type B dissections. 
Indeed, the outcome of medically 
versus surgically treated patients 
over a longer follow-up period is 
needed, with particular interest paid
to late morbidity and mortality. If 
there is evidence of an increased 
incidence of sudden death from aor­
tic rupture in medically treated pa­
tients, a case could be made for 
initial surgery. Certainly, all these 
patients should now be followed up 
closely, with particular attention 
paid to the fate of the false lumen 
and possible extension of the origi­
nal dissection, and to the develop­
ment of new aneurysms, demanding 
medical attention.
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BOOK REVIEWS
continued from page 446
The superb section on rheumatoid 
arthritis of the neck, comprising five 
papers, should be read by all those who 
look after patients with rheumatoid 
arthritis. The authors point out that the 
introduction of computed tomography 
and nuclear magnetic resonance imag­
ing is changing our concept of the 
cause of the myelopathy occasioned by 
vertical, supra-axial and horizontal sub- 
axial dislocation. Neural compression 
can occur, not only from the obvious 
bone displacements, but also from the 
build-up of pannus. One paper describes 
the transoral approach for removal of 
both pannus and the odontoid peg in 
severe myelopathies caused by vertical 
dislocation.
The chapters on assessment will be 
of some interest to orthopedic sur­
geons. There is one particularly good 
paper on functional aids for patients 
with rheumatoid arthritis that shows 
how simple changes, such as altering 
the angle of the hand grip on elbow 
crutches, can help considerably. It also 
demonstrates the clean simple look that
has become the hallmark of Scandina­
vian design.
A paper by Yeoman on the follow-up 
of patients who have ankylosing spon­
dylitis dispels the notion that the joint 
will restiffen after total hip replacement. 
The enduring Scandinavian debate on 
the value of surgical synovectomy con­
tinues. While recognizing its value in 
the odd case, most orthopedic surgeons 
on this side of the world limit its use to 
the rare cases of failure of synovectomy 
with radioactive chemicals.
The section on revision surgery is 
interesting. There are papers on the 
treatment of failed Meuli and Swanson 
wrist prostheses and failed total replace­
ments of elbows, shoulders and ankles. 
The results of one study of the Thomp­
son total ankle replacement were sur­
prisingly good, with only 3 failures out 
of 66 replacements, all done above a 
triple arthrodesis. In another paper on 
the same ankle prosthesis the results 
were poor; however, the numbers were 
small, and the results may simply reflect 
a low position on the learning curve.
The papers on hip and knee revision 
were good but, of necessity, limited. 
Revision of these joints is now such a 
huge field that a separate book could be 
written on the revision of either joint. 
The papers show the European surgical 
trend towards noncemented implants, 
especially for revision, and the contin­
ued use of the threaded cup. The 
Mecron ring singlehandedly destroyed 
the threaded cup market in North 
America. I was surprised to see one 
author advocate the use of the Mecron 
ring with structural allografts. Since 
this is one of the absolute contraindica­
tions to the use of a smooth threaded 
cup, I would expect the author’s results 
to change fairly dramatically in the next 
few years.
All in all, this is a worthwhile book. 
It provides an excellent window into 
northern European thinking in the 
treatment of rheumatoid arthritis.
Hugh U. Cameron, MB, ChB, FRCSC
Ste. 318,
43 Wellesley St. E,
Toronto, Ont.
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Determination of Operability in 
Candidates Who Undergo Lung Resection 
for Bronchogenic Carcinoma
Terrence P. Murphy, MD; M. Thomas Casey, MD, FRCSC
In this prospective study the authors attempted to determine the effect of lung 
resection for bronchogenic carcinoma on final pulmonary function in patients who 
had severe limitation of lung air flow preoperatively and were therefore likely to 
have severe, progressive pulmonary failure and in those who had acceptable 
pulmonary function preoperatively.
Preoperative and postoperative pulmonary function tests were performed on 20 
patients chosen to undergo various types of resection for bronchogenic carcinoma. 
Those who underwent pneumonectomy had changes in lung volume that were 
expected for a resection of that magnitude. Patients who underwent lesser resections 
had more variable postoperative lung volumes and flows. The patients whose 
preoperative pulmonary function was poorest had the least change postoperatively 
and even, in some cases, showed some improvement in function, yet they were the 
ones most likely to be denied surgery, because of their poor preoperative pulmonary 
function.
Dans ce projet d’etude, les auteurs tentent de cerner l’effet de la resection 
pulmonaire pour epithelioma bronchique sur le fonctionnement pulmonaire ultime 
chez les patients qui presentaient une capacite pulmonaire tres limitee avant 
l’operation et par consequent sujets a une defaillance pulmonaire progressive grave 
et chez ceux qui jouissaient d’une fonction pulmonaire preoperatoire acceptable.
Des tests fonctionnels pulmonaires pre et postoperatoires ont ete effectues chez 
20 patients designes pour subir divers types de resection pour epithelioma 
bronchique. Ceux qui ont subi une pneumonectomie presentaient des changements 
de volume pulmonaire previsibles pour une resection de cette ampleur. Les patients 
qui ont subi des resections moins importantes presentaient des volumes pulmonaires 
et des debits plus variables. Les patients qui presentaient la fonction pulmonaire 
preoperatoire la plus mauvaise presentaient le moins de modifications post­
operatoires et meme, en certains cas, benificiaient d’une certaine amelioration 
fonctionnelle; ils etaient pourtant ceux a qui Ton refusait le plus souvent la 
chirurgie, a cause de leur mauvaise fonction pulmonaire preoperatoire.
Once the resectability of a pul­monary malignant tumour has 
been determined for a given patient,
operability must be assessed. Usual­
ly pulmonary function tests (PFTs) 
in combination with split-lung ra­
dionuclide scanning is carried out 
to estimate the postoperative pul­
monary function of the candidate 
for pneumonectomy. Values calcu­
lated in this manner are taken into 
consideration, along with the over­
all medical status of the patient, in 
determining the ability of the pa­
tient to tolerate the planned sur­
gery. Adherence to strict guidelines, 
with respect to operability may, 
however, deny a number of patients 
a potentially curable procedure.
Assessment of this higher risk 
group of patients has involved more 
invasive and technologically de­
manding techniques. The equip­
ment and special skills required to 
perform the tests are not readily 
accessible to most practising tho­
racic surgeons so they resort to 
established, more fundamental eval­
uation techniques, such as physical 
examination, bronchoscopy, pulmo­
nary function tests, split-lung scan­
ning and clinical judgement. Re­
cently, we randomly selected for 
lung resection 20 candidates on 
whom we performed preoperative 
and postoperative pulmonary func­
tion testing. We wished to compare 
the postoperative pulmonary func­
tion of higher risk candidates, that 
is, those with severe limitations of 
lung flow, who are more likely to 
suffer severe, progressive pulmo­
nary failure, with the postoperative 
values of those who had acceptable 
preoperative pulmonary function.
Patients and Methods
The study group consisted of 20
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randomly selected patients (17 men, 
3 women) who were being seen 
during postoperative follow-up of 
lung resection. The preoperative 
work-up of these patients had con­
sisted of history and physical exam­
ination, a complete blood count, 
liver profile, determination of urea, 
creatinine and electrolyte levels, and 
urinalysis. Electrocardiography was 
performed. Pulmonary function 
tests included measurement of lung 
volumes and flows. Perfusion mac­
Table 1. Operative Procedures Performed 
on 20 Patients Who Underwent 
Pneumonectomy or Lobectomy
Procedure No. of patients
Right pneumonectomy 4
Left pneumonectomy 2
Left upper lobectomy 9
Right upper lobectomy 
Right middle/lower
2
lobectomy 1
Right lower lobectomy 1
Left lower lobectomy 1
Table II. Pathological Findings of Lung
Resection Specimens
Tumour type No. of patients
Squamous cell 11
Adenocarcinoma 4
Bronchoalveolar
carcinoma 3
Carcinoma 1
Small-cell carcinoma 1
roaggregate scanning was per­
formed in selected patients. Once 
resectability was established, opera­
bility was evaluated.
The patients ranged in age from 
54 to 85 years (mean 65.2 years). 
They had an average pack-year 
smoking history of 38.1 years. The 
operative procedures (Table I) were 
performed between September 1981 
and June 1985. Pulmonary function 
testing was performed on average 
15.5 months postoperatively (range 
from 3 to 45 months); 14 of the 20 
patients had their PFTs performed 
within 12 months of surgery. The 
pathological diagnoses are listed in 
Table II; there were 16 stage I and 
4 stage II lesions.
Pulmonary function testing was 
performed on a P.K. Morgan Dry 
Rolling Spirometer. Functional re­
sidual capacity (FRC) was deter­
mined by helium dilution (multiple- 
breath technique) and diffusion ca­
pacity of carbon monoxide (DCo) 
was determined by the single-breath 
breath-holding technique. Three 
sets of maneuvers with values with­
in 5% of each other were necessary 
for successful tests of forced vital 
capacity (FVC) and forced expirato­
ry volume in 1 second (FEVi).
Other measurements routinely 
made were residual volume (RV), 
total lung capacity (TLC) and vital 
capacity (VC). We selected FEVx, 
FVC and TLC as indicators of pre­
operative and postoperative pulmo­
nary function. The differences were 
analysed by Student’s t-test.
Results
The selected parameters and the 
differences (preoperative versus 
postoperative) in the six patients 
who underwent pneumonectomy 
are presented in Table III. The 
average decreases in the postopera­
tive value over the preoperative 
value for left and right pneumonec­
tomy respectively were 42.5% and 
37% for FEV!, 44% and 37% for 
FVC, and 41.5% and 33% for TLC. 
Because of the small number of 
patients these differences are not 
statistically significant.
The selected parameters and their 
differences (preoperative versus 
postoperative) in patients who un­
derwent lobectomy are presented in 
Table IV. For all lobectomy pa­
tients, the average percentage de­
creases of postoperative over preop­
erative values for FEVi, FVC and
Table III. Preoperative and Postoperative Values and Their Differences for Forced Expiratory Volume in 1 Second (FEV,), Forced Vital Capacity (FVC)
and Total Lung Capacity (TLC) in Patients Who Underwent Pneumonectomy_________________________________
FEV, FVC__________ __________TIC
Patient/age, yr Procedure Litres %Pr Litres %Pr Litres %Pr
1, 59 Left pneumonectomy Preop 3.40 98 4.70 107 7.19 108
Postop 2.12 61 3.11 70 4.64 69
Diff -1 .2 8 -1 .5 9 -2 .5 5
2,58 Left pneumonectomy Preop 1.82 58 2.74 69 5.34 89
Postop 0.96 32 1.26 33 2.80 48
Diff -0 .8 6 -1 .4 8 - 2 .5 4
3, 61 Right pneumonectomy Preop 2.75 83 3.74 88 5.27 81
Postop 1.94 60 2.78 68 3.68 58
Diff -0 .8 3 -0 .9 6 —1.59
4, 62 Right pneumonectomy Preop 2.92 94 4.68 116 6.67 103
Postop 1.97 63 2.60 64 4.23 64
Diff -0 .9 5 -2 .0 8 -2 .4 4
5, 62 Right pneumonectomy Preop 1.99 62 2.79 68 5.17 82
Postop 1.28 42 1.98 51 3.53 59
Diff -0 .7 1 -0 .8 1 -1 .6 4
6, 60 Right pneumonectomy Preop 2.80 76 4.21 90 6.37 89
Postop 1.44 40 2.13 46 4.29 61
Diff -1 .3 6 -2 .0 8 -2 .0 8
%Pr =  percentage of the predicted value for that patient. Diff =  difference between preoperative and postoperative values.
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TLC were 11.4, 5.0, and 11.4 re­
spectively (p < 0.01 for all three 
parameters).
All patients were ambulatory and 
doing well at the time of postopera­
tive pulmonary function testing.
Discussion
In determining the operability of 
the lung resection candidate, the 
surgeon must complete a total as­
sessment of the physical status of 
the patient and weigh the risks of 
the operative procedure against the
risk of death from an untreated or 
partially treated malignant lesion. 
Included in this evaluation is a 
prediction of the postoperative pul­
monary function of that patient, 
that is, the ability to ventilate and 
oxygenate blood without unaccept­
able pulmonary hypertension.
Many studies have been under­
taken to establish objective guide­
lines for acceptable predicted post­
operative pulmonary function. Kris- 
tersson, Lindell and Svanberg1 sug­
gested a predicted postoperative 
FEV] of 1.0 L as the lower level of
operability. Boushy and associates2 
showed that tests for forced expir­
atory flow of 200 to 1200 ml 
(FEF20o-i2oo), FEF25_ FRC, RV 
and maximal ventilatory volume 
(MW) are useful in predicting 
death in lung resection candidates, 
in addition to FEVj. They empha­
sized the importance of age in de­
termining risk when patients were 
older than 60 years and had a 
preoperative FEV] of less than 2 L; 
these patients do especially poorly. 
Miller, Grossman and Hatcher3 list­
ed specific criteria for the various
Table IV. Preoperative and Postoperative Values and Their Differences for FEV„ FVC and TLC in Patients Who Underwent Lobectomy
FEV, FVC TLC
Patient/age, yr Procedure Litres %Pr Litres %Pr Litres %Pr
7, 75 Left lower lobectomy Preop 1.45 58 2.33 71 4.75 87
Postop 1.44 58 2.45 77 5.47 103
8, 68
Diff -0 .0 1 +0.12 +0.72
Right middle/lower Preop 1.80 93 2.34 96 4.54 114
lobectomy Postop 1.32 69 1.97 82 2.38 61
Diff -0 .4 8 -0 .3 7 -2 .1 69, 70 Right lower lobectomy Preop 2.79 90 4.83 120 7.70 120
Postop 2.14 72 4.11 107 7.55 122
10, 64
Diff -0 .6 5 -0 .7 2 -0 .1 5
Right upper lobectomy Preop 2.10 91 2.59 89 4.98 102
Postop 1.64 71 2.33 80 4.39 90
11, 67
Diff -0 .4 6 -0 .2 6 -0 .5 9
Right upper lobectomy Preop 2.34 78 3.58 93 6.39 105
Postop 1.86 65 2.92 79 5.81 98
12, 73
Diff -0 .4 8 -0 .6 6 -0 .5 8
Left upper lobectomy Preop 1.28 68 2.22 93 4.24 98
Postop 1.33 71 1.64 68 3.94 97
13, 62
Diff +0.05 -0 .5 8 -0 .3 0
Left upper lobectomy Preop 2.14 66 3.49 83 6.10 95
Postop 1.95 60 3.58 86 4.96 77
14, 54
Diff -0 .1 9 +0.09 -1 .1 4
Left upper lobectomy Preop 1.39 48 2.69 73 7.73 140
Postop 1.35 46 3.16 84 5.45 97
15, 85
Diff -0 .0 4 +0.50 -2 .2 8
Left upper lobectomy Preop 2.03 70 3.07 80 6.40 98
Postop 1.90 66 2.90 76 5.99 91
16, 62
Diff -0 .1 3 -0 .1 7 -0 .4 1
Left upper lobectomy Preop 2.45 71 4.05 93 7.46 111
Postop 2.23 64 4.58 102 7.85 114
17, 66
Diff -0 .2 2 +0.53 +0.39
Left upper lobectomy Preop 2.93 87 4.00 93 6.70 99
Postop 2.34 70 3.02 85 6.19 90
18, 60
Diff -0 .5 9 -0 .9 8 -0 .5 1
Left upper lobectomy Preop 2.97 86 4.21 96 7.77 117
Postop 2.53 72 3.86 86 5.89 87
19, 58
Diff -0 .4 4 -0 .3 5 -1 .8 8
Left upper lobectomy Preop 2.73 83 3.77 91 6.85 108
Postop 2.77 89 3.79 89 6.06 95
20, 67 Left upper lobectomy
Diff -0 .0 4 +0.02 -0 .7 9
Preop 2.19 78 3.17 87 5.12 90
Postop 2.01 76 3.50 102 5.19 94
Diff -0 .1 8 +0.33 +0.07
/oPr percentage of predicted value for that patient. Diff =  difference between preoperative and postoperative values.
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types of pulmonary resection, in­
cluding pneumonectomy, lobectomy 
and wedge resection; however, their 
criteria for establishing these limits 
were quite vague.
The effectiveness of various 
methods of predicting postoperative 
pulmonary function in patients who 
undergo pneumonectomy is well es­
tablished. DeMeester and col­
leagues4 and Olsen, Block and 
Tobias5 have shown the reliability 
of ventilation-perfusion radionu­
clide studies, used in conjunction 
with standard PFTs, to predict the 
postoperative pulmonary function 
of pneumonectomy candidates. Sev­
eral studies6’7 have supported the 
use of the simple lateral position 
test (LPT), described by Bergan8 in 
1960, which does not require any 
elaborate equipment. DeMeester 
and colleagues4 found the LPT less 
reliable, and Schoonover and asso­
ciates9 found notable variability of 
the LPT in patients who had 
marked obstruction. Olsen and col­
leagues10 used temporary unilateral 
pulmonary artery occlusion in com­
bination with macroaggregate lung 
scanning to determine operability in 
a high-risk group of patients who 
might otherwise have been denied a 
lung resection. This technique, 
however, requires technology and 
expertise unavailable to the majori­
ty of thoracic surgeons.
Although methods for predicting 
postoperative pulmonary function 
and, thus, morbidity and mortality 
in patients who undergo pneumo­
nectomy are well established, simi­
lar criteria for predicting the out­
come of patients who undergo less­
er lung resections are not well 
identified. Both Wernly and associ­
ates11 and Ali and colleagues12 have 
developed formulas for predicting 
postoperative pulmonary function 
in patients who are candidates for 
lung resection, based on the num­
ber of segments removed. These 
methods, however, are inaccurate in
the resection of small numbers of 
segments and require more sophisti­
cated radionuclide scanning analy­
sis than is readily available in most 
centres.
In our study, we looked at two 
groups of patients: those who had 
pneumonectomy and those who had 
lobectomy. The patients who had 
pneumonectomy demonstrated aver­
age expected drops in lung flows 
and volumes postoperatively. The 
results in the lobectomy patients, 
however, were much more variable. 
Many of these patients showed a 
minimal decrease in flows and vol­
umes over preoperative values and 
some even showed improvement. 
The patients with the worst preop­
erative values showed the least 
change. They were patients who, 
based on their preoperative evalua­
tion, were most likely to be denied 
surgery. Boushy and associates2 
pointed out that many patients with 
severe obstructive disease experi­
ence no worsening of their dyspnea 
after lung resection and that those 
with more normal PFT results pre- 
operatively are more likely to suffer 
a decrease in exercise tolerance 
postoperatively.
Parameters determined by preop­
erative PFTs and their relation to 
previously established criteria for 
prognosis must be interpreted in 
the light of the physical-medical 
status of each patient. Broncho- 
scopic findings, such as an ob­
structed bronchus, leading to the 
lobe to be resected, are indicators of 
minimal change in postoperative 
PFT results and even of improve­
ment. A small, thin patient is un­
likely to require the suggested 
FEV! of 1.0 L /s  to ventilate and 
oxygenate the blood adequately.
A close look at the patients in 
our study showed that those with 
borderline function on preoperative 
pulmonary function testing may be 
the patients who will have the least 
change postoperatively. Therefore,
surgeons must be careful not to 
deny seemingly high-risk patients 
curative resections on the basis of 
previously established criteria of 
safety.
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Improvement in Thoracic Aortic Pressure 
After Proximal Aortic Cross-Clamping 
by Balloon Occlusion of the Distal Aorta
Paul A. Spence, MD, FRCSC;* Robert M. Lust, PhD;*t You Su Sun, MD;* Hiroshi Iida, MD;* Samuel B. 
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Spinal cord hypoperfusion injury is a devastating complication of cross-clamping the 
proximal thoracic aorta. The collateral circulation around the cross-clamp is 
generally poorly developed, and the run-off is immense, resulting in extremely low 
thoracic aortic and spinal cord perfusion pressures. The authors postulated that 
balloon occlusion of the abdominal aorta might confine this reduced collateral flow 
around the cross-clamp to the thoracic aorta. In 8 of 16 dogs subjected to aortic 
cross-clamping of the aorta just beyond the arch vessels, the abdominal aorta was 
also occluded by a balloon. Thoracic aortic pressure and spinal cord perfusion 
pressure were significantly higher in the animals with aortic balloon occlusion than 
in those without balloon occlusion (77 ± 8 mm Hg versus 26 ± 1 mm Hg, p < 0.01, 
and 67 ± 8 mm Hg versus 18 ±  2 mm Hg, p < 0.01, at 10 minutes after 
cross-clamping). Abdominal aortic balloon occlusion increases thoracic aortic 
pressure after the aorta is cross-clamped proximally. Further studies are necessary 
in primates to assess the effect of this procedure in spinal cord perfusion and the 
rate of paraplegia.
Les dommages causes par hypoperfusion de la moelle epinere demeurent une 
complication catastrophique du clampage total de l’aorte thoracique proximale. La 
circulation collaterale autour de clampage est habituellement peu developpee, et 
l’ecoulement est immense, resultant en des pressions de perfusion de l’aorte 
thoracique et de la moelle extremement basses. Les auteurs ont considere que 
l’occlusion de l’aorte abdominale au moyen d’un ballonet pourait contenir cette 
chute du debit de la circulation collaterale autour de clampage de l’aorte thoracique. 
Chez 8 de 16 chiens soumis au clampage total l’aorte thoracique tout just au dela 
des vaisseaux de l’arc, l’aorte abdominale a aussi ete obstruee par un ballonet. La 
pression de perfusion de I’aorte thoracique et de la moelle fut sensiblement plus 
elevee chez les animaux avec occlusion par ballonet aortique abdominal que chez 
ceux qui n’avaient pas d’ocdusion par ballonet aortique (77 ± 8 mm Hg versus 26 ± 
1 mm Hg, p < 0,01, et 67 ± 8 mm Hg versus 18 ± 2 mm Hg, p < 0,01, 10 minutes 
apres clampage total). L’occlusion par ballonnet aortique augmente la pression 
aortique thoracique apres clampage proximal de l’aorte. II importe d’effectuer 
d’autres etudes chez des primates pour verifier l’effet de cette manoeuvre sur la 
perfusion de la moelle et le taux de paraplegie.
From the *Division o f  Cardiac Surgery and tDepartment o f Physiology. East Carolina 
University, School o f  Medicine, Greenville, NC
Presented at the 9th annual meeting o f  the Canadian Society o f  Cardiovascular and Thoracic 
Surgeons, held in conjunction with the 58 th annual meeting o f  the Royal College o f  Physicians 
and Surgeons o f  Canada, Edmonton, Alta., Sept. 22, 1989
S pinal cord injury is a dreaded complication of aortic sur­
gery. 1-2 Many clinical and experi­
mental investigations have been car­
ried out to discover its cause and to 
prevent it. Factors thought to be 
important in its pathogenesis in­
clude a large decrease in the thorac­
ic aortic pressure after cross-clam­
ping, 1"3 an increase in cerebrospinal 
fluid pressure, 1-4 5 division of vessels 
perfusing the spinal cord1-6 and pe­
rioperative hypotension. 1"5 Various 
techniques have been used to avert 
spinal cord injury. Shunts from the 
ascending aorta to the descending 
aorta have been used ,7-8 and femoral 
vein to femoral artery bypass has 
been studied.9 Recently, Svensson 
and colleagues10 described the in­
trathecal use of papaverine to im­
prove blood flow through the ante­
rior spinal artery.
When the aorta is cross-clamped 
proximally the distal thoracic pres­
sure drops markedly, because col­
laterals around the cross-clamp are 
normally poorly developed and the 
run off is immense (to the abdomi­
nal viscera, the kidneys and the 
lower limbs). We postulated that it 
may be possible to occlude the 
entire abdominal aorta below the 
level of the spinal cord arteries, 
thereby confining this limited collat­
eral flow to the thoracic aorta, 
increasing thoracic aortic pressure 
distal to the proximal cross-clamp 
and, presumably, increasing the spi­
nal cord perfusion pressure.
Accepted fo r publication Nov. 27, 1989
Address reprint requests to: Dr. Paul A. Spence, Division o f Cardiac Surgery, School o f 
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Materials and Methods
Sixteen mongrel dogs, weighing
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18 to 24 kg, were anesthetized with 
sodium pentobarbital (30 mg/kg, 
supplemented as needed), intubated 
and ventilated. Ventilation was ad­
justed to maintain an arterial oxy­
gen pressure above 100 mm Hg and 
carbon dioxide pressure at approxi­
mately 40 mm Hg. Bicarbonate was 
added to maintain the pH between 
7.35 and 7.45.
A midline incision was made in 
the neck, and the carotid artery and 
jugular vein were exposed and en­
circled. The carotid artery was can- 
nulated with a Millar Mikro-Tip 
pressure transducer (Millar Instru­
ments, Houston, Tex.), which was 
advanced into the aortic arch. The 
jugular vein was cannulated with a 
fluid-filled catheter advanced into 
the right atrium. A 21-gauge can­
nula was positioned in the lumbar 
cerebospinal fluid (CSF) and con­
nected to a fluid-filled transducer to 
monitor CSF pressure.
Thoracotomy was performed 
through the left fifth intercostal 
space and the aorta encircled just 
beyond the arch in preparation for 
cross-clamping. Distal to the site 
designated for aortic clamping, a 
pursestring suture was placed in 
the aorta, and an identical Millar 
pressure transducer was positioned 
in the descending thoracic aorta. 
The pericardium was opened and 
the main pulmonary artery dissect­
ed and encircled with a calibrated 
flow probe (Zepeda Instruments, Se­
attle, Wash.) for continuous mea­
surement of right ventricular out­
put. A second pursestring suture 
was then placed in the distal thorac­
ic aorta. Through this suture, an 
intra-aortic balloon catheter (Data- 
scope Corp., Paramus, NJ) was ins­
erted and advanced into the lumbar 
aorta so that its proximal end lay at 
the LI level and its distal end at the 
aortic bifurcation (Fig. 1). The bal­
loon was of sufficient calibre that it 
completely occluded the aorta when 
it was inflated.
Baseline hemodynamic measure­
ments including heart rate, proxi­
mal aortic pressure, distal aortic 
pressure, right atrial pressure, car­
diac output and CSF pressure were 
then obtained. The aorta was cross- 
clamped just beyond the arch ves­
sels. In 8 of the 16 animals, the 
balloon, which had been positioned 
but left deflated, was inflated with 
air to occlude the lumbar aorta 
completely. In the remaining eight 
animals, the balloon was not inflat­
ed; these dogs served as controls. 
Every 10 minutes after cross-clamp­
ing all hemodynamic parameters 
were measured. After 30 minutes 
of aortic cross-clamping, the proxi­
mal aortic clamp was released and 
the balloon deflated completely in 
the experimental animals. All he­
modynamic parameters were again 
measured. The animals were killed 
by a lethal overdose of anesthetic.
All recorded data were analysed 
using SAS software (SAS Institute, 
Cary, NC). The results are reported 
as the mean ± the standard devia­
tion. The spinal cord perfusion gra­
dient was calculated as the differ­
ence between mean thoracic aortic 
pressure and the higher of CSF or 
central venous pressure. All statisti­
cal comparisons were made using 
analysis of variance and significant 
differences were specified by a mod­
ified t-test (Duncan’s). Significant 
differences were specified at p < 
0.01. All animals received humane 
care in compliance with the Princi­
ples o f Laboratory Animal Care for­
mulated by the National Society for 
Medical Research and the Guide for 
the Care and Use o f Laboratory 
Animals (NIH publication no. 
80-23, revised 1978).
Results
There were no differences in the 
baseline measurements between the 
two groups. Ascending aortic pres­
sure increased significantly in both
groups after cross-clamping (Fig. 
2), but the increases were similar. 
Thoracic aortic pressures (Fig. 3) 
and spinal cord perfusion gradients 
(Fig. 4) were significantly higher in 
the animals with distal aortic occlu­
sion at all times after proximal 
cross-clamping. Cerebrospinal fluid 
pressures increased slightly in all 
animals after cross-clamping (Fig. 
5), but the changes were insignifi­
cant. Right atrial pressures (Fig. 6) 
and pulmonary artery flows (Fig. 7) 
were not significantly different, al­
though both tended to be higher in 
the control group.
Discussion
When the aorta is cross-clamped 
just beyond the subclavian vessels, 
the distal thoracic pressure falls 
precipitously.1' 4 Collaterals around 
the clamps are normally poorly de­
veloped and the run-off for this 
limited collateral flow is immense. 
Wadouh and colleagues11 noted 
that proximal cross-clamping of the 
descending aorta resulted in a mean 
thoracic aortic pressure of 18 mm 
Hg, but when a second clamp was 
applied at the T13 level, the thorac­
ic pressure increased to 48 mm Hg
FIG. 1. Occlusive balloon in abdominal 
aorta.
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Cross-clamp time, min
FIG. 2. Significant increase in mean ascending aortic pressure 
is noted in both groups (dark bars = experimental group, 
light bars =  control group) after aortic occlusion. ■ = p < 
0.01 versus baseline, ▲ = p < 0.001 versus baseline.
FIG. 4. Gradient to spinal cord perfusion was significantly 
higher at all times after cross-clamping in animals with 
abdominal aortic balloon occlusion (dark bars). Light bars = 
control animals, * =  p < 0.01 versus no balloon, ▲ = p < 
0.001 versus baseline, ■ = p < 0.01 versus baseline, O = p < 
0.05 versus baseline.
2 0 0 "
3
?  1 5 0 "
E
Baseline 10 20 30
Cross-clamp time, min
FIG. 3. Pressure in thoracic aorta was significantly higher in 
animals that underwent balloon occlusion (dark bars) of aorta 
after cross-clamping. Light bars = control animals, * = p < 
0.01 versus no balloon, ▲ = p < 0.001 versus baseline, ■ = p 
< 0.01 versus baseline.
15
Baseline 10 20 30
Cross-clamp time, min
FIG. 5. Cerebrospinal fluid levels were higher (but not 
significantly) in animals with balloon occlusion (dark bars). 
Light bars = control animals.
100 ‘ *  ■
FIG. 6. Right atrial pressures were not significantly different. 
Dark bars = experimental animals, light bars = control 
animals.
6
Baseline 10 20 30
Cross-clamp time, min
FIG. 7. Pulmonary artery flow tended to be higher (NS) in 
animals without balloon occlusion (light bars). Dark bars = 
experimental animals.
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above and 14 mm Hg below the 
second clamp. This indicated that 
distal aortic clamping could im­
prove thoracic aortic pressure. It 
also indicated that the second clamp 
did not prevent collateral flow from 
entering the abdominal aorta, since 
the pressure measured distal to the 
second clamp (14 mm Hg) would 
almost certainly be higher than the 
simultaneous central venous pres­
sure in a healthy dog. These indica­
tions suggested to us that balloon 
occlusion of the distal aorta could 
further confine collateral flow 
around the proximal clamp to the 
thoracic aorta and thus improve 
spinal cord flow.
The results of this experiment 
confirmed previous observations 
that thoracic aortic pressure after 
proximal aortic cross-clamping is 
extremely low (mean 26 mm Hg). In 
animals that underwent abdominal 
aortic balloon occlusion the mean 
thoracic aortic pressure was ap­
proximately 77 mm Hg. The calcu­
lated spinal cord perfusion gradient 
(67 mm Hg) obtained with balloon 
occlusion is also well above perfu­
sion pressures suggested by previ­
ous investigators as necessary for 
adequate spinal cord protection.12
In evaluating angiographic tech­
niques to visualize the spinal cord 
arteries, Chiro, Fried and Dopp- 
man13 found that a combination of 
increased intra-arterial pressure and 
abdominal compression produced 
the greatest visualization of the 
spinal cord arteries. Balloon occlu­
sion of the distal aorta appears to 
provide a higher pressure and a 
lower run-off in much the same 
way.
The rise in CSF pressure after 
aortic cross-clamping observed by 
other investigators4514 was not 
found in our experiments; little 
change in CSF pressure was noted 
in either group of animals. Eleva­
tion of CSF pressure may be impor­
tant since it limits spinal cord perfu­
sion by decreasing the hemodynam­
ic gradient to flow and has been 
postulated as a mechanism for spi­
nal cord injury during aortic sur­
gery. However, neither cross-clamp­
ing nor balloon occlusion appeared 
to have a marked effect on CSF 
pressure in these experiments.
There are also disadvantages. If 
the balloon is inadvertently inflated 
so that the spinal cord arteries are 
occluded, paraplegia might be in­
duced rather than prevented. It is 
also possible that profound renal, 
intestinal and limb ischemia could 
result in multiorgan failure, if all 
distal perfusion was eliminated by 
the occluding balloon. Balloon oc­
clusion could not be used when the 
thoracic aorta is opened. The great­
est potential use for balloon occlu­
sion is probably during repair of 
traumatic aortic tears, especially in 
situations where shunts and bypass 
equipment are not easily available.
Conclusions
The use of abdominal balloon 
occlusion appears to increase tho­
racic aortic pressure and spinal cord 
perfusion gradients. The dog model 
did not allow the assessment of 
abdominal aortic occlusion on spi­
nal cord perfusion or paraplegia 
rates. Further studies in primate 
models are necessary to investigate 
this method.
We gratefully acknowledge the techni­
cal assistance of Roshi Moghadam and 
Kathy Dennis in the conduct of these 
experiments. The assistance of Mike 
Dulude in preparing the illustrations 
and of Kay Stallings and Laurie Rouse 
in preparing the manuscript is recog­
nized.
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Kndoscopic Nd:YAG Laser Therapy of 
Malignant Esophageal Obstruction 
on an Outpatient Basis
Pasquale Ferraro, MD; Gilles Beauchamp, MD, FRCSC; Guy Aumais, MD, FRCPC
Between May 1985 and December 1988, 41 patients were treated palliatively with 
endoscopic neodymium:yttrium-aluminum-garnet laser therapy for obstruction of 
the esophagus by malignant disease. All were considered incurable, because they 
presented with distant metastases, severe systemic disease, extensive local disease or 
recurrent disease. Thirty-nine percent were managed as outpatients; the remainder 
required admission to hospital. Sixty-three percent of the outpatients had 
adenocarcinoma, and 31% had squamous cell carcinoma; over 90% of the tumours 
were less than 8 cm long, and 63% were in the distal one-third of the esophagus or 
the cardia. Forty-four percent of the inpatients had adenocarcinoma, and 44% had 
squamous cell carcinoma; in this group, over 90% of the tumours were less than 8 
cm long, and 56% were in the distal one-third of the esophagus or the cardia. The 
mean number of sessions and laser energy administered were 2.6 and 4949 J for 
outpatients and 2.7 and 4974 J for inpatients. Palliation of dysphagia was good to 
excellent in all outpatients but was not as good for the inpatient group, in which 
one major complication occurred. The mean length of survival for outpatients and 
inpatients was 6.3 months (range from 1 to 16 months) and 3.9 months (range from 
1 to 18 months) respectively.
De mai 1985 a decembre 1988, 41 patients ont ete traites de maniere palliative au 
moyen de laser endoscopique neodymium:yttrium-aluminium-grenat pour occlusion 
de l’oesophage par neoplasme. Tous etaient reputes incurables, car ils presentaient 
des metastases a distance, une maladie generalise grave, un envahissement local 
important ou une recidive de la maladie. Trente-neuf pour cent des patients furent 
traites en extern; les autres ont du etre hospitalise. Soixante-trois pour cent des 
patients externes presentaient un adenocarcinome, et 31 pour cent presentaient un 
epithelioma spino-cellulaire; plus de 90 pour cent des tumeurs mesuraient moins de 
8 cm de longueur, et 63 pour cent occupaient le tiers distal de l’oesophage ou le 
cardia. Quarante-quatre pour cent des patients hospitalises presentaient des 
adenocarcinomes et 44 pour cent des epithelioma spino-cellulaires; de ce groupe, 
plus de 90 pour cent des tumeurs mesuraient moins de 8 cm de longueur, et 56 pour 
cent se trouvaient au tiers distal de l’oesophage ou au cardia. La frequence moyenne 
des sessions et l’energie laser administree fut de 2,6 et 4949 J pour les patients 
externes et 2,7 et 4974 J pour les hospitalises. La palliation de la dysphagie fut 
bonne a excellente chez tous les patients externes mais ne fut pas aussi bonne chez 
le groupe des hospitalises, chez lequel une complication majeure s’est produite. La 
survie moyenne pour les externes et les hospitalises fut respectivement de 6,3 mois 
(de 1 a 16 mois) et 3,9 mois (de 1 a 18 mois).
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Gastroesophageal carcinoma re­mains a highly lethal and mor­
bid disease, which, in most cases, is 
incurable at the time it is diag­
nosed. During its course all patients 
will suffer serious complications. 
Obstruction of the esophagus with 
dysphagia or aspiration with pneu­
monitis are the complications most 
often encountered.
Palliative therapy is generally all 
that can be offered to patients with 
advanced disease. The use o f en- 
doluminal prostheses to maintain a 
patent esophageal lumen has dimin­
ished, and an increasing number of 
studies have shown that therapy 
with the neodymium:yttrium-alum- 
inum-garnet (Nd:YAG) laser is an 
effective form of palliation.1^ 3 Few 
studies, however, have reported its 
use on an outpatient basis.
In this report, we present our 
results o f Nd:YAG laser therapy in 
41 patients suffering from esopha­
geal obstruction due to malignant 
disease and describe our experience 
with laser therapy on an outpatient 
basis.
Patients and Methods
The study group comprised 41 
consecutive patients with biopsy 
proven gastroesophageal carcinoma 
treated at the Maisonneuve- 
Rosemont Hospital between May 
1985 and December 1988. Most 
patients had previously undergone 
treatment for their disease (Table I). 
Nevertheless their disease was con­
sidered incurable because they pre­
sented with distant metastases
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(46%), severe systemic disease 
(20%), extensive local disease (20%) 
or recurrent disease (12%). One 
patient (2%) refused surgery.
Patients were assessed to deter­
mine what form of palliation would 
be most appropriate. Those for 
whom we elected to use laser thera­
py received their first treatment in 
hospital. Thereafter all patients 
whose general condition permitted 
were offered laser therapy on an 
outpatient basis. Sixteen patients 
(39%) accepted and were treated as 
outpatients. This group comprised 
14 men and 2 women; the group 
treated in hospital comprised 17 
men and 8 women. The mean ages 
were 72.3 years (range from 43 to 
91 years) for the outpatient group 
and 66.4 years (range from 47 to 
88) for the inpatient group.
Each patient’s dysphagia was 
graded as follows: (1) able to eat all 
foods, (2) difficulty swallowing sol­
ids but able to swallow liquids, (3) 
unable to swallow solids and diffi­
culty swallowing liquids and (4) 
unable to swallow solids or liquids.
Inpatients were treated every 3 to 
5 days during their hospitalization. 
Outpatients were admitted the 
morning of their procedure and 
discharged 2 to 4 hours after the 
treatment. They were treated on 
average every 2 to 4 weeks. Surveil­
lance during the laser sessions was 
provided by an anesthesiologist. Pa­
tients were sedated with diazepam 
and meperidine, given intravenous­
ly.
After laser therapy, palliation of 
the dysphagia was considered excel­
lent if patients had achieved grade 
1, good if patients improved from 
grade 4 to 3 or from grade 3 to 2 
and poor if the patient’s grade was 
unchanged.
Laser Technique
Upper gastrointestinal endoscopy 
was performed using an Olympus
GIF-D2 endoscope (Olympus Corp., 
Lake Success, NY) after appropriate 
topical pharyngeal anesthesia. 
Laser therapy was administered 
through the flexible endoscope with 
a MEDILAS 2 (model K621101; 
MBB-At Angewandte Technologie, 
Munich) laser system. The power 
source was set between 80 and 100 
W and the laser pulse duration at 
1.0 to 2.5 s. Most patients were 
treated by a retrograde technique. 
As described by Pietrafitta and 
Dwyer,4 an initial dilatation with an 
Eder-Puestow wire-guide system is 
carried out. The tumour is then 
vaporized and coagulated under di­
rect vision, beginning at the distal 
margin and moving retrogradely to­
ward the proximal end. The ante­
grade technique as described by
Fleischer and Sivak5 was also used. 
Beginning at the tumour’s proximal 
margin laser pulses are applied cir­
cumferentially. At the start of the 
second treatment, the proximal 
margin is debrided to evacuate tu­
mour debris and laser therapy is 
resumed.
Results
The majority (63%) of cancers in 
the outpatient group were adeno­
carcinomas; in the inpatient group 
equal numbers (44%) were adeno­
carcinomas and squamous cell car­
cinomas (Table II). Over 90% of the 
tumours in both groups were less 
than 8 cm long.
All the patients complained of 
dysphagia, and two had a history of
Table 1. Clinical Data on 41 Patients Who Received Nd:YAG Laser Therapy for Esophageal 
Obstruction by Malignant Disease
Data No. of patients %
Previous or associated treatment
Radiotherapy 5 12
Surgery 2 5
Chemotherapy 1 2
Combination of above 3 7
Endoluminal prosthesis 4 10
Dilatation 9 22
None 17 42
Contraindication to curative therapy
Metastatic disease 19 46
Severe systemic disease 8 20
Extensive local disease 8 20
Recurrent disease 5 12
Refused surgery 1 2
Table II. Histologic Type, Location and Length of Gastroesophageal Tumours in the 16 
Outpatients and 25 Inpatients
Outpatients Inpatients
Tumour No. °/o No. %
Histologic type
Adenocarcinoma 10 63 11 44
Squamous cell carcinoma 5 31 11 44
Other 1 6 3 12
Location*
Cervical 3 19 1 4
Mid 3 19 10 40
Distal/cardial 10 63 14 56
Length, cm
< 5 7 44 12 48
5 - 8 8 50 12 48
> 8 1 6 1 4
'Cervical =  < 20 cm, mid =  20 -  30 cm, distal =  > 30 cm from pharynx.
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hematemesis (Table III). The dys­
phagia was light to moderate (grade 
2 or 3) in 94% of the outpatients 
and 92% of the inpatients. Eighty- 
six percent of the outpatients had 
good to excellent results of laser 
therapy compared with only 37% of 
the inpatients; in 63% of the inpa­
tients there was no change after 
laser therapy (Table IV).
The patients in the two groups 
received a similar number of treat­
ments (2.6 versus 2.7) with an 
equivalent average dose of laser 
energy (4949 J versus 4974 J). The 
total dose per patient was sightly 
greater in the outpatient group. 
The average length of survival from 
the time of diagnosis was 6.3 
months in the outpatient group and 
3.9 months in the inpatient group. 
No major complications were de­
tected in the outpatient group; one 
patient in the inpatient group suf­
fered a perforation.
The average length of hospital­
ization was 38 days for the inpa­
tients.
Discussion
The palliation of esophageal tu­
mours holds great interest for the 
clinician who manages patients with 
gastroesophageal cancer. The op­
tions available for the patient with 
incurable disease include surgery, 
radiotherapy, insertion of endolumi- 
nal prostheses and laser therapy. 
The popularity of laser therapy has 
increased as preliminary studies,1'4 
followed by more extensive series, 
demonstrated the safety and effec­
tiveness of esophageal laser thera­
py-
In our series of patients the re­
sults were functionally satisfactory
in the majority of outpatients, with 
an 86% initial success rate. The 
results are comparable to those ob­
tained by Fleischer and Sivak5 
(80%), Brunetaud and colleagues6 
(83%) and Naveau and colleagues7 
(82%). In a group of patients ma­
naged on an outpatient basis, Light- 
dale, Zimbalist and Winawer8 re­
ported a 70% success rate.
The effectiveness of treatment 
should not be considered solely on 
the basis of patency of the esopha­
geal lumen, as shown by Fleischer 
and Sivak,5 Mellow and Pinkas2 and 
Naveau and colleagues.7 Factors 
such as anorexia, poor general 
health and tumour load often deter­
mine to what extent adequate oral 
intake will be re-established. Re­
gardless of the type of palliative 
treatment the nutritional status of 
the patient generally remains poor. 
A patent lumen, however, reduces 
the risk of aspiration. The ameliora­
tion of symptoms was less marked 
in the inpatient group, in which 
there was only a 37% initial success 
rate. Since the tumours in the two 
groups were similar in most re­
spects and since nearly equivalent 
treatments were given, we believe 
that the patient’s overall condition 
was responsible for the difference in 
response to therapy. This is also 
reflected in the length of survival of 
the inpatients compared with the 
outpatients. The outpatients lived 
substantially longer (6.3 versus 3.9 
months) because they were in better 
general health at the start of treat­
ment and responded better. To con­
firm this impression, a greater num­
ber of patients and a more objective 
evaluation of the patients’ perfor­
mance status, such as the Kar- 
nofsky score, would be needed.
The parameters affecting initial 
response to therapy were first es­
tablished by Fleischer and Sivak5 as 
location of tumour in the upper 
one-third of the esophagus, length 
of tumour and endoscopic appear­
T a b le  I I I .  S y m p to m s  and R e su lts  o f L a se r T h e rapy
O utpatients Inpatien ts
S ym p tom s/resu lts No. % No. %
P resen ting  s y m p to m s
D ysphag ia 8 50 3 12
D y s p h a g ia /w e ig h t lo ss 7 44 17 68
D ys p h a g ia /d y sp h o n ia 0 0 4 16
H em a tem es is 1 6 1 4
G rade o f d ysphag ia
1 1 6 1 4
2 10 63 16 64
3 5 31 7 28
4 0 0 1 4
R e su lts *
E xce llen t 5 33 2 8
Good 8 53 7 29
P oo r 2 13 15 63
*F o r 15 o u tp a tie n ts  and 24  in p a tie n ts .
T a b le  IV . D eta ils  o f Lase r T h e ra p y  and S urv iva l
D etails O utpatien ts In p a tie n ts
T o ta l no. o f tre a tm e n ts 43 6 9
M ean tre a tm e n ts /p a t ie n t,  no. 2 .6 2 .7
M ean dose  o f la se r e n e rgy  p e r tre a tm e n t, J 4 9 4 9 4 9 7 4
M ean to ta l d o se  per p a tien t, J 16  731 11 3 3 3
M ean leng th  o f h o s p ita liz a tio n , d — 38
M a jo r c o m p lic a tio n s , n o .* 0 1
M ean su rv iva l f ro m  d ia g n o s is , m o 6 .3 3 .9
Range o f s u rv iv a l, m o 1 - 1 6 1 - 1 8
'D e a th , p e rfo ra tio n , f is tu la , he m o rrha g e .
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ance. Studies by Brunetaud and 
colleagues6 and Naveau and col­
leagues7 added the following param­
eters: recurrence after non-laser 
therapy and age-related type of sur­
gical contraindication. More con­
trolled trials, taking into account 
these parameters, are necessary to 
establish the effectiveness of laser 
therapy.
In an interesting report Nava and 
associates9 compared the use of 
endoscopic monopolar electroful- 
guration with laser therapy. They 
achieved similar results with the 
two techniques, and the complica­
tion rates were low. Further studies 
comparing the two techniques are 
certainly warranted when one con­
siders the differences in cost and 
the paucity of lasers outside major 
centres.
Safety is an important component 
of any palliative therapy. We en­
countered one major complication 
(a perforation) in 112 treatments 
administered to 41 patients. Many 
workers1' 8 have reported major 
complication in 8% to 10% of pa­
tients. Murray and associates10 re­
ported a complication rate of 26% 
and questioned the safety of laser 
therapy in older patients. However, 
we must also consider the rate of 
major complications and the com­
plications directly attributable to 
the laser procedure. The natural 
evolution of obstructive esophageal 
lesions and the risks that accompa­
ny the use of prostheses or radio­
therapy are in themselves formida­
ble, and the laser remains a safe 
alternative.
How does Nd:YAG laser therapy 
compare to endoluminal prostheses? 
The effectiveness of endoluminal 
prostheses has been demonstrated 
in cases of esophagotracheal Fistula. 
Buess and colleagues11 recently re­
ported a 90% success rate and a 
9.5% death rate in patients with 
fistulas. When there is malignant 
obstruction of the esophagus, how­
ever, complication rates as well as 
the effectiveness of prostheses to 
relieve dysphagia vary from series 
to series. Tytgat12 reported an 
11.2% complication rate, Hegarty, 
Angorn and Bryer13 a 16% rate and 
Ogilvie and colleagues14 a 27.1% 
rate. Toure, Beauchamp and Basti- 
en,15 from our centre, reported a 
37% global morbidity and 11% mor­
tality, and Chavy and colleagues16 
had a 20% rate of complications in 
their study. Lasers have proven less 
effective in fibrous strictures and 
long stenotic lesions, as shown by 
Buset and colleagues17 and oth- 
e r s _57.8,i8 These lesions remain po­
tential indications for intubation.
There is no doubt that the use of 
the Nd:YAG laser as palliative ther­
apy for esophageal tumours holds 
much promise. In our series of 
patients it was possible to adminis­
ter safe and effective treatment on 
both an inpatient and an outpatient 
basis. The laser meets most criteria 
for ideal palliation: it is effective 
and rapid, well tolerated and safe. 
The cost can be greatly reduced if 
patients are managed through the 
outpatient department. The patients 
in turn benefit emotionally and 
physically from their home environ­
ment. However, we must not ne­
glect the use of prostheses and the 
possibility of other treatment meth­
ods in association with laser thera­
py-
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Laparoscopic Cholecystectomy: 
a Report of 60 Cases
Yves-Marie Dion, MD, FRCSC, FACS; Jacques Morin, MD, FRCSC
From April to August 1990, 60 patients underwent laparoscopic cholecystectomy. 
Patients with biliary colic were included, but those who had florid acute 
cholecystitis, morbid obesity or scars in the upper portion of the abdomen were 
excluded. Three patients had acute cholecystitis, 56 had chronic cholecystitis and 1 
had hydrops of the gallbladder. Nineteen patients had had previous lower abdominal 
surgery. Five patients did not require analgesia, but the remainder needed 
parenteral analgesia on an average of 1.7 occasions and enteral analgesia on an 
average of 1.8 occasions. There were no intraoperative complications, and no patient 
had the procedure completed by standard surgery. Postoperative hospital stay 
averaged 2.5 days. The mean follow-up was 39 days. Few postoperative 
complications were noted: two patients suffered from ileus; two patients had biliary 
colic postoperatively (one required endoscopic sphincterotomy with stone extraction, 
and in the other no common-duct stones were seen on retrograde cholangiography); 
one patient had an intra-abdominal abscess, which was drained percutaneously; and 
one patient complained of upper abdominal pain that was incisional in origin. 
Laparoscopic cholecystectomy should be considered the procedure of choice for 
elective treatment of uncomplicated symptomatic gallstone disease.
Entre avril et aout 1990, 60 patients ont ete soumis a une cholecystectomie par 
laparoscopie. Les patients souffrant de coliques hepatiques etaient candidate. Les 
patients presentant une cholecystite aigue severe, une obesite morbide ou des 
cicatrices dans la partie superieure de l’abdomen furent exclus. Aucune complication 
operatoire ne fut notee, et aucun patient n’a du subir une cholecystectomie standard 
suite a l’echec de la cholecystectomie par laparoscopie. Trois patients souffraient de 
cholecystite aigue, 56 de cholecystite chronique et 1 d’une mucocele. Dix-neuf 
patients avaient subi anterieurement une chirurgie a l’etage inferieur de l’abdomen. 
Cinq patients n’ont re?u aucune analgesie postoperatoire. Les autres patients a 
reclame en moyenne de l’analgesie parenterale a 1.7 reprises et de l’analgesie 
enterale a 1.8 reprises. Le sejour hospitalier postoperatoire fut en moyenne de 2.5 
jours. Apres un suivi moyen de 39 jours, peu de complications ont ete notees: deux 
patients ont presente un ileus; deux patients ont presente des douleurs ressemblant 
a des coliques hepatiques (un fut traite par sphincterotomie endoscopique, et aucun 
calcul ne fut demontre chez l’autre a la cholangiographie retrograde); un abces 
intra-abdominal fut draine de fa?on percutanee; et la douleur abdominale presentee 
par un patient etait d’origine incisionnelle. La cholecystectomie par laparoscopie 
devient la procedure chirurgicale de choix pour le traitement non urgent de la 
cholelithiase symptomatique.
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Recent developments in endo­scopic equipment have allowed 
physicians to treat by laparoscopy 
conditions that previously could be 
managed only by conventional sur­
gery. Laparoscopy is now used rou­
tinely to treat some gynecologic 
diseases.12 Endoscopic appendecto­
my is performed frequently3 (Mou- 
ret P: Personal communication, 
1988). Laparoscopic surgery has 
also been considered safe for lysis 
of adhesions.1-3 Laparoscopic chole­
cystectomy has been suggested as a 
safe and advantageous alternative 
to the standard procedure.45 We 
report our experience with 60 lapa­
roscopic cholecystectomies.
Patients, Materials and 
Methods
From Apr. 18 to Aug. 27, 1990, 
60 patients (51 women, 9 men), 
ranging in age from 21 to 73 years 
(mean 43 years), were offered lapa­
roscopic cholecystectomy. An oper­
ative consent form, stating the pur­
pose of this intervention as well as 
the potential complications, was 
signed by the patient before the 
procedure. Patients with biliary 
colic were candidates, but those 
with florid acute cholecystitis, mor­
bid obesity or scars in the upper 
portion of the abdomen were ex­
cluded.
The follow-up extended from 4 to  
135 days (mean 39 days). Seventeen 
patients were followed up for 4 to 
15 days, 19 patients for 16 to 30
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days and 24 patients for 31 to 135 
days.
The laparoscopic instruments, 
the Aqua-Purator for irrigation, the 
insufflator, the video camera and 
the monitor were all supplied by 
Raymond Laborie & Associates 
Inc., Brossard, PQ. The clip applica­
tors for the cystic duct and artery 
were supplied by Ethicon Ltd., 
Montreal.
Under general anesthesia, the pa­
tient is placed in the modified lithot­
omy position (Fig. 1). A Veress 
needle (Laborie) is inserted in the 
upper portion of the umbilicus for 
insufflation of carbon dioxide (3.5 
to 5 L) (Fig. 2). The intra-abdomi­
nal pressure is constantly moni­
tored and is not allowed to exceed 
20 mm Hg.
A 1-cm skin incision is then made 
in the upper portion of the umbili­
cus for insertion of an 11-mm tro­
car through which a 10-mm laparo­
scope is inserted (Fig. 3). A 5-mm 
incision is made in the epigastric 
region, slightly to the right of the 
midline to avoid the falciform liga­
ment. A 5-mm trocar is inserted and 
an atraumatic grasping forceps in­
troduced; this is used to retract the 
fundus of the gallbladder and the 
liver. Another 5-mm incision is 
made in the right subcostal region 
laterally. Through a second 5-mm 
trocar, another atraumatic grasping 
forceps is introduced to hold Hart­
mann’s pouch. These two forceps 
can be manipulated together to re­
move omental adhesions on the 
gallbladder. A fourth incision, 1 cm 
wide, is made midway between the 
umbilicus and the xyphoid process 
but on the left paramedian line, to 
insert an 11-mm trocar through 
which the working instruments 
(scissors, electrocoagulating hook, 
clip applicators and Aqua-Purator) 
are introduced.
The patient is then placed in 
Fowler’s position with the right side 
elevated. This gives better visualiza­
tion of the gallbladder and related 
structures by allowing the omen­
tum, transverse colon, duodenum 
and stomach to be displaced caudal- 
ly and toward the midline. Clips are
applied to the cystic duct and the 
cystic artery before division of these 
structures, and the gallbladder is 
dissected from its bed starting at 
the cystic duct. Care is taken to 
visualize the common duct and es­
pecially the common hepatic duct, 
which could easily be injured.
The gallbladder is extracted 
through the umbilical wound under 
the guidance of an endoscope ins­
erted through the left paramedian 
trocar. When the stones are too 
large to be removed through this 
1-cm incision, their extraction with 
a stone forceps or by widening the 
fascial opening with a hemostat will 
permit the passage of the gallblad­
der through the abdominal wall (the 
fascia is closed only when a hemo­
stat is used). The subphrenic and 
subhepatic spaces are irrigated 
with the Aqua-Purator and the 
cystic duct and artery stumps are 
inspected.
Results
Three patients had acute chole­
cystitis, 56 had chronic cholecysti­
tis and 1 had a hydrops of the 
gallbladder. Nineteen patients had 
undergone previous lower abdomi­
nal surgery. Two patients had two 
scars each from previous surgical 
procedures. Nine patients had previ­
ously undergone appendectomy, 
eight had undergone gynecologic 
procedures that included hysterec-
FIG. 2. Site of insertion of Veress 
needle at umbilicus. After creation of 
pneumoperitoneum one trocar will be 
inserted at site of each black circle.
FIG. 1. Performance of laparoscopic cholecystectomy in operating room. Surgeon 
stands at end of table. Assistant and scrubbed nurse is on left of patient. Shown 
above surgeon’s left hand are video monitor, camera system and Aqua-Purator for 
irrigation. Left hand of unscrubbed nurse points to insufflator.
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tomy, cesarean section and salpin- 
go-oophorectomy, two had under­
gone inguinal herniorrhaphy and 
two had undergone lipectomy.
No intraoperative complications 
were noted and no patient had the 
procedure completed by standard 
surgery.
Pain medication was notably less 
than with standard cholecystecto­
my. During their postoperative hos­
pital stay, which varied from 2 to 6 
days (mean 2.5 days) (Fig. 4), five 
patients took no pain medication. 
No patient took more than four 
parenteral injections of narcotics
for pain (mean 1.7 injections). The 
average number of times oral medi­
cation was given was 1.8 (range 
from 0 to 6 times).
Postoperative Complications
The complication rate was low. 
Two patients had a postoperative 
ileus, but they were discharged 
home by postoperative day 6. One 
patient complained of upper abdom­
inal pain 1 week postoperatively. 
The pain was diagnosed as incision­
al (over the left paramedian inci­
sion), and it resolved spontaneously 
over 3 days. No herniation was 
demonstrated. Investigation of this 
patient (vital signs, complete blood 
count, liver function tests, echogra­
phy of the abdomen) revealed no 
abnormality.
Ten days postoperatively one pa­
tient was readmitted because of an 
episode of abdominal pain due to 
choledocholithiasis. She underwent 
endoscopic sphincterotomy and re­
moval of her common-duct stones. 
A second patient was readmitted 17 
days after surgery with symptoms 
compatible with choledocholithiasis. 
Endoscopic retrograde cholangiog­
raphy revealed no residual stone 
and she was asymptomatic when 
discharged. Preoperatively these pa­
tients had normal liver function test 
results and no common-duct abnor­
mality on ultrasonography.
One patient was readmitted 8 
days postoperatively with fever and 
upper abdominal pain. Ultrasonog­
raphy and computed tomography 
revealed an infrahepatic fluid collec­
tion. It was drained percutaneously 
by the interventional radiologist, 
and Escherichia coli was cultured 
from the drainage. Leakage from 
the stump of the cystic duct was 
documented by injecting radiopaque 
material through the percutaneous 
drain. The patient made a smooth 
recovery.
There were no deaths.
FIG. 3. Photograph taken from cephalad position. Surgeon holds electrocoagulat- 
ing hook in right hand and atraumatic grasping forceps in left. Assistant holds 
video camera in left hand and atraumatic grasping forceps in right.
FIG. 4. Postoperative hospital stay.
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Discussion
Laparoscopic cholecystectomy 
was first reported 3 years ago,45 
but it was not until recently that 
the potential benefits of this proce­
dure were recognized: rapid disap­
pearance of pain, no danger of 
wound dehiscence, improved cos­
metic appearance and a shorter hos­
pital stay and recovery period. All 
these advantages were noted in our 
series. Pain or discomfort was often 
located in the supraumbilical re­
gion, corresponding to the site of 
insertion of the laparoscope, which 
is also the site of removal of the 
gallbladder. Pain was most often 
noted when the fascial opening had 
been widened with a hemostat to 
allow large stones to be extracted.
Some of our patients returned to 
work 3 days after the procedure, 
but we routinely allow them a 
2-week recovery period. Our esti­
mated operative time has been re­
duced from just over 120 minutes 
to 45 to 75 minutes depending on 
the size of the patient and the 
operative findings.
The only contraindications to la­
paroscopic cholecystectomy are 
morbid obesity, severe cholecystitis 
and scars from previous surgery in 
the upper half of the abdomen. 
Previous lower abdominal surgery, 
provided it was not for generalized 
peritonitis, is not a contraindica­
tion. Some of our patients had 
infraumbilical midline incisions or 
McBurney incisions, which did not 
present any technical difficulty.
At present we do not perform 
operative cholangiography because 
we cannot complete adequate com­
mon-duct exploration by laparos­
copy. Dubois and colleagues5 rely 
on preoperative intravenous cholan­
giography. When choledocholithia- 
sis is noted, they do a preoperative 
endoscopic sphincterotomy with 
stone extraction. However, intrave­
nous cholangiography is positive in 
less than 30% of the cases. Reddick 
and Olsen4 do peroperative cholan­
giography and perform postopera­
tive endoscopic sphincterotomy if 
common-duct stones are noted. We 
adopted the following attitude: if 
choledocholithiasis is suspected 
preoperatively, either by ul­
trasonography or from the results 
of liver function tests, endoscopic 
retrograde cholangiography is car­
ried out; if stones are demonstrated, 
sphincterotomy and stone extrac­
tion are done. If choledocholithiasis 
is suspected after laparoscopic cho­
lecystectomy has been performed, 
endoscopic retrograde cholangiog­
raphy and, if necessary, sphinc­
terotomy and stone extraction are 
done.
Two of our 60 patients present­
ed, at follow-up, with symptoms of 
choledocholithiasis. One underwent 
successful stone removal with endo­
scopic sphincterotomy. Retrograde 
cholangiography did not demon­
strate common-duct stones in the 
second patient.
Indications for surgical common- 
duct exploration are likely to de­
crease with the combined availabili­
ty of laparoscopic cholecystectomy 
and endoscopic sphincterotomy 
with stone extraction.
Although results from our series 
were good, the number of patients 
was insufficient to provide reliable 
data about the true complication 
rate when this procedure is applied 
to a large number of patients.
In view of our low morbidity and 
mortality rates, we recommend la­
paroscopic cholecystectomy as the 
procedure of choice for most pa­
tients with gallbladder disease. 
However, proper training in the 
procedure is highly recommended 
because of the disastrous complica­
tions that could follow inappropri­
ate entry into the abdomen and the 
injuries that could be inflicted on 
the common bile duct during chole­
cystectomy with electrocoagulating 
instruments. There is a definite 
learning curve associated with the 
acquisition of this technique.
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Renal Cell Carcinoma: 
Incidental Detection
H.P. Lanctin, MD; N.G. Futter, MB, BS, FRCSC
The mode of presentation of renal cell carcinoma is changing; in 40% of cases the 
condition is now found incidentally during the investigation of complaints other 
than those usually associated with this tumour. Chemotherapy and radiotherapy 
have not improved the survival of patients with renal cell carcinomas, but, with the 
introduction of ultrasonography, renal cell carcinomas, including those found 
incidentally, are being diagnosed earlier than they were a decade ago, resulting in 
improved survival rates.
Le mode de detection des cancers des cellules renales se modifie; dans 40% des cas 
cette maladie est maintenant decouverte accidentellement, au cours d'examens relies 
a des symptomes autres que ceux qui sont habituellement associes a cette tumeur. 
La chimiotherapie et la radiotherapie n’ont pas ameliore la survie des victimes du 
cancer des cellules renales. Neanmoins, avec la venue de l’echographie, les cancers 
des cellules renales decouverts de fa?on accidentelle ou autrement, sont diagnosti- 
ques plus precocement qu’ils ne l’etaient il y a une decennie, ce qui ameliore le taux 
de survie.
The presenting symptoms, signs and laboratory findings of renal 
cell carcinoma are diverse and often 
obscure. Only 10% of patients with 
this tumour present with the classic 
triad of pain, a mass and hematuria. 
Renal cell carcinoma is associated 
with a wide spectrum of paraneo­
plastic syndromes, including hyper­
calcemia, hypertension, ery- 
throcytosis and abnormal results of 
liver function tests, as well as the 
nonspecific features of malignant 
disease — weight loss, anemia and 
fatigue. Metastases may be solitary 
and in unusual sites. This diversity 
has resulted in the renal cell carci­
noma being called “the internist’s 
tumour” .
With the increased availability of 
noninvasive imaging techniques, 
particularly ultrasonography, unex­
pected and incidental findings are 
inevitable. Increasingly more renal 
cell carcinomas are being diagnosed 
this way. In this paper the impact of 
serendipitous detection of renal cell 
carcinoma on tumour staging is 
discussed.
Patients and Methods
Between 1979 and 1986, 202 
patients (120 men, 82 women) with 
proven renal cell carcinoma were 
managed at the Ottawa General 
Hospital and the Ottawa Civic Hos­
pital. The age, sex, mode of presen­
tation, pathological staging and 
subsequent follow-up were reviewed 
and recorded.
Patients were divided into four 
groups according to their mode of 
presentation. Group 1 comprised 
those presenting with the classic 
urologic symptoms and signs of 
renal cell carcinoma; that is, pain, 
gross and microscopic hematuria or 
a mass, alone or in combination. In 
group 2 were those presenting with 
metastatic disease. Group 3 con­
tained patients presenting with pa­
raneoplastic syndromes of fatigue, 
weight loss, hypercalcemia, ery- 
throcytosis and hypertension. In 
group 4 were patients whose tu­
mour was found incidentally.
Ultrasonography was done in 33 
patients and intravenous pyelogra­
phy in 26. Seven underwent com­
puted tomography, one nuclear 
scanning and one laparotomy.
All tumours were staged from the 
pathological findings, according to 
Robson’s criteria:1 stage I — tu­
mour confined to the parenchyma 
within the renal capsule; stage II — 
invasion of the perinephric fat with 
Gerota’s fascia intact; stage III — 
involvement of renal vein, inferior 
vena cava or regional nodes; stage 
IV — distant metastases or involve­
ment of contiguous structures.
The follow-up and the patient’s 
condition (free of disease, alive with 
metastases or dead) was recorded.
Computed tomography became 
available at both hospitals late in 
1981, and ultrasonography was
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available in most clinics in the city 
at that time. To assess the impact 
of these imaging techniques pa­
tients were divided into subgroups 
of those presenting before and after 
1981.
Findings
Grouping
The average age of the 202 pa­
tients was 60 years. Their grouping 
by mode of presentation is shown in 
Table I.
Of the patients who presented 
before 1982, 49% had the classic 
urologic symptoms of renal cell 
carcinoma, and 21% were found 
incidentally. From 1982 onward 
42% of patients presented with 
pain, mass and hematuria; 40% of 
tumours were found incidentally. 
There was a corresponding decrease 
in the numbers presenting because 
of metastases (from 21% to 7%).
Investigation
Table II shows the manner in 
which the incidentally found tu­
T a b le  1. M od e  o f P re se n ta tio n
1981 or before , A fte r  1981,
no. (% ) no. (% )
Group (n =  68) (n  =  134)
1 -  pa in, m ass , he m a tu ria 33  (49 ) 5 6  (42)
2  -  m e tas tases 1 4 (2 1 ) 1 0 (7 )
3  -  p a ra n eo p las tic  s y n d ro m e s 7 ( 1 0 ) 1 4 (1 0 )
4  -  in c id e n ta l f in d in g 1 4 (2 1 ) 5 4  (40)
T a b le  II .  D iagnostic  Im a g in g  M e th o d s
M ethod 1981 or before A fte r 1981
U ltra s o n o g ra p h y 4 29
In travenous p ye lo g ra p h y 8 18
O ther 2 7
FIG. 1. Pathological stage of renal cell tumour at time of diagnosis in patients with 
classic symptoms and signs (cross-hatched bars) and those with carcinoma found 
incidentally (hatched bars).
mours were diagnosed. Increasingly 
ultrasonography was the principal 
source of serendipitously found tu­
mours. After 1981, 55% of tumours 
were detected by ultrasonography 
(Table II).
The investigations were carried 
out for the following reasons: gas­
trointestinal symptoms such as dys­
pepsia or biliary colic (33 patients); 
urologic problems including bladder 
outlet obstruction, follow-up of 
proven renal cysts and urolithiases 
(16 patients); and staging and fol­
low-up of other malignant tumours 
(7 patients). When symptoms were 
lateralized to one side of the body 
there was an equal distribution of 
tumours to either side.
Tumour Stage
Figure 1 shows the pathologic 
stage at the time of diagnosis for 
the tumours found in patients pre­
senting with urologic symptoms 
and those found incidentally; the 
tumours were confined to the renal 
capsule (stage I) in 44% and 53% 
respectively. On subsequent investi­
gation 15% of patients presenting 
with classic symptoms and 14% of 
those whose tumour was found in­
cidentally had stage I disease.
Discussion
Our data show that the presenta­
tion of renal cell carcinoma has 
changed substantially since the in­
troduction of ultrasonography. In 
this series computed tomography 
scanning had little impact on the 
number of tumours found inciden­
tally, probably because it is rarely 
performed without previous ultra 
sonography at the University of 
Western Ontario teaching hospitals. 
Riches, Griffiths and Thackery2 in 
1951 reported on 1746 renal cell 
carcinomas; 4% were found inciden­
tally. Skinner and colleagues3 in
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1971 reported that 6% of 309 tu­
mours were incidental findings, and 
Haertig and Kuss4 in 1982 reported 
8%. Konnack and Grossman5 com­
pared the presentation of 56 pa­
tients between 1961 and 1973 with 
46 presenting between 1980 and 
1984. The incidence of incidentally 
found tumours in the two groups 
was 13% and 48%. Veda and Miha- 
ra5 who reviewed 53 cases in similar 
time frames reported that 13% and 
35% of tumours were found inci­
dentally. In our series 40% of renal 
cell carcinomas in patients present­
ing after 1981 were found inciden­
tally; and 55% were diagnosed by 
ultrasonography.
In our patients tumour stage at 
the time of diagnosis was similar for 
those with incidentally found tu­
mours and those presenting with 
classic features. That renal cell car­
cinomas presenting with classic 
urologic symptoms and signs are 
being recognized at an earlier stage 
now than 10 years ago can be 
attributed to physician awareness of 
the tumour and need for investiga­
tion of hematuria, and particularly 
to the availability of ultrasonogra­
phy, which allows the detection of 
smaller lesions than those found on 
intravenous urography. The con­
cept that any renal parenchymal 
mass less than 3 cm in diameter be 
considered a benign adenoma must 
now be seriously questioned. Other 
series13 have shown a lower tumour 
stage of incidentally detected tu­
mours, but the comparison can be 
questioned because the patients 
were gathered over 10 to 20 years, 
and the authors did not compare
tumours found in the same limited 
time span. The number of cases of 
renal cell carcinoma diagnosed an­
nually has shown an increase in 
recent years. Data from the Ontario 
Cancer Treatment and Research 
Foundation7 showed the incidence 
to be 5.6/100 00 for males in 1976 
and 2.7/100 000 for females. In 
1985 the figures were 7.4 and 4.4, 
respectively.8
All primary tumours are clinically 
silent initially; some maintain this 
silence even after the development 
of metastases. The fortuitous diag­
nosis of renal cell carcinomas 
should result in tumour recognition 
at an earlier pathologic stage and 
fewer tumours presenting with me­
tastases. From our data no differ­
ence was noted in the pathologic 
staging, but the percentage of pa­
tients presenting with metastatic 
disease after the introduction of 
ultrasonography was reduced from 
21% to 7%.
A full assessment of the behavi­
our of these tumours will have to 
await 5- and 10-year follow-up ex­
aminations. At present the disease 
free interval of tumours found inci­
dentally and tumours in patients 
presenting with classic symptoms is 
determined by the stage at the time 
of recognition. Thompson and 
Peek9 reported that 90% of patients 
with incidentally diagnosed stage I 
tumours were alive and disease-free 
after 5 years. Since Robson1 
showed improved 5-year survival 
with radical nephrectomy in 1963, 
there have been no important ad­
vances in the treatment of this 
disease. Chemotherapy and radio­
therapy have had no notable impact 
on patient survival at any stage of 
the disease. Improving the overall 
survival figures for patients with 
renal cell carcinoma at this time 
depends upon an early diagnosis. 
Population screening with ul­
trasonography cannot be justified; 
however, consideration should be 
given to renal cell carcinoma in all 
patients having ultrasonography of 
the upper abdomen — a “quick 
peek’’ adds little to the examina­
tion; any solid lesion in the kidney 
demands further investigation.
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Long-term Pain and Disability in Relation 
to Residual Deformity After Displaced 
Pelvic Ring Fractures
A C. McLaren, MD, FRCSC; C.H. Rorabeck, MD, FRCSC; J. Halpenny, MD, FRCSC
In a retrospective review and follow-up study of 43 patients who had had 
high-energy pelvic fractures 5 or more years earlier, the occurrence of late pain and 
the functional outcome were adversely related to residual deformity of the pelvic 
ring. Among patients who had no residual deformity (displacement less than I cm), 
88% had no serious pain and 82% had normal function. Of patients who had residual 
deformity (displacement more than 1 cm posteriorly), only 30% had no serious pain 
(p < 0.01) and only 30% had normal function (p < 0.01). Definitive reduction and 
stabilization is therefore recommended early after the injury whenever possible.
Dans une etude retrospective et une etude de post-cure portant sur 43 patients qui 
avaient subi, au moins 5 ans plus tot, des fractures pelviennes a haute vitesse 
d’impact, l’apparition de douleurs tardives et les resultats fonctionnels etaient 
negativement relies a la difformite residuelle de l’anneau pelvien. Parmi les patients 
qui n’avaient aucune difformite residuelle (un deplacement inferieur a 1 cm), 88% 
n’avaient aucune douleur importante et 82% etaient fonctionnellement normaux. 
Chez les patients qui presentaient une difformite residuelle (un deplacement 
posterieur superieur a 1 cm), seulement 30% ne souffraient pas de douleurs intenses 
(p < 0.01) et seulement 30% avaient une fonction normale (p < 0.01). II est done 
recommande de pratiquer une reduction et une stabilisation definitives tot apres la 
blessure, chaque fois que cela est possible.
The current management of pel­vic fractures is aimed at imme­
diate stabilization to control hem­
orrhage and subsequent definitive 
fixation to prevent malunion.1"4 Be­
fore aggressive orthopedic treat­
ment was recommended in trauma 
protocols, patients with pelvic frac­
tures were generally managed con­
servatively. This often resulted in 
marked residual displacement,56 
which appears to have been accept­
ed in many patients.
If residual deformity were an im­
portant determinant of late morbidi­
ty, one would expect patients with 
such deformity to present a contin­
uing management problem. Howev­
er, few patients were seen at follow­
up with long-term functional dis­
ability or late pain following pelvic 
fracture.
At the University of Western On­
tario aggressive management of un­
stable pelvic fractures has become 
the norm. However, the principle of
accurate reduction and fixation to 
prevent residual deformity can only 
be justified if this leads to an im­
proved outcome. It was our pur­
pose, therefore, to review the out­
come in patients who had been 
treated for high-energy pelvic frac­
tures at the University of Western 
Ontario teaching hospitals.
Patients and Methods
We searched all medical records 
in the University of Western Ontar­
io teaching hospitals from 1978 to 
1982 for patients in whom a diag­
nosis of pelvic fracture had been 
made. The mechanism of injury was 
reviewed, and only those patients 
who had sustained a high-energy 
pelvic fracture were included.
Each patient’s chart and available 
x-ray films were reviewed. The pa­
tients were all examined again, and 
new x-ray films were obtained, in­
cluding anteroposterior, inlet and 
outlet views of the pelvis. Radiolog­
ic assessment included determina­
tion of the fracture pattern6 and the 
amount of residual displacement.
We identified fractures of the 
sacrum, dislocations and fracture- 
dislocations of the sacroiliac joint, 
and fractures of the iliac wing en­
tering the sciatic notch as involving 
the posterior aspect of the pelvic 
ring. Displacement of the posterior 
elements greater than 1 cm in any
From the Department o f  Surgery, University Hospital, University o f  Western Ontario, London, 
Ont.
Accepted fo r publication Oct. 12, 1989
Reprint requests to: Dr. A.C. McLaren, 345 Westminster Ave., London, Ont. N6C 4V3
*
I
A
S '
-A
■ A
'‘m.
492 CJS, VOL. 33, NO. 6, DECEMBER 1990
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direction was considered a signifi­
cant residual deformity. Clinical 
evaluation included questioning the 
patient to assess the current levels 
of pain, neurologic, gastointestinal 
or genitourinary symptoms and 
measurement of leg length and de­
gree of function.
Findings
There were 43 patients (32 men, 
11 women) in our review, 41 with 
closed fractures and 2 with open 
fractures. The patients ranged in 
age from 18 to 50 years (median 29 
years) (Table I). The follow-up 
ranged from 5 to 9 years (median 
6.5 years).
Thirty-five patients had received 
injuries to other systems, and 15 
had local pelvic visceral injuries 
(Table II).
Twenty-six patients had had ei­
ther incomplete reduction or loss of 
reduction of the posterior ring, with 
a resultant displacement of more 
than 1 cm. Patients with displaced 
pelvic fractures had been managed 
by 12 orthopedic surgeons over 4 
years by a variety of treatment 
methods, including pelvic sling, 
skeletal traction, external fixation 
and open reduction with internal 
fixation.
Fifteen (88%) of 17 patients with 
less than 1 cm of residual displace­
ment had no pain (Table III); 14 
(82%) had no functional restrictions 
in their daily, recreational or work- 
related activities. Of 26 patients 
who had more than 1 cm of residual 
displacement, only 8 (30%) had no 
pain, and only 8 (30%) had no 
functional disability. Both pain and 
function were significantly worse in 
the group with more than 1 cm of 
displacement (p < 0.01, Student’s 
t- test).
Thirteen patients had sustained 
bladder or urethral injuries at the 
time of pelvic fracture (Table II).
Chronic urinary symptoms were not 
noted in any of the five patients 
whose pelvic fracture had healed 
with less than 1 cm of displace­
ment, but were present in three of
the eight patients with more than 1 
cm of displacement (Table III).
Paresthesia was present in 2 of 
the 17 patients without residual 
deformity. More patients with resid-
Table 1. Characteristics of 43 Patients Treated From 5 to 9 Years Earlier for High-Energy Pelvic
Ring Fractures
Displacement of posterior ring
Feature < 1 cm (n =  17) >  1 cm (n =  26)
Age (range), yr 26 (18-44) 34 (21-50)
Sex, M:F 12:5 16:10
Fracture pattern 
Anteroposterior compression 8 6
Lateral compression 6 15
Vertical shear 3 5
Table II. Associated Injuries and Conditions, Local and Remote (n =  35)
Site or type of injury/condition _____________ _______ Ncr
Bladder 9
Urethra 4
Rectum 2
Bowel 2
Kidney 2
Spleen or liver 7
Head 6
Cervical spine 2
Lumbar spine 3
Upper extremity 11
Lower extremity 18
Acquired respiratory distress syndrome 5
Pulmonary embolism 3
Pneumonia 2
Fat embolism syndrome 1
Table III. Occurrence of Pain and Disability
Displacement of posterior ring
Findings < 1 cm (n =  17) > 1  cm (n =  26)
Pain
None 15 8
With activity, no analgesia 2 12
Continued analgesia needed 0 6
Function
8No restriction 14
Modified physical activities or job 2 13
Modified daily activities or inability to
work 1 5
Neurologic symptoms
Paresthesia 2 5
Weakness 0 10
Paresthesia and weakness 0 2
Urologic problems’
8Structural injury to bladder or urethra 5
Residual incontinence 0 3
’ Thirteen patients had had bladder or urethral injuries at the time of pelvic fracture, 5 i 
with < 1 cm of displacement and 8 among those with > 1 cm of displacement.
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ual deformity had neurologic prob­
lems (p < 0.01); there was pares­
thesia in 5 and muscle weakness in 
10 (Table III).
Leg-length discrepancies of more 
than 1.5 cm had occurred in six 
patients with residual deformity; 
three of them had serious back 
pain. The importance of this trend 
could not be determined because of 
other factors such as lumbar spine 
injuries and degenerative disc dis­
ease.
Discussion
The results of this study support 
aggressive treatment of pelvic frac­
tures to prevent malunion of the 
pelvic ring. Significant residual de­
formity of the posterior portion of 
the pelvic ring is associated with 
increased long-term pain and dis­
ability. These conclusions are con­
sistent with those in the report by 
Henderson, Nepola and Claverie7 
and do not support the conclusion 
of Monohan and Taylor8 that there 
is minimal late morbidity associated 
with malunion of the pelvic ring.
The stability of pelvic fractures is 
determined by more than the pat­
tern of bony injury and the associ­
ated soft-tissue injury. Fractures as­
sociated with extensive soft-tissue 
disruption are more unstable and 
have a greater risk of malunion if 
left unstabilized. The importance of 
this factor is difficult to assess on 
late follow-up. The displacement 
that occurs during the injury is
often far greater than might be 
expected from the initial x-ray 
films, and the final, healed position 
does not reliably indicate the severi­
ty of the soft-tissue injury, al­
though one would expect a greater 
degree of initial soft-tissue disrup­
tion when there is substantial resid­
ual deformity. Visceral injuries are 
most likely related to the degree of 
initial displacement. The residual 
deformity at healing cannot be con­
sidered a reliable indicator for the 
recovery of bladder and bowel func­
tion either.
Trauma-management protocols 
generally include stabilization of 
pelvic fractures in the acute phase, 
usually by immediate anterior exter­
nal fixation.3-4 This is our current 
practice. Displaced posterior frac­
tures require subsequent reduction 
and stabilization. In the meantime, 
the pelvis is generally stable enough 
with the anterior fixator to allow 
for nursing care. The fixator pro­
vides sufficient pelvic stability for 
transportation to a trauma unit if 
the expertise for posterior stabiliza­
tion is not locally available.
It has been our experience that 
reduction becomes increasingly dif­
ficult as time passes. There can be 
delays of up to 3 or 4 weeks before 
reduction can be carried out in 
multiply injured patients, so while 
the patients are awaiting definitive 
stabilization we maintain them in 
skeletal traction to prevent migra­
tion of the hemipelvis. This traction 
can be removed and reapplied as 
required for nursing care. Prefera­
bly, these patients are returned to 
the operating room 3 to 5 days 
after injury for reduction and stabi­
lization.
Patients in this follow-up study 
had all abandoned seeking further 
orthopedic attention, even though 
they had significant pain and dis­
ability; they had been discharged 
without further treatment being of­
fered. The fact that patients do not 
return with long-term disability 
should therefore be attributed to 
their having ceased looking for 
help, rather than to an actual lack 
of long-term morbidity.
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Laser-Assisted Balloon Angioplasty: 
Initial 18 Months’ Experience
D.L. Doyle, MD, FRCSC; P.D. Fry, MD, FRCSC
The authors describe their initial 18-month experience with laser-assisted balloon 
angioplasty (LABA) of femoral arteries in 44 patients. Primary patency was achieved 
in 28 patients, but within 30 days the artery became occluded in 9 of them. 
Perforation occurred much more frequently early in the study. Complications 
associated with antegrade femoral artery puncture have led to more liberal use of 
LABA through an operative approach in the femoral artery. Attention to technical 
detail is critical. When LABA fails it does not appear to worsen the patient’s 
condition clinically or radiologically. Endovascular procedures are undergoing 
continued, rapid change, so ongoing development and assessment of results are 
necessary for those who perform LABA.
Les auteurs font part de leur experience initiale de 18 mois en angioplastie par 
ballonet aidee de laser (ABAL) des arteres femorales de 44 patients. Une 
permeabilite primaire a ete obtenue chez 28 patients, mais en dedans de 30 jours 
l’artere s’est obstruee chez 9 d’entre eux. Une perforation s’est produite beaucoup 
plus souvent au debut de l’etude. Les complications associees a la ponction 
antegrade de l’artere femorale ont mene a une utilisation de ABAL beaucoup liberate 
par approche chirurgicale de l’artere femorale. Une attention toute particuliere doit 
etre vouee aux details techniques. En cas de faillite du ABAL, il ne semble pas que 
la condition du patient en soit affectee cliniquement ou radiologiquement. Les 
interventions endovasculaires subissent des changements continuels et rapides; la 
poursuite des ameliorations et l’etude des resultats sont necessaires a ceux qui 
utilisent le ABAL.
The ability to re-establish arteri­al flow through previously oc­
cluded blood vessels using percuta­
neous transluminal techniques has 
great appeal. The ideal technique 
has not yet been developed but 
would be applicable to long- as well 
as short-segment occlusions of 
large- and small-calibre arteries. Re­
canalization would be possible in 
the presence of soft and calcified 
plaque, and the technique would
have a high initial and long-term 
success rate and employ relatively 
inexpensive technology.
Since the early reports of suc­
cessful laser vaporization of athero­
sclerotic plaque in cadaveric ves­
sels1 and, later, in animals, laser 
angioplasty has been greatly modi­
fied. Laser-assisted balloon angio­
plasty (LABA) is widely used.2-6 In 
this paper we report our early expe­
rience with laser angioplasty.
Patients and Methods
The first LABA performed in 
western Canada was at University 
Hospital, UBC Site, in Vancouver in 
June 1987. The series included 44 
patients (30 men, 14 women) who 
had claudication and threatened 
limb loss. They had a relatively 
short segment (less than 12 cm) of 
superficial femoral or popliteal ar­
tery occlusion that could not be 
crossed with a guide wire. Patients 
were admitted to hospital the day 
before the procedure and started on 
acetylsalicylic acid, 325 mg twice 
daily. After an overnight fast, pa­
tients were taken to the operating 
room. In patients who had no dis­
ease of the common femoral artery, 
the Seldinger technique with ante­
grade common femoral artery punc­
ture and local anesthesia was used 
to place a no. 8 French sheath in 
the common femoral artery with its 
tip in the superficial femoral artery. 
In patients requiring a common 
femoral thromboendarterectomy, a 
femoral arteriotomy was performed 
under local, regional or, occasional­
ly, general anesthesia. The choice 
of anesthetic was directed by pa­
tient factors and anesthetist prefer­
ence. After thromboendarterectomy, 
with or without a patch, the arteri­
otomy was nearly closed and a no. 8 
French sheath placed directly into 
the common and superficial femoral 
arteries. Patients were systemically 
heparinized, and a slow, steady in­
fusion of dilute heparin in normal 
saline was begun through the side 
port of the sheath.
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A Trimedyne Laserprobe (Trime- 
dyne, Santa Ana, Calif.) was cou­
pled to a continuous-wave 12-W 
Trimedyne argon laser, set between 
8 and 10 W. Lasing and dilatation 
were conducted under fluoroscopic 
control. All fluoroscopic images 
were recorded on 1.9-cm videotape. 
This allows for immediate image 
review and long-term data storage. 
After the Laserprobe had been 
passed to the level of the occlusion 
the laser was activated and the 
probe was slowly passed through 
the occlusion. Continuous fluoro­
scopic guidance with a slow, steady 
injection of nonionic contrast mate­
rial was maintained throughout 
laser recanalization. In long-seg­
ment occlusions, the recanalization 
proceeded in stages. The Laser­
probe was withdrawn and accumu­
lated charring cleaned from the tip. 
In all cases, once laser recanaliza­
tion was complete, balloon angio­
plasty was performed to dilate resid­
ual stenosis.
Perforation of the artery was not 
necessarily a signal to abandon the 
procedure, unless the perforation 
was large or associated with an 
arteriovenous fistula or loss of con­
tinuity of the distal vessel. Pressure 
was briefly maintained on the site of 
arterial perforation and reconstruc­
tive bypass surgery performed at 
the surgeon’s discretion.
After successful laser angioplasty 
by cutdown, sheaths were removed 
and arteriotomies and wounds 
closed. For percutaneous proce­
dures, sheaths were removed and 
pressure was maintained on the 
puncture site until hemostasis oc­
curred; later in the study, sheaths 
were left in place for 12 to 24 hours 
and intra-arterial infusion of hepa­
rin was continued. Angiography 
was done, and if all appeared well 
the sheaths were removed. All pa­
tients were heparinized for 24 
hours after the procedure. Acetyl- 
salicylic acid administration was re­
sumed and patients were discharged 
home 24 to 48 hours after the 
procedure.
As a result of some initial prob­
lems with vasospasm during and 
after the procedure, we chose to 
start all patients who were not 
normally taking calcium channel 
blockers on nifedipine, 10 mg oral­
ly, three times a day. The nifedipine 
was begun the evening before the 
procedure and continued for 48 to 
72 hours after.
Ankle-brachial pressure indices 
were measured before and after 
LABA.
Laser angioplasty was considered 
successful if the completion angio­
gram demonstrated free flow of 
contrast material from the proximal 
vessel through the previously oc­
cluded segment. Ongoing patency 
was assessed by clinical and labora­
tory means, including the disap­
pearance or marked reduction of 
symptoms, improvement in ankle- 
brachial pressure indices, the pres­
ence of previously absent pedal 
pulses and the successful healing of 
ischemic ulcers or digital amputa­
tion wounds. Repeat angiography 
was performed when symptoms oc­
curred, when ankle-brachial pres­
sure indices fell or when segmental 
Doppler flow velocities rose.
Results
The mean age of the 44 patients 
was 69 years for men and 67 years 
for women. Fourteen were diabet­
ics. Twenty-one procedures were 
done percutaneously and 23 were 
open procedures; femoral cutdown 
was necessary in three patients be­
cause of a failed percutaneous ap­
proach. In 20 patients disease of 
the common femoral or deep femo­
ral artery necessitated thromboen- 
darterectomy. Four procedures 
were performed under general anes­
thesia; in one of them it was used
because a spinal anesthetic failed. 
The other three general anesthetics 
were used early in our laser angio­
plasty experience. In 18 sheath in­
sertions, laser angioplasty was per­
formed with lidocaine infiltration of 
the inguinal area. Regional (spinal 
or epidural) anesthesia was per­
formed in 22 patients. Thirty-six 
LABAs were performed for claudi­
cation with a walking distance of 
between one-half and three blocks; 
8 were performed for limb salvage. 
Three of the 44 procedures were 
performed by a visiting authority. 
The mean ankle-brachial pressure 
index for each symptom category is 
listed in Table I.
Twenty-nine occlusions were of 
the distal superficial femoral artery. 
There were 11 combined occlusions 
of the distal superficial femoral ar­
tery and the proximal popliteal ar­
tery. Laser angioplasty was at­
tempted in two patients who had 
isolated popliteal artery occlusions, 
in one who had occlusion of the 
popliteal artery and tibioperoneal 
trunk and in one who had an 
isolated occlusion of the common 
iliac artery.
Primary patency was obtained in 
28 patients. There were 13 perfora­
tions. Three perforations occurred 
because of disconnection of the 
fibre tip, which allows the laser 
energy to spray indiscriminately 
within the vessel. One perforation 
was caused by a guide wire after a 
successful laser recanalization.
Table I. Symptoms and Average 
Ankle-Brachial Pressure Index
Mean
Symptoms
No. of 
patients
ankle-brachial 
pressure index
Gangrene 6 0.33
Rest pain 
Claudication
2* 0.59
< 1/2 block 
1/2 to 2
4 0.57
blocks 29 0.60
> 2 blocks 3 0.72
'Both patients were diabetic.
496 CJS, VOL. S3, NO. 6, DECEMBER 1990
LASER-ASSISTED ANGIOPLASTY
There was one vessel dissection; the 
true lumen could be entered with a 
guide wire but could not be entered 
with the Laserprobe, so that reca­
nalization could not be completed. 
In one case the guide wire would 
not cross a channel created and 
subsequently widened by repeat 
passage of the laser.
Of the 28 procedures in which 
primary patency was obtained, 2 
were “rescued perforations”. Both 
vessels reoccluded within 1 month. 
Seven other laser angioplasties also 
failed within 1 month; one of the 
failures occurred in a patient who 
had both LABA of an occluded 
segment and a balloon angioplasty 
of a hemodynamically significant 
nonocclusive lesion. Restenosis oc­
curred at the nonlased balloon angi­
oplasty site. The patient refused 
repeat balloon angioplasty. In two 
patients the vessel became occluded 
within 3 months. In one patient the 
vessel at the angioplasty site oc­
cluded at 6 months. One man, a 
diabetic, died of a sudden myocardi­
al infarction 3 months after laser 
angioplasty; the vessel at the angio­
plasty site was still patent at the 
time of his death. Another diabetic 
man who underwent laser angio­
plasty for frank gangrene died of 
multiorgan failure associated with 
chronic renal failure 6 weeks after
Table II. La te  Fa ilu res  o f L a se r-A ss is te d
B a lloon  A n g io p la s ty
Time to occlusion, mo No. of patients
< 0 .2 5 5
>1 4
3 2
6 1
Table III. L o n g -T e rm  P a tency  o f V esse ls
S ub jec ted  to  L a se r-A ss is te d  B a lloon
A n g io p la s ty
Time after 
angioplasty, mo No. of vessels
0 .5 1
3 4
6 2
9 2
12 5
successful laser angioplasty. The 
vessel at the angioplasty site re­
mained patent and the amputation 
wounds of his gangrenous toes had 
healed. The arteries at all other 
laser angioplasty sites remained pa­
tent. The average rise in the ankle- 
brachial pressure index in patients 
whose arteries at LABA sites re­
mained patent at least 1 month was 
0.4. An average rise of up to 0.1 
was seen in patients with an angio- 
graphically patent LABA in whom 
clinical or radiologic failure was 
seen within 30 days of angioplasty.
The long-term results are shown 
in Tables II and III.
Discussion
Like others357 we have demon­
strated that laser angioplasty can 
successfully recanalize arterial seg­
ments that cannot be reopened by 
balloon angioplasty alone. All pa­
tients in our series had lesions that 
could not be crossed by a guide 
wire. Vessel wall perforation is an 
ongoing problem, but it does not 
seem to be a life- or limb-threaten­
ing complication. Some perforations 
can be “rescued” by a channel 
created through the occlusion, and 
subsequent balloon angioplasty can 
achieve patency in those with small 
perforations, without arteriovenous 
fistulas in whom the distal vessel 
can continue to be visualized. We 
found that long-term patency could 
not be maintained in these vessels. 
All the recanalized segments in 
those with so-called rescued perfo­
rations occluded within 1 month. 
Probably the added trauma leaves a 
surface that is more thrombogenic 
after angioplasty than usual. Per­
haps the addition of a stent at these 
sites will improve patency.
The effects of the learning curve 
have once again been confirmed. 
The likelihood of achieving primary 
patency was much higher later in
our series. Attention to fine techni­
cal details is critical. Like others357 
we found that longer segments 
were more difficult to recanalize 
and were associated with a lower 
long-term patency rate. Our num­
bers are small and our follow-up is 
relatively short, so that detailed 
statistical analysis of patency is not 
meaningful.
We encountered a higher fre­
quency of problems with antegrade 
femoral puncture than did other 
investigators. These problems in­
cluded failure to cannulate the ves­
sel and hemodynamically important 
bleeding at the puncture site. In 
one case of short-segment occlu­
sion, a hemodynamically important 
lesion at the origin of the superfi­
cial femoral artery was not detected 
and therefore not dilated. This 
proximal lesion caused occlusion 6 
weeks after laser angioplasty and 
led to secondary occlusion of the 
artery at the lased site. We are now 
much more liberal in our indica­
tions for an open approach to laser 
angioplasty than we were earlier in 
our experience. Patients with ab­
dominal “aprons” that drape over 
the groin, those with a very short 
common femoral artery and those 
with any suggestion of disease in 
the common, superficial or deep 
femoral artery now undergo femoral 
cutdown, thromboendarterectomy 
and patch angioplasty. This proce­
dure is routinely done under local 
or regional anesthesia. Nearly 40% 
of our procedures are now done 
using an open femoral approach. 
The incidence of groin complica­
tions has fallen markedly.
We prefer to use a regional anes­
thetic. An epidural or spinal anes­
thetic is well tolerated in this age 
group, and the frequency of head­
ache is low. The sympathetic block­
ade associated with regional anes­
thesia decreases the likelihood of 
vasospasm during or after the pro­
cedure, and this may improve pat-
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ency. We have found that patients 
in whom LABA is performed under 
local anesthesia experience mild dis­
comfort during lasing. Not infre­
quently, the patients move their 
legs as an involuntary response to 
this sensation. Regional anesthesia 
provides excellent sensory and 
motor blockade.
Guidance and steerability remain 
major problems with this technique. 
We do laser angioplasty under fluo­
roscopic guidance. The vessel is 
visualized with a slow, steady injec­
tion of nonionic contrast material. 
Transcutaneous duplex scanning 
has proved cumbersome in our ex­
perience. It can be difficult to com­
bine with fluoroscopy, as the ul- 
trasonographer’s hand may be ex­
posed to radiation. An exciting new 
development is endovascular ul­
trasonography. The laser probe and 
its relation to the luminal surface 
are seen more clearly with this 
technique than with transcutaneous 
imaging. The margin between suc­
cess and perforation is greater. The 
problem of steerability continues to 
be addressed. Cables that deflect 
the tip have been added to allow for 
one degree of freedom. “Over-the- 
wire” probes are now available for 
peripheral and coronary lesions that 
can be crossed with a guide wire. 
Eccentric metal probes have been 
developed; they allow control of 
ablation in eccentric atherosclerotic 
plaque.
Our long-term follow-up is too 
short and our numbers are too 
small to compare the patency 
achieved by LABA with that 
achieved by femoropopliteal bypass. 
Others have reported an incidence 
of failure between 6 months and 1 
year of up to 30% for those with 
occlusions of the superficial femoral 
artery who underwent LABA.8 This 
failure is believed due to neointimal 
hyperplasia. We have seen some 
failures at this stage. The majority 
of our intermediate failures, howev­
er, are not at the laser angioplasty 
site. Our experience suggests that if 
the vessel at the angioplasty site 
can be kept patent for 1 month 
after the procedure intermediate- 
term patency is likely. The early 
failures seem to be related to tech­
nical problems with perforation and 
the creation of a thrombogenic sur­
face and possibly large flaps.
Laser balloon angioplasty seems 
to have application in a fairly small 
percentage of patients with athero­
sclerotic occlusive disease. For 
those in whom it is successful, 
revascularization is achieved with 
low risk, decreased cost and a 
shortened hospital stay when com­
pared with femoropopliteal bypass. 
For those in whom it fails, it does 
not appear to worsen the patient’s 
status clinically or radiologically.
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SESAP VI Critique
Item 125
Life-threatening hemorrhage is an all-too-common complication of 
pelvic fractures. Mortality up to 40% has been reported. The control of 
bleeding has been problematic. External pelvic fixation devices to 
stabilize the fracture have greatly reduced morbidity and the require­
ment for transfusion. The external fixation device should be applied as 
soon as the unstable fracture is recognized. If external fixation fails to 
control the bleeding, arteriography with embolization, or open reduc­
tion and internal fixation with control of hemorrhage, may subsequently 
be required. m
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Malignant Transformation Occurring 
in Mature Cystic Teratomas of the Ovary
G. Richardson, MD;* D.I. Robertson, MD, PhD, FRCPC;*t M.E. O’Connor, MB, FRCPC;*
J.G. Nation, MD,FRCSC;t G.C.E. Stuart, MD, FRCSCt
Two cases in which tumours of contrasting malignant potential arose in mature 
cystic teratomas (dermoid cysts) of the ovary are presented: one patient had a 
spindle-cell sarcoma and the other a trabecular carcinoid. The first patient’s clinical 
course was characterized by rapid recurrence of the tumour and death 3 months 
after surgery. The second patient is alive and well with no evidence of residual 
carcinoid, although the follow-up time is short. Since the surgical procedure of 
choice differs substantially if malignant transformation occurs in an ovarian dermoid 
cyst, the pathologist should be consulted intraoperatively in selected cases.
On presente deux cas ou des tumeurs ayant une potentialite cancerigene tres 
differente se sont developpees a partir de teratomes kystiques ovariens murs (kystes 
dermoides): il s’agissait d’un sarcome a cellules fusiformes dans un cas et d’un 
carcinoi'de trabeculaire dans l’autre. devolution clinique de la premiere patiente fut 
caracterisee par une recidive rapide de la tumeur et son deces 3 mois apres 
l’operation. La seconde patiente est saine et sauve, sans signes de carcinoi'de 
residuel, bien que la periode de post-cure soit courte. Comme le choix de 
l’intervention chirurgicale differe sensiblement quand il y a transformation maligne 
d’un kyste dermoide ovarien, un pathologiste devrait etre consulte durant l’opera­
tion dans les cas choisis.
Malignant transformation is an uncommon complication in a 
mature cystic teratoma (dermoid 
cyst) of the ovary, usually being 
reported in about 2% of cases,1-2 
although one series reported a fre­
quency of 4%.3 Sarcomatous trans­
formation is even rarer, occurring 
in only 7% of malignant tumours 
that develop from dermoid cysts.2
In a comprehensive review, up to 
1957, of malignant tumours devel­
oping from dermoid cysts, Peter­
son1 noted that the first dermoid 
cyst of the ovary was reported by 
Johannes Schultetus in 1659 and 
was accompanied by “excellent il­
lustrations” . Peterson credited 
Pesch, in 1857, with the first de­
tailed discussion of a malignant 
tumour complicating a dermoid cyst 
and Pommier in 1864 with the first 
case of sarcomatous degeneration. 
Since Peterson’s review only a few
isolated reports of sarcomatous 
transformation occurring in a der­
moid cyst have appeared in the 
English literature.4^ 6 This report 
was prompted by our recent experi­
ence with two unusual examples of 
malignant tumours occurring in 
ovarian dermoid cysts. One tumour 
was of high-grade and the other of 
low-grade malignancy.
Case Reports
Case 1
An 83-year-old woman, gravida 
3, para 3, complained of progres­
sive abdominal distension for 2 
months, bloating after eating and 
early satiety for 2 weeks and uri­
nary retention for 3 days. The abdo­
men was distended, with tenderness 
to deep palpation in both lower 
quadrants. Pelvic examination re­
vealed a smooth-edged mass filling 
the pelvis and displacing the uterus 
anteriorly. A computed tomography 
scan confirmed the presence of a 
large mass located centrally within 
the pelvis, with associated marked 
compression and displacement of 
the posterior aspect of the urinary 
bladder and bilateral hydronephro­
sis.
At operation, the mass posterior 
to the uterus was found to extend 
deeply into the cul-de-sac and onto 
the pelvic side wall. Further dissec­
tion revealed that most of the mass
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consisted of blood clot and edema­
tous connective tissue encasing the 
left ovary, which had undergone 
torsion on its pedicle several times. 
A left salpingo-oophorectomy was 
performed, and examination of a 
frozen section revealed a malignant 
tumour arising in a dermoid cyst.
The tumour was considered most 
likely to be an undifferentiated car­
cinoma. The right ovary was also 
enlarged, and frozen-section exami­
nation showed that it too contained 
a dermoid cyst but without any 
apparent malignant transformation. 
A total hysterectomy was per­
formed, and at the end of the 
operation no residual tumour was 
visible in the abdomen. The patient 
had a smooth recovery and was 
transferred to the referring institu­
tion for follow-up care.
She did not receive adjuvant che­
motherapy because of its potentially 
limited benefits and her advanced 
age.
Three weeks later vaginal bleed­
ing developed and re-exploration 
was necessary. Tissue fragments 
were found floating in the pelvis 
and were sent for pathological ex­
amination. The pelvis was packed in 
an attempt to achieve hemostasis. 
However, vaginal bleeding contin­
ued, and the patient required up to 
four units of blood daily. Despite 
another laparotomy, the vaginal 
bleeding continued, so the patient 
was again transferred to the Foot­
hills Hospital. Angiography re­
vealed a tumour blush in the pelvis, 
which was thought to represent 
recurrent tumour. The bleeding was 
unresponsive to radiotherapy and to 
internal iliac artery embolization, 
necessitating a further laparotomy, 
at which time the hypogastric arter­
ies were ligated. Tissue from the 
pelvic tumour was again obtained 
for pathological examination. The 
patient recovered but had internal 
bleeding 1 week later. She died of 
complications from her tumour 3 
months after her original surgery. 
No autopsy was performed.
Pathological findings. The left 
ovary measured 9 X 8 X 5  cm. On 
sectioning, it was was found to be 
unicystic and filled with sebaceous 
material and hairs. At one pole the 
wall was irregularly thickened and 
firm. Paraffin-embedded sections 
showed areas of respiratory and 
squamous epithelium as well as 
mature adipose, skeletal and carti- 
lagenous tissues. Arising within the 
dermoid cyst was an undifferentiat­
ed spindle-cell sarcoma (Fig. 1), 
which extended to the capsule of
FIG. 1. Case 1. Undifferentiated spindle-cell sarcoma; many mitotic figures are 
present (original magnification X 200).
FIG. 2. Case 1. Section stained to show vimentin (immunoperoxidase stain, original 
magnification X 200).
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the ovary. The malignant compo­
nent was composed of solid and 
myxoid areas without neoplastic os­
teoid or cartilage components. The 
mitotic rate was high, with more 
than 10 mitoses per single high- 
power field. Immunoperoxidase
stains for epithelial differentiation, 
including AE1,3 (a mixture of anti­
bodies to different molecular weight 
cytokeratins), CTK (a mixture of 
antibodies to other different mole­
cular weight cytokeratins) and EMA 
(epithelial membrane antigen), all
gave negative results. Markers for 
mesenchymal differentiation includ­
ing vimentin (Fig. 2) and actin were 
detected; myoglobin showed only 
rare focal positivity. Desmin and 
S-100 (a protein with a molecular 
weight of 21 000) gave negative 
results. Tumour obtained in the 
peripheral hospital during the sec­
ond operation had an identical ap­
pearance and similar immunoperox­
idase staining characteristics.
Tumour obtained from the last 
operation was submitted for elec­
tron microscopy and showed an 
undifferentiated sarcoma with focal 
rhabdomyosarcomatous differentia­
tion (Fig. 3). Flow cytometry of a 
tumour specimen revealed an aneu- 
ploid cell population, with 36% of 
the cells being in the S phase of the 
cell cycle.
Case 2
In 1985, at the age of 41 years, a 
woman underwent laparotomy for 
an intussusception of the terminal 
ileum, which was involved by a 
low-grade malignant lymphoma. A 
left ovarian mass was noted during 
surgery, but it was not removed. 
She received a course of chemother­
apy and remained in good health. In 
1989 she requested tubal ligation 
and removal of the ovarian mass, 
which had not changed in size, 
according to ultrasonographic ex­
amination. A left ovarian cystecto­
my was performed in addition to the 
tubal ligation. The patient recov­
ered smoothly and was well 3 
months later.
Pathological findings. The cyst 
measured 6.5 X 4.5 X 3 cm and 
contained sebaceous material and 
hair. Paraffin-embedded sections of 
the cyst revealed a predominantly 
squamous lining and skin adnexal 
structures. Other cell types identi­
fied included a minor enteric epithe­
lial component, mature fat, glia and 
smooth muscle. No immature ele-
F1G. 3. Case 1. Electron photomicrograph of undifferentiated sarcoma. Note highly 
convoluted and irregular nucleus, paucity of cytoplasmic organelles, many interme­
diate filaments, absence of basement membrane and lack of intercellular junctions 
(original magnification X 5000).
FIG. 4. Case 2. Carcinoid tumour composed of anastomosing trabeculae of columnar 
cells (hematoxylin and eosin, original magnification X 40).
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ments were identified. In the cyst 
wall a firm nodule measuring up to 
1.5 cm in diameter was noted.
In the thickened part of the cyst 
wall a secondary cyst, up to 6 mm 
in its greatest dimension, was iden­
tified. Arising on a stalk and largely 
filling this smaller cyst was a tra­
becular carcinoid composed of intri­
cately anastomosing trabeculae or 
cords of columnar cells (Fig. 4). 
Some of these cells had eosinophilic 
subnuclear vacuoles.
The Grimelius stain was strongly 
positive in many cells (Fig. 5). Im- 
munoenzyme staining by the perox­
idase-antiperoxidase technique was 
strongly positive in some cells for 
chromogranin and diffusely but 
weakly positive for neuron-specific 
enolase. The carcinoid was entirely 
confined to the smaller, secondary 
cyst.
Discussion
When dermoid cysts of the ovary 
were recognized over 300 years ago 
they were thought to represent a 
baby, and a major concern at the 
time was whether or not the “baby” 
should be baptized.1 We now know
that dermoid cysts do not represent 
the products of conception but re­
sult from the parthenogenic devel­
opment of a single germ cell.7
The primary management of pa­
tients with a high-grade malignant 
tumour arising from a dermoid cyst 
remains surgical excision, although 
the extent has varied from cystecto­
my to total abdominal hysterectomy 
and bilateral salpingo-oophorecto- 
my. However, if the malignant na­
ture of the tumour is recognized at 
laparotomy, the surgical procedure 
of choice is complete removal of the 
pelvic genital organs. Such exten­
sive surgery may lead to improved 
survival.8
The role of chemotherapy or ra­
diotherapy postoperatively is un­
clear. Radiotherapy alone appears 
not to be efficacious.9 The role of 
adjuvant chemotherapy is difficult 
to assess, since there are only anec­
dotal reports of a variety of largely 
ineffective combinations.8 Since 
high-grade malignant tumours aris­
ing from ovarian dermoid cysts are 
so uncommon, it is unlikely that 
meaningful conclusions regarding 
treatment will be reached without 
extrapolation from results of treat­
ment for malignant mixed mullerian
tumours, which contain similar 
high-grade malignant elements.1041
The survival of patients with 
high-grade malignant tumours aris­
ing in a dermoid cyst is extremely 
poor; the majority die within 12 
months of diagnosis.8 There have 
been no long-term survivors when 
the malignant element has been a 
sarcoma.1 In view of the advanced 
age of many of these patients and 
their concomitant medical prob­
lems, clinical judgement should be 
exercised before prescribing treat­
ments that have unproven or limit­
ed value and will increase morbidi­
ty-
By contrast, trabecular carcinoids 
developing in ovarian dermoid cysts 
are regarded as tumours of low 
malignant potential.12 In only one 
case has recurrence been reported; 
it resulted in death 5V& years after 
diagnosis.13 If a patient wishes to 
preserve her fertility and if the 
trabecular carcinoid component is 
recognized at surgery, a unilateral 
salpingo-oophorectomy is the pro­
cedure of choice. However, if the 
patient is postmenopausal and if the 
trabecular carcinoid component is 
recognized at surgery, the proce­
dure of choice is total hysterectomy
FIG. 5. Case 2. (Left) Diffuse intracytoplasmic staining and concentrated (black) subnuclear staining in some cells (Grimelius 
stain, original magnification X 400). (Right) Black reaction for chromogranin concentrated in subnuclear location 
(immunoperoxidase stain, original magnification X 400).
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and bilateral salpingo-oophorecto- 
my.
As our first case emphasizes, 
intraoperative frozen-section exami­
nation should be considered for 
ovarian dermoids in selected pa­
tients. In addition to the younger 
woman whose dermoid is suspected 
to be part of a mixed malignant 
germ-cell tumour, those with der­
moids that become manifest in the 
peri- or postmenopausal years, 
those that are symptomatic at the 
time of presentation and those with 
cysts that feel solid are more likely 
to harbour an occult, malignantly 
transformed element.
The discovery of this unsuspect­
ed malignant tumour should modify 
the extent of surgery, depending on 
the histologic type of malignant 
transformation. It may also obviate 
the need for a second, more exten­
sive surgical procedure shortly 
thereafter.
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Abstract Submissions for the 
1991 Royal College Annual Meeting
September 20-23, 1991, Quebec, Quebec
In December 1990, the Annual Meeting Committee 
will invite all Fellows of the College and members of 
the Canadian Society for Clinical Investigation to 
submit abstracts of scientific papers for consideration 
by the specialty review panels for the 1991 scientific 
program.
The abstract submission forms will be distributed 
to Fellows as an insert to the December 1990 Annals, 
RCPSC and to members of CSCI in the December 
issue of Clinical and Investigative Medicine. Watch for 
your copy.
Members of participating societies who are neither 
Fellows of the College nor members of CSCI will 
receive abstract forms from their specialty society.
Please note that the deadline for receipt of the 
abstracts with the processing fees will be Feb. 27, 
1991.
Presentation des resumes pour 
I’assemblee annuelle de 1991 du College royal
20-23 septembre 1991, Quebec, Quebec
En decembre 1990, le Comite de I’assemblee 
annuelle invitera les Associes du College et les 
membres de la Societe canadienne de recherches 
cliniques a soumettre des resumes d’articles scienti- 
fiques dans le cadre du programme scientifique de 
1991 pour etre evalues par les comites de revision 
des specialties.
Les formules pour presentation de resumes seront 
distributes aux Associes en encart aux Annates du 
CRMCC de decembre 1990 et aux membres de la 
SCRC en encart au numero de decembre de Mede- 
cine clinique et experimental. Assurez-vous d’avoir 
votre exemplaire.
Les membres des societes participantes qui ne 
sont ni Associes du College ni membre de la SCRC 
recevront les formules pour resumes de leur associa­
tion ou societe de specialistes.
La date limite pour faire parvenir les resumes et les 
frais pour manutention a ete fixee au 27 fevrier 1991.
CIS. VOL. 33, NO. 6, DECEMBER 1990 503
Drs. C.B. Mueller and N. Watters Receive Honorary 
Fellowship in the Canadian Association of General Surgeons
On Friday, Sept. 14, 1990 at the 
14th annual business meeting of 
the Canadian Association of Gen­
eral Surgeons Drs. C. Barber 
Mueller and Neil A. Watters re­
ceived honorary fellowships in 
the association. This award is 
presented annually to Canadian 
general surgeons who have con­
tributed to the advancement of 
surgical education, administra­
tion and research.
In introducing Dr. Mueller to 
the association’s members, Dr. 
Homer Beattie, past chairman of 
the Department of Surgery at 
McMaster University, highlighted 
Dr. Mueller’s career: Dr. Mueller 
graduated from Washington Uni­
versity in St. Louis, Mo. During 
World War II he served in the 
US Navy Marine Corps. After the 
war he was involved in the inves­
tigation of renal function at Har­
vard University. Subsequently he 
was accepted at Barnes Hospital, 
St. Louis, for general surgical 
training and was accepted into 
the teaching faculty. From 1956 
to 1967 he served as chairman 
of the Department of Surgery, 
Upstate Medical Center of the 
State University of New York, at 
Syracuse, NY. He then was ap­
pointed as professor and chair­
man of the Department of Sur­
gery at McMaster University in 
Hamilton, Ont.
Dr. Mueller’s career has been 
highlighted by national and in­
ternational awards, which are
credits to his service to the sur­
gical community at large. He has 
been recognized as an outstand­
ing educator and throughout his 
career has been at the leading 
edge of the development of new 
teaching methods. It is to his 
credit that surgical investigation 
and enquiry into biostatistics and 
epidemiology have been recog­
nized as mandatory for surgical 
postgraduate training.
In 1984, the American Col­
lege of Surgeons recognized Dr. 
Mueller through their highest 
honour — the Distinguished Ser­
vice Award.
The fellowship award was pre­
sented by Dr. Jean Couture, 
president of the Canadian Asso­
ciation of General Surgeons. In 
accepting the award, Dr. Mueller 
acknowledged his appreciation of 
the recognition given to him by 
the association and the enrich­
ment of his life through associa­
tion with Canadian surgical col­
leagues and friends.
Dr. Neil A. Watters was intro­
duced by Dr. John Provan, asso­
ciate dean of postgraduate edu­
cation at the University of To­
ronto. Dr. Watters trained in 
general surgery at the University 
of Toronto and served during 
World War II in the Royal Cana­
dian Army Medical Corps. After 
the war he completed his post­
graduate training in the Gallie 
Course at the University of To­
ronto. He practised general sur­
gery in Guelph, Ont. Subse­
quently he returned to academic 
surgery in Toronto and in 1967 
was appointed surgeon in chief 
at the Wellesley Hospital in To­
ronto. Dr. Watters has had an 
impressive career as a surgeon, 
surgical educator and adminis­
trator. He was instrumental, as 
director of undergraduate educa­
tion for the Department of Sur­
gery at the University of Toron­
to, setting up the clinical clerk­
ship at that school. He was also 
chairman of the Interhospital Co­
ordinating Committee in General 
Surgery. He served as chairman 
of the Examining Board in Gen­
eral Surgery for the Royal Col­
lege of Physicians and Surgeons 
of Canada and was chairman of 
the Royal College Specialty Com­
mittee in General Surgery. He 
has also served as a governor of 
the American College of Sur­
geons. Dr. Watters was one of 
the founding members of the 
Canadian Association of General 
Surgeons and served as president 
of the association. His most re­
cent, continuing contribution to 
the association has been as presi­
dent of the Canadian Surgical 
Research Fund.
In receiving his award, Dr. 
Watters thanked his friends 
and associates in the association 
and acknowledged his heartfelt 
appreciation for the honour be­
stowed on him by the award 
of honorary fellowship.
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BOOKS RECEIVED
continued from page 491
Complication Rates in Medical Prac­
tice. Edited by Wolfgang Mattig. 671 
pp. Denis J. Paradis Editions Inc., Mon­
treal. 1989. Price not stated. ISBN 0- 
920211-02-X
Follies & Fallacies in Medicine. Petr 
Skrabanek and James McCormick. 146 
pp. Prometheus Books, Buffalo, NY. 
1990. $19.95 (US). ISBN 0-87975- 
630-6
In the Country of Hearts: Journeys in 
the Art of Medicine. John Stone. 211 
pp. Delacorte Press, New York. 1990. 
$17.95. ISBN 0-385-30169-3
The Lactation Consultant’s Topical 
Review and Bibliography of the Litera­
ture on Breastfeeding. Edited by Mary- 
Margaret Coates. 188 pp. La Leche 
League International, Franklin Park, 111. 
1990. $25.95 (US). ISBN 0-912500- 
39-5
Laparoscopy for Surgeons. Barry A. 
Salky. 157 pp. Must. Igaku-Shoin Med­
ical Publishers, Inc., New York; W.B. 
Saunders Company, London/Harcourt 
Brace Jovanovich, Inc., Philadelphia; 
HBJ-Holt-Saunders Distribution Ser­
vices, Toronto. 1990. Price not stated. 
ISBN 0-89640-166-9
Lasers in Otolaryngology: Head and 
Neck Surgery. Edited by R. Kim Davis. 
208 pp. Must. W.B. Saunders Compa­
ny, London; HBJ-Holt-Saunders Distri­
bution Services, Toronto. 1990. Price 
not stated. ISBN 0-7216-3124-X
Malignant Cerebral Glioma. American 
Association of Neurological Surgeons 
Publications Committee, Michael L.J. 
Apuzzo. Neurosurgical Topics series. 
231 pp. Must. American Association of 
Neurological Surgeons, PO Box 
94078, Chicago, 111. 1990. AANS mem­
bers, $70, nonmembers, $80, residents, 
$60. (Add $10 outside US). ISBN 0- 
9624246-3-3
Metabolic Bone Disease and Clinically 
Related Disorders. 2nd ed. Edited by 
Louis V. Avioli and Stephen M. Krane. 
912 pp. Must. W.B. Saunders Com- 
pany/Harcourt Brace Jovanovich, Inc., 
Philadelphia. 1990. Price not stated. 
ISBN 0-7216-2766-8
Mirror of Medicine: a History of the 
British Medical Journal. Peter W.J. 
Bartrip. 338 pp. Clarendon Press, Ox- 
ford/Oxford University Press, New 
York/British Medical Journal, London. 
1990. $69 (US). ISBN 0-19-261844-X
Neuroscience Critical Care: Patho­
physiology and Patient Management.
Sharon Bowers Marshall, Lawrence F. 
Marshall, Helen R. Vos et al. 459 pp. 
Must. W.B. Saunders Company, Lon­
don/Harcourt Brace Jovanovich, Inc., 
Philadelphia; HBJ-Holt-Saunders Dis­
tribution Services, Toronto. 1990. Price 
not stated. ISBN 0-7216-2790-0
Pediatric Urology. Keith W. Ashcraft. 
540 pp. Must. W.B. Saunders Compa­
ny, London/Harcourt Brace Jovano­
vich, Inc., Philadelphia; HBJ-Holt- 
Saunders Distribution Services, Toron­
to. 1990. Price not stated. ISBN 0- 
7216-2746-3
Sports Injuries: Diagnosis and Man­
agement. James G. Garrick and David 
R. Webb. 347 pp. Must. W.B. Saunders 
Company, London/Harcourt Brace Jo­
vanovich, Inc., Philadelphia; HBJ- 
Holt-Saunders Distribution Services, 
Toronto. 1990. Price not stated. ISBN 
0-7216-2127-9
Savoir preparer une recherche: la defi- 
nir, la structurer, la financer. Andre- 
Pierre Contandriopoulos, Francois 
Champagne, Louise Potvin et al. 197 
pp. Must. Les presses de l’Universite de 
Montreal, Montreal. 1990. $19. ISBN 
2-7606-1535-9
CLASSIFIED ADVERTISING
As a further service to its readers the Canadian Journal o f Surgery is pleased to accept suitable classified advertisements. The deadline is 1 
month before issue date. Regular classified rates (for each insertion): $55.00 for the first 40 words or less, additional words 700 each (additional 
$21.00 for frame). Special Display under 100 words, 2>/s in X 2‘/s in, $125.00. $15.00 charge (first insertion only) for CJS box numbers. Display 
rates available on request. VISA, MASTERCARD AND AMERICAN EXPRESS ACCEPTED.
Copy should be mailed to the Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
Box replies should be addressed as follows: B o x -----, Canadian Journal o f Surgery, PO Box 8650, Ottawa, Ontario K1G 0G8.
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GENERAL SURGEON: BC -  In beautiful agri­
cultural valley at south end of Kootenay Lake, 
southeastern B.C. Referral population 15 000 
with broad-based economy and mild climate. 
Many recreational and cultural opportunities. 
This 44-acute-bed-hospital staffed by six 
GPs, three GP/anesthetists and one GP/OB- 
/Gyn. Involved in UBC Family Practice Resi­
dency program. Equipped with colonoscope, 
gastroscope, and tw o operating rooms. Po­
tential gross at least $250 OOO. Contact: Dr. 
John Kennedy, Chief of Staff, Creston Val­
ley Hospital. Bag 3000, Creston, BC VOB 
1 GO. Tel: (604) 428-9371; or (604)
428-3562, evenings. -S90-40
GENERAL SURGERY LOCUM WANTED:
BC -  Appropriately qualified general surgeon
required for 6 months to 1 year to  fill in for 
surgeon going on sabbatical. Interest in 
teaching preferred. Expertise in trauma, 
breast disease, and G.l. endoscopy an asset. 
One-in-six-call at Lion's Gate Hospital in North 
Vancouver, B.C. Recreational paradise. Please 
call: Dr. Bob Fris, tel: (604) 980-5141.
-S90-38
GENERAL/GI SURGEON: US -  BC/BE gen­
eral surgeon with Gl training and interest in 
endoscopy/laparoscopy/lazer therapy to join 
busy general surgery practice. Practice seek­
ing to enhance current Gl services in midwest 
market of 90 OOO adjacent to metropolitan 
area and medical schools. Excellent benefits
and competitive salary leading to partnership 
opportunity. Send CV to: Box 066, CJS.
-S90-36
GENERAL/ONCOLOGICAL SURGEON: US
-  BC/BE with training/fellowship in oncology 
to join busy general surgery practice. |n addi­
tion to general surgery, will be responsible for 
the enhancement of current oncologic ser­
vices. Situation will provide opportunity for 
clinical research. Attractive, family-oriented 
midwestern community with service area of 
90 OOO close to metropolitan area. Competi­
tive compensation package with excellent 
benefits and growth opportunities. Early part­
nership available. Send CV to: Box 065, CJS.
-S90-37
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of Alberta
hospitals
j f j S University
of
%/ Alberta
A S S O C IA TE  D IR EC TO R  
Critical Care/Trauma Unit
The University of Alberta Hospitals is accepting applica­
tions for the position of Associate Director, Critical 
Care/Trauma Unit. This multidisciplinary adult ICU 
serves as a regional unit for Central and Northern 
Alberta, Northeastern British Columbia and the Northwest 
Territories.
The successful applicant must have fulfilled the fellowship 
qualifications of the Royal College of Physicians and 
Surgeons of Canada in one of Surgery, Medicine or 
Anaesthesia. Fellowship training or attending staff expe­
rience in Critical Care is required. Primary appointment 
will be to the base specialty with cross appointment to the 
Faculty Division of Critical Care.
The University of Alberta Hospitals is committed to pro­
viding exemplary patient care and education in an atmo­
sphere of compassion and scholarly inquiry while pre­
serving the dignity and rights of patients and their fami­
lies.
Please submit enquiries  to: Dr. S.M. Ham ilton, 
Director, Critical Care/Trauma Unit, 2D4.37 Mackenzie 
Centre, 8440-112 Street, Edmonton, Alberta T6G 2B7 
Telephone: (403) 492-6306 Fax: (403) 492-4923 - S 90-39
TEXAS A&M UNIVERSITY 
College of Medicine
TEMPLE CAMPUS
The Department o f Neurologic Surgery o f the Scott 
and White Institutions and Texas A&M University 
College o f Medicine is seeking applications for 
senior staff physician faculty in the Sections o f 
Pain/Stereotaxic Surgery or Neurosurgical Oncology. 
Residency or post residency experience and a 
defined interest in either subspecialty area together 
with a broad capability and interest in general 
neurosurgical disorders is desired. Basic and clinical 
research opportunities are available commensurate 
with previous experience. Medical student and 
resident teaching/daily responsibilities are required. 
The main campus is located in central Texas, north 
o f Austin in the approximate center o f the Dallas/ Ft. 
Worth, San Antonio, Houston triangle and benefits 
from easy access to other surrounding universities 
(Southwestern University, Georgetown; University o f 
Mary Ilardin-Baylor, Belton; Baylor University, 
Waco.)
For further information, please send curriculum 
vitae and references to:
Mitchell Smigicl, M.D.
Chairman, Neurologic Surgery 
Scott and White, Texas A&M University 
College of Medicine 
2401 South 31st Street 
Temple, TX 76508
—S90-06
! SCOTT&  W H ITE
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THE SURGEON’S CHOICE
STERILE SINGLE USE SURGICAL BLADES & SCALPELS
SURGICAL BLADES SCALPELS WITH BLADES - SINGLE USE
/
Superb sharpness, foil wrapped individually in quick- | E a ch  scalpel is packed in a polyester and aluminum foil to 
dispenser boxes. Made from the highest quality materials, Iprotect blade edges. Unique dispenser box of 20 scalpels, 
for assured uniformity. BEach scalpel in individually inspected.
Available in all sizes: I  Available in all sizes:
#'s 10, II, 12, 14, 15A, 15, 20, 21, 22, 23, 24 and 25. 1 10. 11. 12, 14, I5A, 15, 20, 21, 22, 23, 24 and 25.
Any size, 100 per box. |Any size, 20 per box.
V ER^SPEC IA ^^9^9^^3^I3EG U LA ^^^^5^^^^^^SU PE^^PEC IA L^$6j 9 9 ^ ox^ ^ ^ ^ J3 E G U I A R ^ ^ ^
STAINLESS STEEL HANDLES
Made from Rust-Free stainless steel. Arrow shaped design for assured grip. Simply The Finest. Guaranteed
VERY SPECIAL: $6.95
MICROBLADES AND MICROKNIVES
These Microblades have been developed in conjunction with leading surgeons and have achieved the aim of 
developing a well balanced instrument to ensure precision and consistency in microsurgeiy.
• Sterile and disposable.
• Microblade cutting edges are available in four standard angles.
• Blade after blade, cutting edges are precision-ground for sharpness 
and consistent cutting angles.
Microblades are color-coded to determine different blade angles.
• For greater cutting edge protection, microblades are individually 
encased in plastic and wrapped in a pre-sterilized peel-off pouch.
CODEHlMNO-lSO (Blue)
1*5 5.0mrr
(E wasa J I
)15°:
CODE NrMBS-150 (Blue>
30 3.5,
C00E NtMBS-300 (Black)
CODE NiMND-225 (White)
KEJSEI
4.0mm
r\ t
CODE
kbsb^ K  i ~Liim 
NiMBS-235 (White)
4 5  3.0mm
CODE
K B sc j) I 1________Uiun
NiMBS-450(Tan>
CODE tdMND-300 (Black)
-TI KBSEI
Microblades 
SPECIAL 10/Box: $ 3 9 . 5 0 / b x  REGULAR $59.95
CODE NiMNO-450 (Tan)
(1 KBSEI
Microknives
SPECIAL ONLY: $49.95 10/bx REGULAR $69.95/ 10/bx
MDICL INC.
175 TORYORK DRIVE, UNIT #6 
WESTON, ONTARIO 
M9L2Y7
MICROBLADE HANDLE ONLY SPECIAL: $ 19.95 each
All our products carry a one-year limited warranty
VISA Please call from anywhere in Canada
Toll Free - 1-800-387-7477
CALL 24 HRS A DAY 
TEL: (416) 747-1125
FAX: (416) 783-5795 
VISA & MASTERCARD
Ereamisol' + 5-FU.
The first adjuvant therapy proven to 
reduce recurrence by 41%.
LEVAMISOLE AND FLUOROURACIL FOR ADJUVANT THERAPY OF 
RESECTED COLON CARCINOMA
Abstract Twelve hundred ninety-six patients with resected 
colon cancer that either was locally invasive [Stage BJ or 
had regional nodal involvement [Stage C] were randomly 
assigned to observation or to treatment for one year with 
levamisole combined with fluorouracil. Patients with Stage 
C disease could also be randomly assigned to treatment 
with levamisole alone. The median follow-up time at this 
writing is 3 years [range, 2 to 5'/2).
Among the patients with Stage C disease, therapy with 
levamisole plus fluorouracil reduced the risk of cancer 
recurrence by 41 percent [P <  0.0001], The overall death 
rate was reduced by 33 percent [P ~  0.006], Treatment 
with levamisole alone had no detectable effect. The results 
in the patients with Stage B2 disease were equivocal and
too preliminary to allow firm conclusions. Toxic effects of 
levamisole alone were infrequent, usually consisting of 
mild nausea with occasional dermatitis or leukopenia, 
and those of levamisole plus fluorouracil were essentially 
the same as those of fluorouracil alone-i.e., nausea, 
vomiting, stomatitis, diarrhea, dermatitis, and leukopenia. 
These reactions were usually not severe and did not greatly 
impede patients' compliance with their regimen.
We conclude that adjuvant therapy with levamisole and 
fluorouracil should be standard treatment for Stage C 
colon carcinoma. Since most patients in our study were 
treated by community oncologists, this approach should 
be readily adaptable to conventional medical practice 
[N Engl J Med 1990; 322:352-8.]’
THERAPY SHOULD BE INITIATED WITHIN 5 WEEKS OF SURGERY.
NEW
'Ergamisol
■  LEVAMISOLE HC1IB
in combination with 5-fluorouracil
JANSSEN
P H A R M A C E U T IC A
M  ississauga. Ontario
Now a reason to refer patients 
after surgery 'TrademarkM EM BER
t
4
-4V
AA
A
s
.<■ ’
A
i.
